WO2020219265A1 - Anchor for transcatheter access into the coronary sinus - Google Patents

Anchor for transcatheter access into the coronary sinus Download PDF

Info

Publication number
WO2020219265A1
WO2020219265A1 PCT/US2020/027147 US2020027147W WO2020219265A1 WO 2020219265 A1 WO2020219265 A1 WO 2020219265A1 US 2020027147 W US2020027147 W US 2020027147W WO 2020219265 A1 WO2020219265 A1 WO 2020219265A1
Authority
WO
WIPO (PCT)
Prior art keywords
anchor
coronary sinus
ostium
tubular member
elongate tubular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2020/027147
Other languages
French (fr)
Inventor
Linda Thai
Michael G. VALDEZ
Tarannum Ishaq GUTIERREZ
Don Huy Tran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences Corp
Original Assignee
Edwards Lifesciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edwards Lifesciences Corp filed Critical Edwards Lifesciences Corp
Publication of WO2020219265A1 publication Critical patent/WO2020219265A1/en
Priority to US17/507,734 priority Critical patent/US12678191B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • A61B17/3421—Cannulas
    • A61B17/3423—Access ports, e.g. toroid shape introducers for instruments or hands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
    • A61M25/0133—Tip steering devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/06—Body-piercing guide needles or the like
    • A61M25/0662—Guide tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
    • A61B2017/00238—Type of minimally invasive operation
    • A61B2017/00243—Type of minimally invasive operation cardiac
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/00234—Surgical instruments, devices or methods for minimally invasive surgery
    • A61B2017/00292—Surgical instruments, devices or methods for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
    • A61B17/3421—Cannulas
    • A61B17/3423—Access ports, e.g. toroid shape introducers for instruments or hands
    • A61B2017/3425—Access ports, e.g. toroid shape introducers for instruments or hands for internal organs, e.g. heart ports
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/34—Trocars; Puncturing needles
    • A61B2017/348—Means for supporting the trocar against the body or retaining the trocar inside the body
    • A61B2017/3482—Means for supporting the trocar against the body or retaining the trocar inside the body inside
    • A61B2017/3484—Anchoring means, e.g. spreading-out umbrella-like structure
    • A61B2017/3486—Balloon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2451—Inserts in the coronary sinus for correcting the valve shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2466—Delivery devices therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/1061—Balloon catheters with special features or adapted for special applications having separate inflations tubes, e.g. coaxial tubes or tubes otherwise arranged apart from the catheter tube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/1086—Balloon catheters with special features or adapted for special applications having a special balloon surface topography, e.g. pores, protuberances, spikes or grooves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M25/1002—Balloon catheters characterised by balloon shape

Definitions

  • the present disclosure generally relates to the field of delivering medical implant devices and/or therapies.
  • Transcatheter delivery of implant devices and/or therapies to the heart can be performed to address various heart abnormalities. Delivery of implant devices and/or therapies to the heart can be performed for treatment of elevate pressure in the left atrium.
  • Described herein are methods and devices for providing stable transcatheter access into the coronary sinus from the right atrium via the coronary sinus ostium.
  • the present disclosure relates to a steerable sheath comprising an elongate tubular member which includes an inner lumen configured to receive a plurality of instruments, and a partially circumferential balloon anchor disposed partially circumferentially on a distal portion of the elongate tubular member.
  • the partially circumferential balloon anchor can include a proximal balloon portion and a distal balloon portion.
  • the distal balloon portion When the partially circumferential balloon anchor is in an inflated state, the distal balloon portion can have a tapered longitudinal profile tapering toward a distal end of the partially circumferential balloon anchor, and the partially circumferential balloon anchor can be configured to, while positioned to engage with a coronary sinus, permit blood flow through an ostium of the coronary sinus.
  • the partially circumferential balloon anchor in the inflated state, is configured to be positioned to engage with both the ostium and a portion of the coronary sinus adjacent to the ostium.
  • the tapered longitudinal profile comprises a convex curvature.
  • the partially circumferential balloon anchor is positioned around less than 50% of a circumference of the distal portion of the elongate tubular member.
  • the partially circumferential balloon anchor comprises a textured exterior surface configured to engage with the ostium and a portion of the coronary sinus adjacent to the ostium.
  • the textured exterior surface can comprise either or both of a plurality of bumps and a plurality of ridges.
  • the proximal balloon portion extends laterally from the distal portion of the elongate tubular member, a deformable panel being coupled to the proximal balloon portion.
  • the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location.
  • the therapy device can comprise a shunt device for deployment onto a left atrial wall.
  • a steerable sheath comprises an elongate tubular member which includes an inner lumen configured to receive a plurality of instruments, and a circumferential balloon anchor disposed circumferentially around a distal portion of the elongate tubular member.
  • a plurality of cords can be circumferentially distributed around the circumferential balloon anchor.
  • the plurality of cords can be configured to engage the circumferential balloon anchor to create corresponding circumferentially distributed indentations on the circumferential balloon anchor, and the circumferential balloon anchor can be configured to, while positioned to engage with a coronary sinus, permit blood flow through an ostium of the coronary sinus along a path defined at least in part by the circumferentially distributed indentations.
  • the circumferential balloon anchor in the inflated state, is configured to be positioned to engage with the ostium.
  • the circumferential balloon anchor comprises a proximal balloon portion and a distal balloon portion, and respective distal ends of the plurality of cords are coupled to corresponding locations on the distal balloon portion, the plurality of cords being movable relative to the elongate tubular member along a longitudinal axis of the elongate tubular member. Moving the plurality of cords proximally relative to the elongate tubular member can be configured to engage the circumferential balloon anchor in the inflated state with the plurality of cords to provide the corresponding circumferentially distributed indentations.
  • the plurality of cords comprises five cords.
  • the distal balloon portion comprises a tapered longitudinal profile tapering toward a distal end of the circumferential balloon anchor, the distal balloon portion being configured to engage with the ostium and a portion of the coronary sinus adjacent to the ostium.
  • the circumferential balloon anchor comprises a textured exterior surface configured to engage with the ostium and a portion of the coronary sinus adjacent to the ostium.
  • the textured exterior surface can comprise either or both of a plurality of bumps and a plurality of ridges.
  • the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location.
  • the therapy device can comprise a shunt device for deployment onto a left atrial wall.
  • a method of accessing a heart location can comprise providing a steerable sheath which includes an elongate tubular member, a circumferential balloon anchor circumferentially positioned around a distal portion of the elongate tubular member and a plurality of cords circumferentially distributed around the circumferential balloon anchor.
  • the distal portion of the elongate tubular member can be introduced through an inferior vena cava or a superior vena cava, and into a right atrium.
  • a distal end of the elongate tubular member can be inserted through an ostium of a coronary sinus into the coronary sinus from the right atrium, and the distal end can be positioned at a target location within the coronary sinus.
  • the circumferential balloon anchor can be inflated and an inflated circumferential balloon anchor can be engaged with the plurality of cords to create corresponding circumferentially distributed indentations on the inflated circumferential balloon anchor.
  • the inflated circumferential balloon anchor can be engaged with the coronary sinus while blood flow is permitted through the ostium past the inflated
  • circumferential balloon anchor along a path defined at least in part by the circumferentially distributed indentations.
  • engaging the coronary sinus comprises engaging the inflated circumferential balloon anchor with the ostium of the coronary sinus.
  • the plurality of cords can be moved proximally along a longitudinal axis of the elongate tubular member, respective distal ends of the plurality of cords being coupled to corresponding locations on a distal balloon portion, where moving the plurality of cords compresses the inflated circumferential balloon anchor to provide the corresponding circumferentially distributed indentations on the inflated circumferential balloon anchor.
  • a delivery catheter carrying a therapy device can be inserted into an inner lumen of the elongate tubular member.
  • a distal end of the delivery catheter can be advanced from the distal end of the elongate tubular member for positioning at the target location.
  • the delivery catheter can comprise a shunt delivery catheter carrying an atrial shunt device.
  • a steerable sheath can comprise an elongate tubular member which includes an inner lumen configured to receive a plurality of instruments, and a deformable helical rib anchor disposed around a distal portion of the elongate tubular member, the deformable helical rib anchor being configured to engage with a coronary sinus, and to permit blood flow through an ostium of the coronary sinus along a path defined at least in part by the deformable helical rib anchor while the deformable helical rib is positioned to engage with the coronary sinus.
  • the deformable helical rib anchor is configured to be positioned to engage with both the ostium of the coronary sinus and a portion of the coronary sinus adjacent to the ostium.
  • a height at which the deformable helical rib anchor extends from the distal portion of the elongate tubular member increases with increased distance from a distal end of the elongate tubular member. In some embodiments, a height at which the deformable helical rib anchor extends from the distal portion of the elongate tubular member is uniform along a dimension of the deformable helical rib anchor parallel with a longitudinal axis of the elongate tubular member.
  • the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location.
  • the therapy device can comprise a shunt device for deployment onto a left atrial wall.
  • a steerable sheath can comprise an elongate tubular member which includes an inner lumen configured to receive a plurality of instruments, and a first expandable coil anchor disposed around a distal portion of the elongate tubular member, the first expandable coil being configured to engage with a coronary sinus and to permit blood flow through an ostium of the coronary sinus while the first expandable coil anchor is in an expanded state and positioned to engage with the coronary sinus.
  • the first expandable coil is configured to be positioned to engage with the ostium of the coronary sinus.
  • the steerable sheath further comprises a second expandable coil anchor positioned distally adjacent to the first expandable coil anchor, the second expandable coil anchor comprising a diameter smaller than that of the first expandable coil anchor, the second expandable coil anchor being configured to engage with a portion of the coronary ostium adjacent to the ostium when in an expanded state.
  • the first expandable coil anchor and the second expandable coil anchor can be configured to permit blood flow through the ostium while the first expandable coil anchor and the second expandable coil anchor are positioned to engage with the ostium and the portion of the coronary sinus adjacent to the ostium.
  • the inner lumen can be configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location.
  • the therapy device can comprise a shunt device for deployment onto a left atrial wall.
  • a steerable sheath can comprise an elongate tubular member which includes an inner lumen configured to receive a plurality of instruments, and a partially circumferential ring anchor disposed partially circumferentially on a distal portion of the elongate tubular member, the partially circumferential ring anchor being configured to permit blood flow through an ostium of a coronary sinus while the partially circumferential ring anchor is positioned to engage with the coronary sinus.
  • the partially circumferential ring anchor is configured to be positioned to engage with the ostium.
  • the partially circumferential ring anchor comprises a proximal ring portion and a distal ring portion, the distal ring portion comprising a tapered longitudinal profile tapering toward a distal end of the ring, the partially circumferential ring anchor being configured to engage with the ostium and a portion of the coronary sinus adjacent to the ostium.
  • the partially circumferential ring is disposed around less than 50% of a circumference of the distal portion of the elongate tubular member.
  • the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location.
  • the therapy device can comprise a shunt device for deployment onto a left atrial wall.
  • a method of accessing a heart location can comprise providing a steerable sheath which includes an elongate tubular member and an anchor positioned on a distal portion of the elongate tubular member.
  • the distal portion of the elongate tubular member can be introduced through an inferior vena cava or a superior vena cava, and into a right atrium.
  • a distal end of the elongate tubular member can be inserted through an ostium of a coronary sinus into the coronary sinus from the right atrium, and the distal end can be positioned at a target location within the coronary sinus.
  • the anchor can be engaged with the coronary sinus while blood flow is permitted through the ostium past the anchor.
  • engaging the coronary sinus comprises engaging the ostium of the coronary sinus with the anchor.
  • a delivery catheter carrying a therapy device can be inserted into an inner lumen of the elongate tubular member, and a distal end of the delivery catheter can be advanced from the distal end of the elongate tubular member for positioning at the target location.
  • the delivery catheter carrying a therapy device can comprise a shunt delivery catheter carrying an atrial shunt device
  • Figure 1 is a cross-sectional view of a human heart.
  • Figure 2 is another cross-sectional view of the human heart.
  • Figures 3 A and 3B show examples of pathways for accessing the coronary sinus from the right atrium.
  • Figure 4 is a schematic diagram of an example of a delivery system comprising a steerable sheath and a delivery catheter received within an inner lumen of the steerable sheath.
  • Figure 5 is a schematic diagram of the steerable sheath of Figure 4 positioned from a first body chamber or lumen into a second body chamber or lumen.
  • Figure 6 is a schematic diagram of a side view of an example of a steerable sheath comprising a partially circumferential balloon anchor.
  • Figure 7 is a schematic diagram of a view of the distal portion of the steerable sheath of Figure 6.
  • Figure 8 shows the steerable sheath of Figure 6 positioned for accessing a target location within the coronary sinus.
  • Figure 9 is a schematic diagram of an example of a steerable sheath comprising a partially circumferential balloon anchor and a deformable panel coupled thereto.
  • Figures 10A and 10B are schematic diagrams of examples of steerable sheaths which comprise a partially circumferential balloon anchor, where the partially circumferential balloon anchor can comprise a textured surface thereon.
  • Figures 11A and 11B are schematic diagrams showing an example of a steerable sheath which comprises a circumferential balloon anchor and a plurality of cords circumferentially distributed around the circumferential balloon anchor.
  • Figures 12A and 12B are schematic diagrams showing the plurality of cords engaged with the circumferential balloon anchor of Figures 11A and 1 IB, so as to form corresponding indentations on the circumferential balloon anchor.
  • Figures 13 A and 13B are schematic diagrams showing examples of steerable sheaths comprising a helical rib anchor.
  • Figures 14A and 14B are schematic diagrams showing examples of steerable sheaths comprising one coil anchor and two coil anchors, respectively.
  • Figure 15 is a schematic diagram showing an example of a steerable sheath comprising a partially circumferential ring anchor.
  • Figure 16 is a flow diagram of an example of a procedure for deploying a steerable sheath into the coronary sinus.
  • Figure 17 is a flow diagram of an example of a procedure for deploying a steerable sheath comprising a circumferential balloon anchor into the coronary sinus.
  • the present disclosure relates to systems, devices, and methods for providing reliable positioning of delivery sheaths into the coronary sinus from the right atrium via the coronary sinus ostium.
  • the steerable sheaths can comprise an anchor configured to engage with the coronary sinus ostium, or both the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, for providing stable transcatheter access into the coronary sinus.
  • Certain standard anatomical terms of location are used herein to refer to the anatomy of animals, and namely humans, with respect to the preferred embodiments.
  • certain spatially relative terms such as“outer,”“inner,”“upper,”“lower,”“below,” “above,”“vertical,”“horizontal,”“top,”“bottom,” and similar terms, are used herein to describe a spatial relationship of one device/element or anatomical structure to another device/element or anatomical structure, it is understood that these terms are used herein for ease of description to describe the positional relationship between element(s)/structures(s), as illustrated in the drawings.
  • spatially relative terms are intended to encompass different orientations of the element(s)/structures(s), in use or operation, in addition to the orientations depicted in the drawings.
  • an element/structure described as“above” another element/stmcture may represent a position that is below or beside such other element/structure with respect to alternate orientations of the subject patient or element/structure, and vice-versa.
  • the heart 1 includes four chambers, namely the left atrium 2, the left ventricle 3, the right ventricle 4, and the right atrium 5.
  • a wall of muscle referred to as the septum 10, separates the left atrium 2 and right atrium 5, and the left ventricle 3 and right ventricle 4.
  • Blood flow through the heart 1 is at least partially controlled by four valves, the mitral valve 6, aortic valve 7, tricuspid valve 8, and pulmonary valve 9.
  • the mitral valve 6 separates the left atrium 2 and the left ventricle 3 and controls blood flow therebetween.
  • the aortic valve 7 separates and controls blood flow between the left ventricle 3 and the aorta 12.
  • the tricuspid valve 8 separates the right atrium 5 and the right ventricle 4 and controls blood flow therebetween.
  • the pulmonary valve 9 separates the right ventricle 4 and the pulmonary artery 11, controlling blood flow therebetween.
  • the heart valves can properly open and close in response to a pressure gradient present during various stages of the cardiac cycle (e.g., relaxation and contraction) to at least partially control the flow of blood to a respective region of the heart and/or to blood vessels.
  • a pressure gradient present during various stages of the cardiac cycle (e.g., relaxation and contraction) to at least partially control the flow of blood to a respective region of the heart and/or to blood vessels.
  • Deoxygenated blood arriving from the rest of the body generally flows into the right side of the heart for transport to the lungs, and oxygenated blood from the lungs generally flows into the left side of the heart for transport to the rest of the body.
  • deoxygenated blood arrive in the right atrium 5 from the inferior vena cava 15 and superior vena cava 16 to flow into the right ventricle 4, and oxygenated blood arrive in the left atrium 2 from the pulmonary veins to flow into the left ventricle 3.
  • deoxygenated blood from the right ventricle 4 can flow into the pulmonary artery 11 for transport to the lungs (e.g., via the left 14 and right 13 pulmonary arteries), and oxygenated blood can flow from the left ventricle 3 to the aorta 12 for transport to the rest of the body.
  • a number of conditions can contribute to a higher than normal pressure in the left atrium.
  • Dysfunction of the mitral valve can contribute to elevated left atrial pressure.
  • Conditions such as mitral valve regurgitation and/or stenosis may result in difficulty in pumping blood from the left atrium to the left ventricle, contributing to elevated pressure in the left atrium.
  • Valve stenosis can cause a valve to become narrowed or obstructed.
  • Mitral valve stenosis can restrict blood flow from the left atrium to the left ventricle.
  • Valve regurgitation occurs when a valve does not close properly. For example, regurgitation can occur due to improper coaptation of the valve leaflets. Mitral valve regurgitation can result in blood flow leakage back into the left atrium 2 from the left ventricle 3 when the left ventricle 3 contracts.
  • Restricted flow of blood from the left atrium 2 into the left ventricle 3, and blood flow leakage from the left ventricle 3 back into the left atrium 2 can both contribute to elevated atrial pressure.
  • Dysfunction in the left ventricle 3 can also contribute to elevated left atrial pressure. Elevated left atrial pressure may lead to left atrial enlargement, producing symptoms such as shortness of breath during exertion, fatigue, chest pain, fainting, abnormal heartbeat, and swelling of the legs and feet.
  • FIG. 2 is another view of the heart 1 and shows the coronary sinus 18 around the left atrium 2.
  • a conduit can be provided to allow blood flow from the left atrium 2 into a portion of the heart with lower pressure, such as the coronary sinus 18.
  • a conduit can be formed on the wall of the left atrium 2 adjacent to the coronary sinus 18 to allow blood flow from the left atrium 2 into the coronary sinus 18.
  • the coronary sinus 18 receives blood from coronary veins and empties into the right atrium 5. Blood diverted into the coronary sinus 18 from the left atrium 2 can then be delivered into the right atrium 5.
  • a shunt device can be positioned at a location on the left atrial wall, such as at a location on the left atrial wall which is accessible from the coronary sinus 18, to form a blood flow pathway from the left atrium 2 into the coronary sinus 18.
  • Access into the coronary sinus 18 can comprise navigating into the right atrium 5 and entering through the coronary sinus ostium 17.
  • Figures 3A and 3B show examples of pathways for accessing the coronary sinus 18 through the right atrium 5 to deliver a shunt or other implant device to a portion of the left atrial wall.
  • a steerable sheath 40 is shown as being inserted through the inferior vena cava 15 and into the right atrium 5.
  • the steerable sheath 40 can be introduced through the femoral vein, and then inserted through the inferior vena cava 15. The steerable sheath 40 can then be advanced from the right atrium 5 through the coronary sinus ostium 17 and into the coronary sinus 18.
  • the steerable sheath 40 is shown as being inserted through the superior vena cava 16 and into the right atrium 5.
  • the steerable sheath 40 can be introduced through the subclavian vein or jugular vein, and then inserted through the superior vena cava 16.
  • the steerable sheath 40 can be positioned from the right atrium 5 through the coronary sinus ostium 17 and into the coronary sinus 18.
  • the steerable sheath 40 can be bent when positioned from the inferior vena cava 15 or the superior vena cava 16 into the right atrium 5 and from the right atrium 5 through the coronary sinus ostium 17.
  • This curvature in the steerable sheath 40 can render stable positioning of the steerable sheath 40 difficult when moving instrumentation through an inner lumen of the steerable sheath 40 to position instrumentation within the coronary sinus 18.
  • Advancing and/or retracting instrumentation through the steerable sheath 40, and/or rigidity of the steerable sheath 40 may inadvertently move the steerable sheath 40 and dislodge the steerable sheath 40 from its desired position. Movement of instrumentation within the steerable sheath 40 can push a distal end of the steerable sheath 40 positioned within the coronary sinus 18 back toward the coronary sinus ostium 17.
  • the present disclosure relates to devices, systems and/or methods for providing stable transcatheter access into the coronary sinus from the right atrium via the coronary sinus ostium.
  • delivery sheaths including steerable sheaths, for positioning into the coronary sinus, the steerable sheaths comprising an anchor configured to engage with the coronary sinus ostium, or both the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium.
  • the anchor can be on a distal portion of an elongate tubular member of the steerable sheath, a distal end of the steerable sheath being configured to be positioned within the coronary sinus for accessing the left atrial wall.
  • the anchor can allow stable positioning of the distal end within the coronary sinus to facilitate reliable delivery of one or more medical implant devices and/or therapies to a target tissue site on the left atrial wall.
  • an elongate tubular member of a steerable sheath can be bent when positioned through the coronary sinus ostium from the right atrium.
  • the steerable sheath can be inserted into the right atrium through the inferior vena cava or superior vena cava.
  • the bend or curvature in the elongate tubular member can present difficulties in maintaining a stable and secure position within the coronary sinus. Insertion and/or retraction of instrumentation through the elongate tubular member, such as to deliver implant devices and/or therapies to the left atrial wall, can cause undesired movement of the distal portion of the elongate tubular member.
  • the distal portion may be pushed back towards the right atrium, dislodging the elongate tubular member from its desired location within the coronary sinus.
  • Engaging an anchor with the coronary sinus ostium, or with both the coronary sinus ostium and an adjacent portion of the coronary sinus can facilitate docking of the elongate tubular member against the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion. Force can be exerted upon the elongate tubular member to maintain the distal portion of the elongate tubular member at its desired position within the coronary sinus. Engaging the anchor with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion, can prevent over insertion of the elongate tubular member into the coronary sinus, while reducing or avoiding movement of the elongate tubular member back towards the right atrium.
  • the anchor can provide secure positioning of the elongate tubular member within the coronary sinus such that desired therapy device implants and/or therapeutic procedures can be delivered thereto.
  • Engaging the anchor with the coronary sinus ostium can provide improved stability and/or reduce or prevent damage to the coronary sinus, such as compared to steerable sheaths comprising anchors for engaging only with portions within the coronary sinus.
  • An anchor can be positioned on a distal portion of an elongate tubular member, spaced from or at a distal end of the elongate tubular member.
  • the anchor can comprise a shape configured to engage with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion.
  • a cross-sectional size of the coronary sinus decreases along a direction extending into the coronary sinus and away from the ostium.
  • at least a portion of the anchor can comprise a taper configured to engage with the coronary sinus ostium and an adjacent portion of the coronary sinus.
  • a distal portion of the anchor can have a longitudinal profile comprising a taper toward a distal end of the anchor, the longitudinal profile extending along a direction parallel or substantially parallel to a longitudinal axis of the elongate tubular member.
  • the tapered distal portion can comprise a curvature, including a convex curvature.
  • an anchor can comprise a textured exterior surface configured to provide desired engagement with the coronary sinus ostium and/or an adjacent portion of the coronary sinus.
  • the anchor can be configured to be in engagement with the coronary sinus ostium and an adjacent portion of the coronary sinus, while permitting blood flow through the ostium past the anchor. Permitting blood flow through the ostium can advantageously allow performance of delivery procedures while a heart is beating, providing a lower risk of complications, shorter hospital stay and/or quicker recovery for the patient.
  • the anchor can be configured so as not to occlude the ostium.
  • the anchor can comprise any one of a partially circumferential balloon anchor, a circumferential balloon anchor comprising longitudinal indentations formed thereon, a helical rib anchor, a coil anchor, a partially circumferential ring anchor, and a suction anchor.
  • a partially circumferential anchor can refer to any anchor configured to be positioned on, disposed around and/or extending from, any partial portion of the circumference of a distal portion of an elongate tubular member, and where the anchor does not circumscribe the distal portion.
  • a body chamber or lumen can refer to any one of a number of fluid channels, blood vessels, and/or organ chambers (e.g., heart chambers).
  • sheaths can refer or apply generally to any type of elongate tubular delivery device comprising an inner lumen configured to slidably receive instrumentation, such as for positioning within an atrium or coronary sinus.
  • Sheaths”,“delivery sheaths” and/or“steerable sheaths” can include, for example, delivery catheters and/or cannulas. It will be understood that other types of medical implant devices and/or procedures can be delivered to the coronary sinus using a steerable sheath as described herein, including for example ablation procedures, drug delivery and/or placement of coronary sinus leads.
  • FIG 4 is a schematic diagram of a delivery system 50 which comprises a steerable sheath 100 that includes an anchor 140.
  • the steerable sheath 100 can comprise an elongate tubular member 110 having a proximal portion 112 and a distal portion 114.
  • the anchor 140 can be on the distal portion 114 of the elongate tubular member 110.
  • the anchor 140 can comprise any one of a partially circumferential balloon anchor, a circumferential balloon anchor having longitudinal indentations formed thereon, a helical rib anchor, a coil anchor, a partially circumferential ring anchor, and a suction anchor, as described herein.
  • the steerable sheath 100 can be configured to facilitate positioning of instrumentation at a target site within various body chambers or lumens. In some embodiments, the steerable sheath 100 can be configured to facilitate positioning of instrumentation at a target site within the coronary sinus, including a target tissue site on the left atrial wall accessible from within the coronary sinus.
  • a delivery catheter 60 can be slidably received within an inner lumen of the elongate tubular member 110.
  • a distal end 116 of the elongate tubular member 110 can be placed at or proximate to a target tissue site, including a target site in the coronary sinus.
  • a distal end 62 of the delivery catheter 60 can be extended from the distal end 116 of the elongate tubular member 110 to position the distal end 62 of the delivery catheter 60 at or proximate to the target tissue site, such as to deploy one or more therapy devices to the target tissue site.
  • the delivery catheter 60 can be configured to carry one or more therapy devices for treatment of elevated left atrial pressure, such as an atrial shunt device.
  • the distal end 62 of the delivery catheter 60 can be positioned at or adjacent to a target site on the left atrial wall so as to facilitate deployment of an atrial shunt device onto the left atrial wall. It will be understood that other instrumentation can be received within the inner lumen, in addition to or instead of the delivery catheter 60.
  • the steerable sheath 100 can be used to access the left atrial wall from within the coronary sinus by entering the coronary sinus from the right atrium through the coronary sinus ostium. As described herein, access into the right atrium can be made through the inferior vena cava or the superior vena cava.
  • the distal portion 114 of the elongate tubular member 110 can be configured to be advanced into the right atrium from the inferior vena cava or the superior vena cava. The distal portion 114 can then be inserted through the coronary sinus ostium from the right atrium, and into the coronary sinus.
  • the anchor 140 on the distal portion 114 can be configured to engage with the coronary sinus ostium.
  • the anchor 140 can be configured to engage with the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium.
  • the anchor 140 can comprise a shape and/or size to provide desired engagement with the coronary sinus ostium, or the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, while permitting flow of blood through the ostium past the anchor 140.
  • the anchor 140 can be at or a distance away from the distal end 116 of the elongate tubular member 110.
  • the anchor 140 such as a distal end of the anchor 140, can be at a distance of less than about 5 centimeters (cm) from the distal end 116 of the elongate tubular member 110, or less than about 4 cm, about 3 cm, about 2 cm, or about 1 cm.
  • the anchor 140 can be about 1 cm, about 2 cm, about 3 cm, or about 4 cm, from the distal end 116.
  • the anchor 140 can be at the distal end 116.
  • the anchor 140 can comprise one or more radiopaque markers 140a to facilitate visualization of the positioning of the anchor 140, the distal portion 114 and/or the distal end 116 of the elongate tubular member 110.
  • the radiopaque markers 140a can facilitate desired positioning of the anchor 140 at the coronary sinus ostium.
  • the one or more radiopaque markers 140a can provide visualization of a shape, orientation, and/or location of the anchor 140 to facilitate correct positioning of the anchor 140 at the coronary sinus ostium, including visualization of a desired deformation of the anchor 140.
  • visualization of the deformation of a partially circumferential balloon anchor, a circumferential balloon anchor, and/or a helical rib anchor can be used to determine whether desired contact is made with the coronary sinus ostium and/or an adjacent portion of the coronary sinus.
  • the anchor 140 can be configured to engage with the coronary sinus ostium, or the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, to reduce or prevent undesired movement of the elongate tubular member 110.
  • the anchor 140 can be configured to prevent dislodging of the elongate tubular member 110 from its desired position within the coronary sinus, such as when
  • elongate tubular member 110 is inserted and/or retracted through the inner lumen of the elongate tubular member 110. Reliable positioning of the elongate tubular member 110 within the coronary sinus can facilitate delivery of therapy device implants and/or application of therapeutic treatments to target sites accessible from within the coronary sinus, including target sites on the left atrial wall.
  • the anchor 140 can be configured to be in engagement with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion of the coronary sinus, while permitting blood flow through the ostium past the anchor 140.
  • the anchor 140 can be configured so as not to occlude the ostium. Permitting blood flow through the ostium can have various advantages, including performance of procedures while a heart is beating.
  • Beating heart surgeries can provide a lower risk of complications, shorter hospital stay and/or quicker recovery for the patient.
  • the anchor 140 can be an integral part of the elongate tubular member 110. In some embodiments, the anchor 140 can be separable from the elongate tubular member 110. For example, the anchor 140 can be a separate component associated with the elongate tubular member 110 where the anchor 140 is configured to be coupled to the distal portion 114 of the elongate tubular member 110. The anchor 140 can be selected for coupling to the elongate tubular member 110. For example, a desired anchor can be selected for positioning onto the elongate tubular member 110 based on a number of factors, including a size and/or shape of the coronary sinus ostium and/or a distance from the ostium of the target site within the coronary sinus.
  • Figure 5 is a schematic diagram showing the steerable sheath 100 positioned from a first body chamber or lumen 20 into a second body chamber or lumen 30.
  • the first body chamber or lumen 20 and the second body chamber or lumen 30 can be any one of a number of fluid channels, blood vessels, and/or organ chambers.
  • the first body chamber or lumen 20 can be the right atrium and the second body chamber or lumen 30 can be the coronary sinus.
  • the distal portion 114 of the elongate tubular member 110 can have a bend while positioned from the first body chamber or lumen 20 into the second body chamber or lumen 30.
  • the anchor 140 can be positioned at the opening of the second body chamber or lumen 30.
  • the distal end 116 of the elongate tubular member 110 can extend into the second body chamber or lumen 30 while the anchor 140 is positioned at the opening of the second body chamber or lumen 30.
  • the anchor 140 can comprise one or more radiopaque markers 140a to facilitate visualization of the positioning of the anchor 140, the distal portion 114 and/or the distal end 116 of the elongate tubular member 110.
  • one or more portions of the anchor 140 can be configured to engage with the opening of the second body chamber or lumen 30. In some embodiments, one or more portions of the anchor 140 can be configured to engage with both the opening of the second body chamber or lumen 30 and a portion of the second body chamber or lumen 30 adjacent to the opening.
  • the anchor 140 can have a proximal portion 142 and a distal portion 144, where the distal portion 144 of the anchor 140 can be configured to engage with the opening of the second body chamber or lumen 30. In some embodiments, the distal portion 144 of the anchor 140 can be configured to engage with both the opening of the second body chamber or lumen 30 and an adjacent portion of the second body chamber or lumen 30. It will be understood that although Figure 5 shows the anchor 140 as being positioned outside of the second body chamber or lumen 30, the anchor 140 can be positioned at least partially within the second body chamber or lumen 30.
  • Engaging the anchor 140 with the opening of the second body chamber or lumen 30, or with both the opening of the second body chamber or lumen 30 and an adjacent portion of the second body chamber or lumen 30, can facilitate docking of the elongate tubular member 110 against the opening of the second body chamber or lumen 30, or both the opening of the second body chamber or lumen 30 and an adjacent portion of the second body chamber or lumen 30.
  • over insertion of the elongate tubular member 110 into the second body chamber or lumen 30, and/or undesired movement of the elongate tubular member 110 can be prevented or reduced.
  • FIG. 6 is a side view of an example of a steerable sheath 200 comprising a partially circumferential balloon anchor 240.
  • the steerable sheath 200 can comprise an elongate tubular member 210 and the partially circumferential balloon anchor 240 can be positioned around only a portion of a circumference of a distal portion 214 of the tubular member 210.
  • a partially circumferential balloon anchor can refer to any balloon anchor configured to be positioned on, disposed around and/or extending from, any partial portion of the circumference of the distal portion 214, and where the balloon anchor does not circumscribe the distal portion 214.
  • the partially circumferential balloon anchor 240 can be inflatable.
  • the steerable sheath 200 can comprise an inflation and deflation lumen 260 extending along at least a portion of the elongate tubular member 210, the inflation and deflation lumen 260 being configured to allow inflation or deflation of the partially circumferential balloon anchor 240.
  • the partially circumferential balloon anchor 240 when in an inflated state, can be configured to contact and engage with the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, so as to facilitate reliable positioning of the elongate tubular member 210 within the coronary sinus.
  • the partially circumferential balloon anchor 240 can comprise a proximal end 246 and a distal end 248.
  • the partially circumferential balloon anchor 240 can be positioned on the distal portion 214 of the elongate tubular member 210 such that both the proximal end 246 and the distal end 248 are on the distal portion 214.
  • the partially circumferential balloon anchor 240 can be positioned a distance away from a distal end 216 of the elongate tubular member 210.
  • the distal end 248 of the circumferential balloon anchor 240 can be spaced from the distal end 216 of the elongate tubular member 210 such that the circumferential balloon anchor 240 can be positioned at the coronary sinus ostium, while the distal end 216 of the elongate tubular member 210 can be positioned further within the coronary sinus, such as at or proximate to a target tissue location.
  • the distal end 248 of the partially circumferential balloon anchor 240 can be at the distal end 216 of the elongate tubular member 210.
  • the partially circumferential balloon anchor 240 can be inflatable.
  • the partially circumferential balloon anchor 240 can comprise a shape configured to engage the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium. As described herein, a cross-sectional size of the coronary sinus decreases along a direction extending into the coronary sinus and away from the ostium. A distal portion 244 of the partially circumferential balloon anchor 240 can be configured to engage with the coronary sinus ostium and an adjacent portion of the coronary sinus.
  • the distal portion 244 can have a longitudinal profile comprising a taper toward the distal end 248 of the partially circumferential balloon anchor 240, the longitudinal profile extending along a direction parallel or substantially parallel to a longitudinal axis of the elongate tubular member 210.
  • the taper of the longitudinal profile can be configured to facilitate desired engagement of the distal portion 244 with the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium.
  • the tapered distal portion 244 can comprise a curvature, such as a convex curvature.
  • the longitudinal profile of the distal portion 244 can comprise a curved taper, such as a curved convex taper, which tapers towards the distal end 248 of the partially circumferential balloon anchor 240.
  • the longitudinal profile of the distal portion 244 can be selected to provide secure engagement of the partially circumferential balloon anchor 240 with the coronary sinus ostium and an adjacent portion of the coronary sinus.
  • circumferential balloon anchor 240 can comprise a shape configured to facilitate movement of the partially circumferential balloon anchor 240 through anatomical pathways, including during retraction of the partially circumferential balloon anchor 240.
  • the proximal portion 242 of the partially circumferential balloon anchor 240 can have a longitudinal profile comprising a taper toward the proximal end 246 of the partially circumferential balloon anchor 240, the longitudinal profile extending along a direction parallel or substantially parallel to a longitudinal axis of the elongate tubular member 210.
  • the longitudinal profile of the proximal portion 242 can comprise a curved taper, such as a curved convex taper, which tapers towards the proximal end 246 of the partially
  • the partially circumferential balloon anchor 240 can have a maximum cross-sectional size at or around a mid-portion of the anchor 240, and a longitudinal profile of both the proximal portion 242 and distal portion 244 comprising a taper, including a curved convex taper, from or around the mid-portion of the anchor 240 toward the proximal end 246 and the distal tend 248, respectively.
  • the partially circumferential balloon anchor 240 can have a length of up to about 10 millimeters (mm), including about 1 mm to about 9 mm, about 2 mm to about 8 mm, or about 3 mm to about 7 mm.
  • the partially circumferential balloon anchor 240 has a length of about 10 mm. In some embodiments, a width of the partially circumferential balloon anchor 240 can be about 1 mm to about 10 mm. In some embodiments, the partially circumferential balloon anchor 240 can have a width which varies from about 1 mm to about 10 mm.
  • the distal portion 244 can taper from a width of about 10 mm to a width of about 1 mm at the distal end 248, including from about 9 mm down to about 1 mm, about 8 mm down to about 1 mm, about 9 mm down to about 2 mm, about 8 mm down to about 2 mm, about 7 mm down to about 3 mm, or about 6 mm down to about 4 mm.
  • the proximal portion 242 can have the same or similar taper in width.
  • the partially circumferential balloon anchor 240 can be kept in a deflated state during at least a part of its insertion to and/or retraction from the coronary sinus ostium.
  • the partially circumferential balloon anchor 240 can assume an inflated state after the distal portion 214 of the elongate tubular member 210 is positioned at a desired location. For example, after the distal end 216 of the elongate tubular member 210 is positioned at or adjacent to the target tissue site and the partially circumferential balloon anchor 240 is at the coronary sinus ostium, the partially
  • circumferential balloon anchor 240 can be inflated.
  • the partially circumferential balloon anchor 240 can be inflated until desired engagement with the coronary sinus ostium and an adjacent portion of the coronary sinus is achieved.
  • the partially circumferential balloon anchor 240 can be inflated before the distal portion 214 of the elongate tubular member 210 is positioned at the desired location.
  • the partially circumferential balloon anchor 240 can assume an inflated state after being positioned within the right atrium but before being positioned to engage the coronary sinus ostium and an adjacent portion of the coronary sinus.
  • the partially circumferential balloon anchor 240 can be expanded both before and after being positioned at a target location.
  • the partially circumferential balloon anchor 240 can assume a partially inflated state while in the right atrium, and further inflation can be performed after being positioned to engage the coronary sinus ostium.
  • a degree of inflation of the partially circumferential balloon anchor 240 can be adjusted during a procedure in response to a size of a coronary sinus ostium and an adjacent portion of the coronary sinus.
  • the partially circumferential balloon anchor 240 can be deflated for retraction.
  • Figure 7 is a view of the distal portion 214 of the elongate tubular member 210.
  • the distal end 248 and the distal portion 244 of the partially circumferential balloon anchor 240 is shown.
  • the partially circumferential balloon anchor 240 can be positioned around only a portion of the circumference of the distal portion 214.
  • the partially circumferential balloon anchor 240 can provide sufficient contact with the coronary sinus ostium and an adjacent portion of the coronary sinus while allowing desired area around the steerable sheath 200 at the coronary sinus ostium such that sufficient blood flow can pass therethrough.
  • the partially circumferential balloon anchor 240 can be positioned around less than about 50% of the circumference of the distal portion 214 of the elongate tubular member 210, or less than about 40%, less than about 30%, less than about 25%, or less than about 20%.
  • an inner lumen 270 of the elongate tubular member 210 extends to the distal end 216 of the elongate tubular member 210.
  • the inner lumen 270 can be configured to receive various instrumentation for delivering one or more therapy devices to a target tissue location.
  • Figure 8 shows the steerable sheath 200 in a position for accessing a target location within the coronary sinus 18.
  • the elongate tubular member 210 can be advanced through the inferior vena cava 15, positioned into the right atrium 5, and inserted through the coronary sinus ostium 17 into the coronary sinus 18.
  • the distal end (not shown) of the elongate tubular member 210 can be positioned within the coronary sinus 18.
  • the partially circumferential balloon anchor 240 can be positioned against the coronary sinus ostium 17 such that the distal portion 244 engages the coronary sinus ostium 17 and a portion of the coronary sinus 18 adjacent to the ostium 17.
  • the distal end of the partially circumferential balloon anchor 240 can be positioned within the coronary sinus 18.
  • FIG. 9 is a schematic diagram of an example of a steerable sheath 300 comprising a partially circumferential balloon anchor 340 and a deformable panel 380 coupled thereto.
  • the steerable sheath 300 can comprise an elongate tubular member 310.
  • a distal portion 314 of the elongate tubular member 310 can comprise the partially
  • the partially circumferential balloon anchor 340 can comprise one or more features of the partially circumferential balloon anchor 240 described with reference to Figures 6 through 8.
  • the partially circumferential balloon anchor 340 can be inflatable.
  • the partially circumferential balloon anchor 340 when in an inflated state, can be configured to contact and engage with the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, so as to facilitate reliable positioning of the elongate tubular member 310 within the coronary sinus.
  • the distal portion 344 of the partially circumferential balloon anchor 340 can comprise a tapered longitudinal profile, the tapered longitudinal profile tapering toward the distal end 348 of the partially circumferential balloon anchor 340.
  • the longitudinal profile can extend along a direction parallel or substantially parallel to a longitudinal axis of the elongate tubular member 310.
  • the tapered longitudinal profile can comprise a curve, including a convex curve.
  • the distal end 348 of the circumferential balloon anchor 340 can be spaced from or at the distal end 316 of the elongate tubular member 310.
  • the partially circumferential balloon anchor 340 can be positioned around less than about 50% of the circumference of the distal portion 314 of the elongate tubular member 310, or less than about 40%, or less than about 30%, or less than about 25%, or less than about 20%.
  • the proximal portion 342 of the partially circumferential balloon anchor 340 can extend laterally from the distal portion 314 of the elongate tubular member 310.
  • the deformable panel 380 can be coupled to the proximal portion 342.
  • the deformable panel 380 can extend laterally from the distal portion 314, including an example which extends perpendicularly or substantially perpendicularly from the distal portion 314.
  • the deformable panel 380 can comprise a proximal surface 382 and a distal surface 384.
  • the distal surface 384 can be coupled to the proximal portion 342 of the balloon anchor 340.
  • the deformable panel 380 can provide mechanical support, for example providing mechanical reinforcement, for the proximal portion 342.
  • the deformable panel 380 can be configured to reduce deformation of an inflated partially circumferential balloon anchor 340, such as when the partially circumferential balloon anchor 340 engages the coronary sinus ostium and an adjacent portion of the coronary sinus. Reduced deformation of the inflated balloon anchor 340 can provide increased reliability in positioning of the elongate tubular member 310 within the coronary sinus.
  • Figures 10A and 10B are schematic diagrams of examples of two steerable sheaths each of which includes a partially circumferential balloon anchor comprising a textured surface thereon.
  • Figure 10A shows an example of a steerable sheath 400 including a partially circumferential balloon anchor 440 which comprises a plurality of bumps 490 on an exterior surface.
  • Figure 10B shows an example of a steerable sheath 500 including partially circumferential balloon anchor 540 which comprises a plurality of ridges 590 on an exterior surface.
  • the plurality of bumps 490 and the plurality of ridges 590 can be on a portion or all of the exterior surface of the partially circumferential balloon anchors 440, 540. In some embodiments, the plurality of bumps 490 and the plurality of ridges 590 can be only on the distal portion 444 or the distal portion 544, respectively. The plurality of bumps 490 and the plurality of ridges 590 can facilitate desired engagement of the balloon anchor 440 or the balloon anchor 540, respectively, with the coronary sinus ostium and an adjacent portion of the coronary sinus.
  • a partially circumferential balloon anchor can comprise a textured exterior surface configured to engage with the coronary sinus ostium and an adjacent portion of the coronary sinus, the textured exterior surface comprising both a plurality of bumps and a plurality of ridges. It will also be understood that textured surfaces comprising one or more other patterns, in addition or in the alternative, can be applicable.
  • the partially circumferential balloon anchors 440, 540 can comprise one or more features of the partially circumferential balloon anchor 340 described with reference to Figure 9.
  • the partially circumferential balloon anchors 440, 540 can be inflatable.
  • the partially circumferential balloon anchors 440, 540 when in an inflated state, can be configured to contact and engage with the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, so as to facilitate reliable positioning of the elongate tubular members 410, 510 within the coronary sinus.
  • the partially circumferential balloon anchors 440, 540 can be positioned on distal portions 414, 514 of the elongate tubular members 410, 510.
  • the distal ends 448, 548 of the circumferential balloon anchors 440, 540 can be spaced from or at the distal ends 416, 516 of the elongate tubular members 410, 510.
  • the partially circumferential balloon anchors 440, 540 can comprise a shape to engage the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium.
  • the distal portions 444, 544 of the partially circumferential balloon anchors 440, 540 can comprise a tapered longitudinal profile, the tapered longitudinal profile tapering toward the distal ends 448, 548 of the partially circumferential balloon anchors 440, 540.
  • the longitudinal profile can extend along a direction parallel or substantially parallel to a longitudinal axis of the elongate tubular members 410, 510.
  • the tapered longitudinal profile can comprise a curve, including a convex curve.
  • circumferential balloon anchors 440, 540 can be coupled to deformable panels 480, 580.
  • the deformable panels 480, 580 can comprise respective proximal surfaces 482, 582 and distal surfaces 484, 584.
  • the distal surfaces 484, 584 can be coupled to the proximal portions 442, 542 of the partially circumferential balloon anchors 440, 540.
  • the partially circumferential balloon anchors 440, 540 can be positioned around less than about 50% of the circumference of the distal portions 414, 514 of the elongate tubular members 410, 510, or less than about 40%, or less than about 30%, or less than about 25%, or less than about 20%.
  • Figures 11A and 11B are schematic diagrams showing an example of a steerable sheath 600 comprising a circumferential balloon anchor 640 circumferentially disposed around an elongate tubular member 610 of the steerable sheath 600 and a plurality of cords 650 circumferentially distributed around the circumferential balloon anchor 640.
  • Figures 11A and 11B show an inflated circumferential balloon anchor 640.
  • Figure 11A is a side view of the steerable sheath 600 and
  • Figure 1 IB is a view of the steerable sheath 600 from a distal end 616 of the elongate tubular member 610.
  • Figures 12A and 12B are schematic diagrams showing the plurality of cords 650 engaged with the inflated
  • FIG. 12A is a view of the steerable sheath 600 from the distal end 616 of the elongate tubular member 610.
  • Figure 12B is a side view of the steerable sheath 600.
  • the elongate tubular member 610 can comprise an inner lumen 670 configured to receive instrumentation for delivering one or more therapy devices to a target location, such as a delivery catheter for carrying an atrial shunt device to a target location on the left atrial wall.
  • the inflated circumferential balloon anchor 640 can be configured to engage with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion of the coronary sinus, while blood flow is permitted through the ostium. Blood flow through the ostium may be along one or more paths defined at least in part by one or more of the plurality of indentations. As shown in the figures, the circumferential balloon anchor 640 can be a distance from the distal end 616 of the elongate tubular member 610. For example, a distal end 648 of the circumferential balloon anchor 640 can be a distance proximal of the distal end 616 of the elongate tubular member 610. In some embodiments, the circumferential balloon anchor 640 can be at the distal end 616 of the elongate tubular member 610.
  • the circumferential balloon anchor 640 can be circumferentially positioned around a distal portion 614 of the elongate tubular member 610.
  • Distal ends 652 of each of the plurality of cords 650 can be coupled to respective locations on the distal portion 644 of the circumferential balloon anchor 640.
  • distal ends 652 of each of the plurality of cords 650 can be coupled to respective locations on the distal portion 614 of the elongate tubular member 610.
  • Each of the plurality of cords 650 can comprise a portion which extends over at least a portion of the circumferential balloon anchor 640, extending along a longitudinal axis of the elongate tubular member 610.
  • respective distal ends 652 of the plurality of cords 650 can be coupled to corresponding locations on the distal portion 644 of the circumferential balloon anchor 640 and be distributed around the circumferential balloon anchor 640.
  • the circumferential balloon anchor 640 can have a longitudinal axis symmetry, for example being symmetrical around an axis parallel or substantially parallel to the longitudinal axis of the elongate tubular member 610.
  • the plurality of cords 650 can be evenly or substantially evenly distributed around the circumferential balloon anchor 640, for example dividing the circumferential balloon anchor 640 into even or substantially even portions.
  • Figure 11B shows five cords 650 positioned around the balloon circumferential anchor 640.
  • the five cords 650 can be evenly or substantially evenly distributed around the circumferential balloon anchor 640 to divide the
  • the plurality of cords 650 may not be evenly distributed around the plurality of cords 650
  • the plurality of cords 650 can engage an inflated circumferential balloon anchor 640 to form corresponding indentations on the inflated circumferential balloon anchor 640.
  • the plurality of indentations can divide the circumferential balloon anchor 640 into a plurality of portions.
  • the five cords 650 can divide the inflated circumferential balloon anchor 640 into five portions 640a, 640b, 640c, 640d, 640e.
  • the five cords 650 can be evenly or substantially evenly distributed around the balloon anchor 640 such that the five portions 640a, 640b, 640c, 640d, 640e are uniform or substantially uniform in size and/or shape.
  • the circumferential balloon anchor 640 can be inflated, and the plurality of cords 650 can be tensioned such that the plurality of cords 650 can compress the inflated circumferential balloon anchor 640 to form the corresponding plurality of indentations.
  • the circumferential balloon anchor 640 can be inflated before and/or after being positioned at the coronary sinus ostium. After the circumferential balloon anchor 640 is in the inflated state, the plurality of cords 650 can be moved proximally relative to the elongate tubular member 610, for example proximally along a longitudinal axis of the elongate tubular member 610, to tension the plurality of cords 650.
  • the plurality of cords 650 can be in a tensioned state prior to inflation of the circumferential balloon anchor 640 such that inflating the circumferential balloon anchor 640 results in formation of the corresponding plurality of indentations. Pre-tensioning the plurality of cords 650 can reduce needed manipulation of the steerable sheath 600 during a procedure, providing a simplified procedure.
  • the circumferential balloon anchor 640 can be configured to engage the ostium of the coronary sinus. In some embodiments, the
  • the circumferential balloon anchor 640 can be configured to engage the ostium and an adjacent portion of the coronary sinus.
  • the distal portion 644 of the circumferential balloon anchor 640 can have a longitudinal profile comprising a taper toward the distal end 648 of the circumferential balloon anchor 640, the longitudinal profile extending along a direction parallel or substantially parallel to the longitudinal axis of the elongate tubular member 610.
  • the taper of the longitudinal profile can be configured to facilitate desired engagement of the distal portion 644 with the coronary sinus ostium and/or the portion of the coronary sinus adjacent to the ostium.
  • the tapered distal portion 644 can comprise a curvature, such as a convex curvature.
  • a proximal portion 642 of the circumferential balloon anchor 640 can comprise a taper to facilitate movement of the circumferential balloon anchor 640, including retraction of the circumferential balloon anchor 640.
  • the longitudinal profile of the proximal portion 642 can comprise a curved taper, such as a curved convex taper, which tapers towards the proximal end 646 of the circumferential balloon anchor 640.
  • the circumferential balloon anchor 640 can have a maximum cross- sectional size at or around a mid-portion of the anchor 640, and a longitudinal profile of both the proximal portion 642 and distal portion 644 comprising a taper, including a curved convex taper, from or around the mid-portion of the anchor 640 toward the proximal end 646 and the distal tend 648, respectively.
  • a circumferential balloon anchor can comprise a textured exterior surface configured to engage with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion of the coronary sinus.
  • the textured exterior surface can comprise one or both of a plurality of bumps and a plurality of ridges. It will be understood that textured surfaces comprising one or more other patterns, in addition or in the alternative, can be applicable.
  • Figures 13A and 13B show examples of steerable sheaths comprising helical rib anchors.
  • Figure 13 A is a perspective view of an example of a steerable sheath 700 comprising a helical rib anchor 740 disposed around a distal portion 714 of an elongate tubular member 710.
  • Figure 13B is a perspective view of another example of a steerable sheath 800 comprising a helical rib anchor 840 disposed around a distal portion 814 of an elongate tubular member 810.
  • the helical rib anchors 740, 840 can be configured to engage with the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium.
  • the helical rib anchors 740, 840 can be deformable to facilitate insertion and/or retraction, and/or secure engagement with the coronary sinus ostium and an adjacent portion of the coronary sinus.
  • the helical rib anchors 740, 840 can be a distance from or at respective distal ends 716, 816 of the elongate tubular members 710, 810 (e.g., distal ends 744, 844 of the helical rib anchors 740, 840 can be a distance from or at respective distal ends 716, 816 of the elongate tubular members 710, 810).
  • the elongate tubular members 710, 810 can comprise respective inner lumens 770, 870 configured to receive instrumentation for delivering one or more therapy devices to a target location, such as a delivery catheter for carrying an atrial shunt device to a target location on the left atrial wall.
  • At least a portion of the helical anchors 740, 840 can be configured to be positioned within the coronary sinus.
  • one or both of the helical rib anchors 740, 840 can be configured to be entirely or substantially entirely positioned within the coronary sinus, both the distal ends 744, 844 and proximal ends 742, 842 being configured to be positioned within the coronary sinus.
  • the proximal ends 742, 842 can be configured to engage with the ostium.
  • one or both of the helical rib anchors 740, 840 can be configured to be only partially positioned within the coronary sinus.
  • the distal ends 744, 844 and not the proximal ends 742, 842 can be configured to be positioned within the coronary sinus.
  • an extent to which the helical rib anchors 740, 840 can be positioned into a coronary sinus can be based on individual anatomy.
  • the helical rib anchors 740, 840 can be configured to allow blood flow through the coronary sinus ostium while the helical rib anchors 740, 840 are in their respective target positions. Blood can flow along a path defined at least in part by the helical rib anchors 740, 840. For example, blood can flow along the helical ribs, such as shown by the arrows in Figures 13A and 13B.
  • helical rib anchors 740, 840 While the helical rib anchors 740, 840 are positioned at their respective target locations, blood can flow along a path defined at least in part by the helical ribs of the helical anchors 740, 840 through the coronary sinus ostium.
  • a height at which the helical rib anchor 740 extends from the elongate tubular member 710 can be uniform or substantially uniform along a dimension parallel or substantially parallel to a longitudinal axis of the elongate tubular member 710.
  • a first height, hi, a second height, h2, and a third height, h3, of the helical rib anchor 740 shown in Figure 13 A can be the same or substantially the same.
  • a height at which the helical rib anchor 840 extends from the elongate tubular member 810 can increase along a dimension parallel or substantially parallel to a longitudinal axis of the elongate tubular member 810, for example increasing with increased distance from the distal end 816 of the elongate tubular member 810.
  • a first height, hi, of the helical rib anchor 840 can be smaller than a second height, h2, which can be smaller than a third height, h3.
  • a decreasing height of the helical rib anchor 840 toward the distal end 816 of the elongate tubular member 810 can be configured to provide improved engagement with the coronary sinus ostium and an adjacent portion of the coronary sinus, such as by conforming to the anatomy of the coronary sinus.
  • Figures 14A and 14B show examples of steerable sheaths comprising one or more coil anchors.
  • Figure 14A is a perspective view of an example of a steerable sheath 900 comprising a coil anchor 940 disposed around a distal portion 914 of an elongate tubular member 910.
  • Figure 14B is a perspective view of an example of a steerable sheath 1000 comprising a first coil anchor 1040 and a second coil anchor 1050 disposed around a distal portion 1014 of an elongate tubular member 1010.
  • Each of the elongate tubular members 910, 1010 can comprise an inner lumen 970, 1070 configured to receive instrumentation for delivering one or more therapy devices to a target location.
  • the inner lumens 970, 1070 can be configured to receive a delivery catheter for carrying an atrial shunt device to a target location on the left atrial wall.
  • the coil anchor 940 of the steerable sheath 900 can be configured to engage with the coronary sinus ostium.
  • the coil anchor 940 can be positioned at the ostium while a distal end 916 of the elongate tubular member 910 can be at or proximate to a target tissue site on the left atrial wall accessible from within the coronary sinus.
  • the coil anchor 940 can be at a distance from the distal end 916 of the elongate tubular member 910 such that the distal end 916 can be positioned into the coronary sinus while at least a portion of the coil anchor 940 is in the ostium.
  • the coil anchor 940 can be positioned to engage the ostium such that a portion of the coil anchor 940 is in the right atrium and a portion of the coil anchor 940 is in the coronary sinus.
  • the coil anchor 940 can be configured to permit blood to flow through the ostium while the coil anchor 940 is in desired engagement with the ostium. For example, blood can flow between the coils of the coil anchor 940.
  • the first coil anchor 1040 of the steerable sheath 1000 can be positioned adjacent to and proximal of second coil anchor 1050 on the distal portion 1014 of the elongate tubular member 1010.
  • the second coil anchor 1050 can include coils comprising a diameter smaller than that of the first coil anchor 1040.
  • the first coil anchor 1040 can be configured to engage the coronary sinus ostium and the second coil anchor 1050 can be configured to engage a portion of the coronary sinus adjacent to the ostium.
  • first coil anchor 1040 and the second coil anchor 1050 can be at a distance from the distal end 1016 of the elongate tubular member 1010 such that the distal end 1016 can be positioned within the coronary sinus while the first coil anchor 1040 and the second coil anchor 1050 engage the coronary sinus ostium and an adjacent portion of the coronary sinus, respectively.
  • the second coil anchor 1050 can be at the distal end 1016 of the elongate tubular member 1010.
  • the coil anchors 1040, 1050 can be configured to permit blood to flow through the ostium while the coil anchors 1040, 1050 are in desired engagement with the coronary sinus ostium and an adjacent portion of the coronary sinus. For example, blood can flow through the ostium between coils of the coil anchors 1040, 1050.
  • one or more of the coil anchors 940, 1040, 1050 can be expandable.
  • One or more of the coil anchors 940, 1040, 1050 can be kept in a compact state during at least a part of the insertion of the elongate tubular members 910, 1010 to the target tissue site.
  • one or more of the coil anchors 940, 1040, 1050 can comprise shape memory material. The one or more coil anchors 940, 1040, 1050 can be maintained in the compact state until a predetermined location is reached.
  • the one or more coil anchors 940, 1040, 1050 can then be allowed to assume an expanded state, such as when the one or more coil anchors 940, 1040, 1050 comprising the shape memory material can assume their respective desired coil configurations.
  • a diameter of the coils of one or more of the coil anchors 940, 1040, 1050 can be adjusted based on patient anatomy. For example, a degree of expansion of the one or more coil anchors 940, 1040,
  • 1050 can be adjusted during an implantation procedure in response to a size of a coronary sinus ostium, and/or an adjacent portion of the coronary sinus.
  • the one or more of the coil anchors 940, 1040, 1050 can assume an expanded state after the coil anchors 940, 1040, 1050 are positioned at respective target locations. For example, after the distal ends 916, 1016 of the elongate tubular members 910, 1010 are positioned at or adjacent to the target tissue site, one or more of the coil anchors 940, 1040, 1050 can assume the expanded state. In some embodiments, the one or more of the coil anchors 940, 1040, 1050 can be expanded until desired
  • one or more of the coil anchors 940, 1040, 1050 can assume an expanded state before the coil anchors 940, 1040, 1050 are positioned at respective target locations.
  • the one or more of the coil anchors 940, 1040, 1050 can be expanded after the one or more of the coil anchors 940, 1040, 1050 are extended from the inferior vena cava or the superior vena cava into the right atrium but before the one or more of the coil anchors 940, 1040, 1050 are positioned at their respective desired locations.
  • the one or more of the coil anchors 940, 1040, 1050 can be expanded both before and after the coil anchors 940, 1040, 1050 are positioned at respective target locations.
  • the one or more of the coil anchors 940, 1040, 1050 can assume a partially expanded state before being positioned at the respective desired locations, such as while the one or more of the coil anchors 940, 1040, 1050 are in the right atrium.
  • the coil anchors 940, 1040, 1050 can then assume a fully expanded state after the one or more of the coil anchors 940, 1040, 1050 are positioned at their respective desired locations.
  • FIG 15 is a perspective view of an example of a steerable sheath 1100 comprising a partially circumferential ring anchor 1140 positioned on an elongate tubular member 1110 of the steerable sheath 1100.
  • the elongate tubular member 1110 can comprise an inner lumen 1170 configured to receive instrumentation for delivering one or more therapy devices to a target location, such as a delivery catheter for carrying an atrial shunt device to a target location on the left atrial wall.
  • the partially circumferential ring anchor 1140 can be positioned on a distal portion 1114 of the elongate tubular member 1110.
  • the partially circumferential ring anchor 1140 can be configured to be positioned to engage with the coronary sinus ostium.
  • the partially circumferential ring anchor 1140 can be a distance from or at the distal end 1116 of the elongate tubular member 1110 (e.g., a distal portion 1144 of the partially circumferential ring anchor 1140 can be a distance from or at the distal end 1116 of the elongate tubular member 1110).
  • the partially circumferential ring anchor 1140 can be positioned around only a portion of the circumference of the distal portion 1114.
  • a“partially circumferential ring anchor” can refer to any ring anchor configured to be positioned on, disposed around and/or extending from, any partial portion of the
  • the partially circumferential ring anchor 1140 can facilitate blood flow through the coronary sinus ostium and past the partially circumferential ring anchor 1140 while the partially circumferential ring anchor 1140 is positioned at and in engagement with the coronary sinus ostium, or the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium.
  • the partially circumferential ring anchor 1140 can provide desired contact with the coronary sinus ostium, or the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, to provide stable positioning of the elongate tubular member 1110, while allowing sufficient area around the steerable sheath 1100 at the coronary sinus ostium such that sufficient blood flow can pass therethrough.
  • the partially circumferential ring anchor 1140 can be positioned around less than about 50% of the circumference of the distal portion 1114 of the elongate tubular member 1110, or less than about 40%, less than about 30%, less than about 25%, or less than about 20%.
  • the partially circumferential ring anchor 1140 can have a proximal portion 1142, a distal portion 1144 and a lateral portion 1146 extending between the proximal portion 1142 and the distal portion 1144.
  • the distal portion 1144 and/or the lateral portion 1146 can be configured to engage with the coronary sinus ostium, or both the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium.
  • at least a portion of the lateral portion 1146 can be configured to engage the ostium, or the ostium and a portion of the coronary sinus adjacent to the ostium.
  • the partially circumferential ring anchor 1140 can be sized such that when at least a portion of the anchor 1140 is positioned within the coronary sinus ostium, the lateral portion 1146 can be configured to engage the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion, to provide stable positioning of the elongate tubular member 1110.
  • the distal portion 1144 can be configured to engage the ostium.
  • the partially circumferential ring anchor 1140 can be positioned against the ostium such that the distal portion 1144 is configured to engage the ostium.
  • the partially circumferential ring anchor 1140 can be positioned against the coronary sinus ostium such that the proximal portion 1142 and the lateral portion 1146 of the partially circumferential ring anchor 1140 are outside or substantially outside of the coronary sinus, and the distal portion 1144 can engage the coronary sinus ostium.
  • a partially circumferential ring anchor can comprise a planar or substantially planar distal portion and/or proximal portion.
  • the distal portion and/or the proximal portion can be non-planar.
  • a distal portion of a partially circumferential ring anchor can comprise a shape and/or dimension to engage the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion of the coronary sinus ostium.
  • the distal portion can have a longitudinal profile comprising a taper toward a distal end of the partially circumferential ring anchor. The longitudinal profile can extend along a direction parallel or substantially parallel to a longitudinal axis of the elongate tubular member.
  • the tapered longitudinal profile may comprise a curved taper, such as a convex taper, configured to engage the coronary sinus ostium and an adjacent portion of the coronary sinus.
  • the lateral portion can be configured to engage the coronary sinus ostium and the distal portion can be configured to engage a portion of the coronary sinus adjacent to the ostium.
  • a steerable sheath can comprise a suction anchor.
  • the steerable sheath can comprise an elongate tubular member, and the suction anchor can be positioned on a distal portion of the elongate tubular member.
  • the suction anchor can be configured to engage with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion, and permit blood to flow through the ostium, while the suction anchor is positioned at the ostium.
  • FIG 16 is a flow diagram of an example of a procedure 1600 for deploying a steerable sheath into the coronary sinus.
  • the steerable sheath can comprise an elongate tubular member and an anchor positioned on a distal portion of the elongate tubular member.
  • the steerable sheath can have one or more configurations as described herein.
  • the anchor can comprise any one of the partially circumferential balloon anchor, circumferential balloon anchor, helical rib anchor, coil anchor, partially circumferential ring anchor, and suction anchor, as described herein.
  • the procedure 1600 involves providing the steerable sheath.
  • the procedure 1600 involves introducing the distal portion of the elongate tubular member through the inferior vena cava or superior vena cava, and into the right atrium.
  • the elongate tubular member can be introduced through a femoral vein and into the inferior vena cava.
  • the elongate tubular member can be introduced through a jugular vein or a subclavian vein and into the superior vena cava.
  • the procedure 1600 involves inserting the distal end of the elongate tubular member into the coronary sinus from the right atrium via the coronary sinus ostium, and the anchor can be positioned at the coronary sinus ostium.
  • the anchor can be on the distal portion of the elongate tubular member and at a distance from a distal end of the elongate tubular member.
  • the anchor can be spaced from the distal end of the elongate tubular member such that while the distal end is placed at or adjacent to a target tissue site, the anchor can be positioned to engage with the coronary sinus ostium.
  • the anchor can be at the distal end of the elongate tubular member.
  • the procedure 1600 involves engaging the anchor with the coronary sinus ostium, while blood flow is permitted through the ostium past the anchor.
  • the anchor can be engaged with both the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium.
  • FIG 17 is a flow diagram of an example of a procedure 1700 for deploying a steerable sheath comprising a circumferential balloon anchor into the coronary sinus.
  • the steerable sheath can comprise an elongate tubular member and a circumferential balloon anchor positioned on a distal portion of the elongate tubular member.
  • a plurality of cords can be circumferentially distributed around the circumferential balloon anchor.
  • Respective distal ends of the plurality of cords can be coupled to corresponding locations on a distal portion of the circumferential balloon anchor. In some embodiments, respective distal ends of the plurality of cords can be coupled to corresponding locations on the distal portion of the elongate tubular member.
  • the procedure 1700 involves providing the steerable sheath.
  • the procedure 1700 involves introducing the distal portion of the elongate tubular member through the inferior vena cava or superior vena cava and into the right atrium.
  • the circumferential balloon anchor can be on the distal portion of the elongate tubular member at a distance away from a distal end of the elongate tubular member.
  • the circumferential balloon anchor can be at the distal end of the elongate tubular member.
  • the procedure 1700 involves inserting the distal end of the elongate tubular member into the coronary sinus from the right atrium via the coronary sinus ostium, and the circumferential balloon anchor can be positioned at the coronary sinus ostium.
  • the procedure 1700 involves inflating the circumferential balloon anchor to engage the circumferential balloon anchor with the plurality of cords to create a plurality of corresponding circumferentially distributed indentations around the inflated circumferential balloon anchor.
  • the plurality of cords can be tensioned such that the plurality of cords can engage the inflated circumferential balloon anchor to provide the corresponding circumferentially distributed indentations.
  • the plurality of cords can be moved proximally in a direction along a longitudinal axis of the elongate tubular member to tension the plurality of cords such that the plurality of cords compress the inflated circumferential balloon anchor.
  • the plurality of indentations can be formed by compression of the inflated circumferential balloon anchor using the plurality of cords.
  • the circumferential balloon anchor can be inflated both before and/or after the distal portion of the elongate tubular member is positioned at a desired location.
  • the circumferential balloon anchor can be kept in a deflated state during at least a part its insertion to the coronary sinus ostium.
  • the circumferential balloon anchor can be inflated after being positioned at the coronary sinus ostium.
  • circumferential balloon anchor can be inflated until desired engagement with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion of the coronary sinus, is achieved.
  • the circumferential balloon anchor can be inflated after the circumferential balloon anchor is inserted into the right atrium but before the circumferential balloon anchor is positioned at the coronary sinus ostium.
  • a degree of inflation of the circumferential balloon anchor can be adjusted in response to individual anatomy.
  • the procedure 1700 involves engaging the inflated circumferential balloon anchor with the coronary sinus ostium, while blood flow is permitted through the ostium along the plurality of indentations.
  • the coronary sinus ostium In some embodiments, the
  • circumferential balloon anchor can be engaged with both the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium.
  • the circumferential balloon anchor can be engaged with both the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium.
  • circumferential balloon anchor can be deflated for retraction after the medical implant device and/or therapeutic procedure has been delivered.
  • Conditional language used herein such as, among others,“can,”“could,” “might,”“may,”“e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is intended in its ordinary sense and is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or steps. Thus, such conditional language is not generally intended to imply that features, elements and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and/or steps are included or are to be performed in any particular embodiment.
  • indefinite articles (“a” and“an”) may indicate“one or more” rather than“one.”
  • an operation performed “based on” a condition or event may also be performed based on one or more other conditions or events not explicitly recited.
  • the spatially relative terms“outer,”“inner,”“upper,”“lower,”“below,” “above,”“vertical,”“horizontal,” and similar terms, may be used herein for ease of description to describe the relations between one element or component and another element or component as illustrated in the drawings. It be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation, in addition to the orientation depicted in the drawings. For example, in the case where a device shown in the drawing is turned over, the device positioned“below” or“beneath” another device may be placed“above” another device. Accordingly, the illustrative term“below” may include both the lower and upper positions. The device may also be oriented in the other direction, and thus the spatially relative terms may be interpreted differently depending on the orientations.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

A delivery sheath can comprise an elongate tubular member and an anchor on a distal portion of the elongate tubular member, the anchor being configured to engage with the coronary sinus ostium, or both the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, so as to provide stable transcatheter access into the coronary sinus. The anchor can be configured to permit blood flow through the ostium while in engagement with the ostium.

Description

ANCHOR FOR TRANSCATHETER ACCESS INTO THE CORONARY SINUS
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. Provisional Patent Application No. 62/836,851, filed April 22, 2019, entitled“ANCHOR FOR TRANSCATHETER ACCESS INTO THE CORONARY SINUS”, the disclosure of which is hereby expressly incorporated by reference herein in its entirety for all purposes.
BACKGROUND
Field
[0002] The present disclosure generally relates to the field of delivering medical implant devices and/or therapies.
Description of Related Art
[0003] Transcatheter delivery of implant devices and/or therapies to the heart can be performed to address various heart abnormalities. Delivery of implant devices and/or therapies to the heart can be performed for treatment of elevate pressure in the left atrium.
SUMMARY
[0004] Described herein are methods and devices for providing stable transcatheter access into the coronary sinus from the right atrium via the coronary sinus ostium. In some implementations, the present disclosure relates to a steerable sheath comprising an elongate tubular member which includes an inner lumen configured to receive a plurality of instruments, and a partially circumferential balloon anchor disposed partially circumferentially on a distal portion of the elongate tubular member. The partially circumferential balloon anchor can include a proximal balloon portion and a distal balloon portion. When the partially circumferential balloon anchor is in an inflated state, the distal balloon portion can have a tapered longitudinal profile tapering toward a distal end of the partially circumferential balloon anchor, and the partially circumferential balloon anchor can be configured to, while positioned to engage with a coronary sinus, permit blood flow through an ostium of the coronary sinus.
[0005] In some embodiments, the partially circumferential balloon anchor, in the inflated state, is configured to be positioned to engage with both the ostium and a portion of the coronary sinus adjacent to the ostium. [0006] In some embodiments, the tapered longitudinal profile comprises a convex curvature.
[0007] In some embodiments, the partially circumferential balloon anchor is positioned around less than 50% of a circumference of the distal portion of the elongate tubular member.
[0008] In some embodiments, the partially circumferential balloon anchor comprises a textured exterior surface configured to engage with the ostium and a portion of the coronary sinus adjacent to the ostium. The textured exterior surface can comprise either or both of a plurality of bumps and a plurality of ridges.
[0009] In some embodiments, the proximal balloon portion extends laterally from the distal portion of the elongate tubular member, a deformable panel being coupled to the proximal balloon portion.
[0010] In some embodiments, the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location. The therapy device can comprise a shunt device for deployment onto a left atrial wall.
[0011] In some implementations, a steerable sheath comprises an elongate tubular member which includes an inner lumen configured to receive a plurality of instruments, and a circumferential balloon anchor disposed circumferentially around a distal portion of the elongate tubular member. A plurality of cords can be circumferentially distributed around the circumferential balloon anchor. When the circumferential balloon anchor is in an inflated state, the plurality of cords can be configured to engage the circumferential balloon anchor to create corresponding circumferentially distributed indentations on the circumferential balloon anchor, and the circumferential balloon anchor can be configured to, while positioned to engage with a coronary sinus, permit blood flow through an ostium of the coronary sinus along a path defined at least in part by the circumferentially distributed indentations.
[0012] In some embodiments, the circumferential balloon anchor, in the inflated state, is configured to be positioned to engage with the ostium.
[0013] In some embodiments, the circumferential balloon anchor comprises a proximal balloon portion and a distal balloon portion, and respective distal ends of the plurality of cords are coupled to corresponding locations on the distal balloon portion, the plurality of cords being movable relative to the elongate tubular member along a longitudinal axis of the elongate tubular member. Moving the plurality of cords proximally relative to the elongate tubular member can be configured to engage the circumferential balloon anchor in the inflated state with the plurality of cords to provide the corresponding circumferentially distributed indentations. In some embodiments, the plurality of cords comprises five cords.
[0014] In some embodiments, the distal balloon portion comprises a tapered longitudinal profile tapering toward a distal end of the circumferential balloon anchor, the distal balloon portion being configured to engage with the ostium and a portion of the coronary sinus adjacent to the ostium.
[0015] In some embodiments, the circumferential balloon anchor comprises a textured exterior surface configured to engage with the ostium and a portion of the coronary sinus adjacent to the ostium. The textured exterior surface can comprise either or both of a plurality of bumps and a plurality of ridges.
[0016] In some embodiments, the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location. The therapy device can comprise a shunt device for deployment onto a left atrial wall.
[0017] In some implementations, a method of accessing a heart location can comprise providing a steerable sheath which includes an elongate tubular member, a circumferential balloon anchor circumferentially positioned around a distal portion of the elongate tubular member and a plurality of cords circumferentially distributed around the circumferential balloon anchor. The distal portion of the elongate tubular member can be introduced through an inferior vena cava or a superior vena cava, and into a right atrium. A distal end of the elongate tubular member can be inserted through an ostium of a coronary sinus into the coronary sinus from the right atrium, and the distal end can be positioned at a target location within the coronary sinus. The circumferential balloon anchor can be inflated and an inflated circumferential balloon anchor can be engaged with the plurality of cords to create corresponding circumferentially distributed indentations on the inflated circumferential balloon anchor. The inflated circumferential balloon anchor can be engaged with the coronary sinus while blood flow is permitted through the ostium past the inflated
circumferential balloon anchor along a path defined at least in part by the circumferentially distributed indentations.
[0018] In some embodiments, engaging the coronary sinus comprises engaging the inflated circumferential balloon anchor with the ostium of the coronary sinus.
[0019] In some embodiments, the plurality of cords can be moved proximally along a longitudinal axis of the elongate tubular member, respective distal ends of the plurality of cords being coupled to corresponding locations on a distal balloon portion, where moving the plurality of cords compresses the inflated circumferential balloon anchor to provide the corresponding circumferentially distributed indentations on the inflated circumferential balloon anchor.
[0020] In some embodiments, a delivery catheter carrying a therapy device can be inserted into an inner lumen of the elongate tubular member. A distal end of the delivery catheter can be advanced from the distal end of the elongate tubular member for positioning at the target location. The delivery catheter can comprise a shunt delivery catheter carrying an atrial shunt device.
[0021] In some implementations, a steerable sheath can comprise an elongate tubular member which includes an inner lumen configured to receive a plurality of instruments, and a deformable helical rib anchor disposed around a distal portion of the elongate tubular member, the deformable helical rib anchor being configured to engage with a coronary sinus, and to permit blood flow through an ostium of the coronary sinus along a path defined at least in part by the deformable helical rib anchor while the deformable helical rib is positioned to engage with the coronary sinus.
[0022] In some embodiments, the deformable helical rib anchor is configured to be positioned to engage with both the ostium of the coronary sinus and a portion of the coronary sinus adjacent to the ostium.
[0023] In some embodiments, a height at which the deformable helical rib anchor extends from the distal portion of the elongate tubular member increases with increased distance from a distal end of the elongate tubular member. In some embodiments, a height at which the deformable helical rib anchor extends from the distal portion of the elongate tubular member is uniform along a dimension of the deformable helical rib anchor parallel with a longitudinal axis of the elongate tubular member.
[0024] In some embodiments, the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location. The therapy device can comprise a shunt device for deployment onto a left atrial wall.
[0025] In some implementations, a steerable sheath can comprise an elongate tubular member which includes an inner lumen configured to receive a plurality of instruments, and a first expandable coil anchor disposed around a distal portion of the elongate tubular member, the first expandable coil being configured to engage with a coronary sinus and to permit blood flow through an ostium of the coronary sinus while the first expandable coil anchor is in an expanded state and positioned to engage with the coronary sinus. [0026] In some embodiments, the first expandable coil is configured to be positioned to engage with the ostium of the coronary sinus.
[0027] In some embodiments, the steerable sheath further comprises a second expandable coil anchor positioned distally adjacent to the first expandable coil anchor, the second expandable coil anchor comprising a diameter smaller than that of the first expandable coil anchor, the second expandable coil anchor being configured to engage with a portion of the coronary ostium adjacent to the ostium when in an expanded state. The first expandable coil anchor and the second expandable coil anchor can be configured to permit blood flow through the ostium while the first expandable coil anchor and the second expandable coil anchor are positioned to engage with the ostium and the portion of the coronary sinus adjacent to the ostium.
[0028] In some embodiments, the inner lumen can be configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location. The therapy device can comprise a shunt device for deployment onto a left atrial wall.
[0029] In some implementations, a steerable sheath can comprise an elongate tubular member which includes an inner lumen configured to receive a plurality of instruments, and a partially circumferential ring anchor disposed partially circumferentially on a distal portion of the elongate tubular member, the partially circumferential ring anchor being configured to permit blood flow through an ostium of a coronary sinus while the partially circumferential ring anchor is positioned to engage with the coronary sinus.
[0030] In some embodiments, the partially circumferential ring anchor is configured to be positioned to engage with the ostium.
[0031] In some embodiments, the partially circumferential ring anchor comprises a proximal ring portion and a distal ring portion, the distal ring portion comprising a tapered longitudinal profile tapering toward a distal end of the ring, the partially circumferential ring anchor being configured to engage with the ostium and a portion of the coronary sinus adjacent to the ostium.
[0032] In some embodiments, the partially circumferential ring is disposed around less than 50% of a circumference of the distal portion of the elongate tubular member.
[0033] In some embodiments, the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location. The therapy device can comprise a shunt device for deployment onto a left atrial wall.
[0034] In some implementations, a method of accessing a heart location can comprise providing a steerable sheath which includes an elongate tubular member and an anchor positioned on a distal portion of the elongate tubular member. The distal portion of the elongate tubular member can be introduced through an inferior vena cava or a superior vena cava, and into a right atrium. A distal end of the elongate tubular member can be inserted through an ostium of a coronary sinus into the coronary sinus from the right atrium, and the distal end can be positioned at a target location within the coronary sinus. The anchor can be engaged with the coronary sinus while blood flow is permitted through the ostium past the anchor.
[0035] In some embodiments, engaging the coronary sinus comprises engaging the ostium of the coronary sinus with the anchor.
[0036] In some embodiments, a delivery catheter carrying a therapy device can be inserted into an inner lumen of the elongate tubular member, and a distal end of the delivery catheter can be advanced from the distal end of the elongate tubular member for positioning at the target location. The delivery catheter carrying a therapy device can comprise a shunt delivery catheter carrying an atrial shunt device
[0037] For purposes of summarizing the disclosure, certain aspects, advantages and novel features have been described herein. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment. Thus, the disclosed embodiments may be carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein.
BRIEF DESCRIPTION OF THE DRAWINGS
[0038] Various embodiments are depicted in the accompanying drawings for illustrative purposes and should in no way be interpreted as limiting the scope of the inventions. In addition, various features of different disclosed embodiments can be combined to form additional embodiments, which are part of this disclosure. Throughout the drawings, reference numbers may be reused to indicate correspondence between reference elements. However, it should be understood that the use of similar reference numbers in connection with multiple drawings does not necessarily imply similarity between respective
embodiments associated therewith. Furthermore, it should be understood that the features of the respective drawings are not necessarily drawn to scale, and the illustrated sizes thereof are presented for the purpose of illustration of inventive aspects thereof. Generally, certain of the illustrated features may be relatively smaller than as illustrated in some embodiments or configurations. [0039] Figure 1 is a cross-sectional view of a human heart.
[0040] Figure 2 is another cross-sectional view of the human heart.
[0041] Figures 3 A and 3B show examples of pathways for accessing the coronary sinus from the right atrium.
[0042] Figure 4 is a schematic diagram of an example of a delivery system comprising a steerable sheath and a delivery catheter received within an inner lumen of the steerable sheath.
[0043] Figure 5 is a schematic diagram of the steerable sheath of Figure 4 positioned from a first body chamber or lumen into a second body chamber or lumen.
[0044] Figure 6 is a schematic diagram of a side view of an example of a steerable sheath comprising a partially circumferential balloon anchor.
[0045] Figure 7 is a schematic diagram of a view of the distal portion of the steerable sheath of Figure 6.
[0046] Figure 8 shows the steerable sheath of Figure 6 positioned for accessing a target location within the coronary sinus.
[0047] Figure 9 is a schematic diagram of an example of a steerable sheath comprising a partially circumferential balloon anchor and a deformable panel coupled thereto.
[0048] Figures 10A and 10B are schematic diagrams of examples of steerable sheaths which comprise a partially circumferential balloon anchor, where the partially circumferential balloon anchor can comprise a textured surface thereon.
[0049] Figures 11A and 11B are schematic diagrams showing an example of a steerable sheath which comprises a circumferential balloon anchor and a plurality of cords circumferentially distributed around the circumferential balloon anchor.
[0050] Figures 12A and 12B are schematic diagrams showing the plurality of cords engaged with the circumferential balloon anchor of Figures 11A and 1 IB, so as to form corresponding indentations on the circumferential balloon anchor.
[0051] Figures 13 A and 13B are schematic diagrams showing examples of steerable sheaths comprising a helical rib anchor.
[0052] Figures 14A and 14B are schematic diagrams showing examples of steerable sheaths comprising one coil anchor and two coil anchors, respectively.
[0053] Figure 15 is a schematic diagram showing an example of a steerable sheath comprising a partially circumferential ring anchor. [0054] Figure 16 is a flow diagram of an example of a procedure for deploying a steerable sheath into the coronary sinus.
[0055] Figure 17 is a flow diagram of an example of a procedure for deploying a steerable sheath comprising a circumferential balloon anchor into the coronary sinus.
DETAILED DESCRIPTION
[0056] The headings provided herein are for convenience only and do not necessarily affect the scope or meaning of the claimed invention.
[0057] The present disclosure relates to systems, devices, and methods for providing reliable positioning of delivery sheaths into the coronary sinus from the right atrium via the coronary sinus ostium. The steerable sheaths can comprise an anchor configured to engage with the coronary sinus ostium, or both the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, for providing stable transcatheter access into the coronary sinus.
[0058] Although certain preferred embodiments and examples are disclosed below, inventive subject matter extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and to modifications and equivalents thereof.
Thus, the scope of the claims that may arise herefrom is not limited by any of the particular embodiments described below. For example, in any method or process disclosed herein, the acts or operations of the method or process may be performed in any suitable sequence and are not necessarily limited to any particular disclosed sequence. Various operations may be described as multiple discrete operations in turn, in a manner that may be helpful in understanding certain embodiments; however, the order of description should not be construed to imply that these operations are order dependent. Additionally, the structures, systems, and/or devices described herein may be embodied as integrated components or as separate components. For purposes of comparing various embodiments, certain aspects and advantages of these embodiments are described. Not necessarily all such aspects or advantages are achieved by any particular embodiment. Thus, for example, various embodiments may be carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other aspects or advantages as may also be taught or suggested herein.
[0059] Certain standard anatomical terms of location are used herein to refer to the anatomy of animals, and namely humans, with respect to the preferred embodiments. Although certain spatially relative terms, such as“outer,”“inner,”“upper,”“lower,”“below,” “above,”“vertical,”“horizontal,”“top,”“bottom,” and similar terms, are used herein to describe a spatial relationship of one device/element or anatomical structure to another device/element or anatomical structure, it is understood that these terms are used herein for ease of description to describe the positional relationship between element(s)/structures(s), as illustrated in the drawings. It should be understood that spatially relative terms are intended to encompass different orientations of the element(s)/structures(s), in use or operation, in addition to the orientations depicted in the drawings. For example, an element/structure described as“above” another element/stmcture may represent a position that is below or beside such other element/structure with respect to alternate orientations of the subject patient or element/structure, and vice-versa.
[0060] Various features of a heart 1 are described with reference to Figure 1 to assist in understanding the present disclosure. The heart 1 includes four chambers, namely the left atrium 2, the left ventricle 3, the right ventricle 4, and the right atrium 5. A wall of muscle, referred to as the septum 10, separates the left atrium 2 and right atrium 5, and the left ventricle 3 and right ventricle 4. Blood flow through the heart 1 is at least partially controlled by four valves, the mitral valve 6, aortic valve 7, tricuspid valve 8, and pulmonary valve 9. The mitral valve 6 separates the left atrium 2 and the left ventricle 3 and controls blood flow therebetween. The aortic valve 7 separates and controls blood flow between the left ventricle 3 and the aorta 12. The tricuspid valve 8 separates the right atrium 5 and the right ventricle 4 and controls blood flow therebetween. The pulmonary valve 9 separates the right ventricle 4 and the pulmonary artery 11, controlling blood flow therebetween.
[0061] In a healthy heart, the heart valves can properly open and close in response to a pressure gradient present during various stages of the cardiac cycle (e.g., relaxation and contraction) to at least partially control the flow of blood to a respective region of the heart and/or to blood vessels. Deoxygenated blood arriving from the rest of the body generally flows into the right side of the heart for transport to the lungs, and oxygenated blood from the lungs generally flows into the left side of the heart for transport to the rest of the body.
During ventricular diastole, deoxygenated blood arrive in the right atrium 5 from the inferior vena cava 15 and superior vena cava 16 to flow into the right ventricle 4, and oxygenated blood arrive in the left atrium 2 from the pulmonary veins to flow into the left ventricle 3. During ventricular systole, deoxygenated blood from the right ventricle 4 can flow into the pulmonary artery 11 for transport to the lungs (e.g., via the left 14 and right 13 pulmonary arteries), and oxygenated blood can flow from the left ventricle 3 to the aorta 12 for transport to the rest of the body. [0062] A number of conditions can contribute to a higher than normal pressure in the left atrium. Dysfunction of the mitral valve can contribute to elevated left atrial pressure. Conditions such as mitral valve regurgitation and/or stenosis may result in difficulty in pumping blood from the left atrium to the left ventricle, contributing to elevated pressure in the left atrium. Valve stenosis can cause a valve to become narrowed or obstructed. Mitral valve stenosis can restrict blood flow from the left atrium to the left ventricle. Valve regurgitation occurs when a valve does not close properly. For example, regurgitation can occur due to improper coaptation of the valve leaflets. Mitral valve regurgitation can result in blood flow leakage back into the left atrium 2 from the left ventricle 3 when the left ventricle 3 contracts. Restricted flow of blood from the left atrium 2 into the left ventricle 3, and blood flow leakage from the left ventricle 3 back into the left atrium 2 can both contribute to elevated atrial pressure. Dysfunction in the left ventricle 3 can also contribute to elevated left atrial pressure. Elevated left atrial pressure may lead to left atrial enlargement, producing symptoms such as shortness of breath during exertion, fatigue, chest pain, fainting, abnormal heartbeat, and swelling of the legs and feet.
[0063] Figure 2 is another view of the heart 1 and shows the coronary sinus 18 around the left atrium 2. To alleviate elevated left atrial pressure, a conduit can be provided to allow blood flow from the left atrium 2 into a portion of the heart with lower pressure, such as the coronary sinus 18. A conduit can be formed on the wall of the left atrium 2 adjacent to the coronary sinus 18 to allow blood flow from the left atrium 2 into the coronary sinus 18. The coronary sinus 18 receives blood from coronary veins and empties into the right atrium 5. Blood diverted into the coronary sinus 18 from the left atrium 2 can then be delivered into the right atrium 5. A shunt device can be positioned at a location on the left atrial wall, such as at a location on the left atrial wall which is accessible from the coronary sinus 18, to form a blood flow pathway from the left atrium 2 into the coronary sinus 18. Access into the coronary sinus 18 can comprise navigating into the right atrium 5 and entering through the coronary sinus ostium 17.
[0064] Figures 3A and 3B show examples of pathways for accessing the coronary sinus 18 through the right atrium 5 to deliver a shunt or other implant device to a portion of the left atrial wall. In Figure 3A, a steerable sheath 40 is shown as being inserted through the inferior vena cava 15 and into the right atrium 5. For example, the steerable sheath 40 can be introduced through the femoral vein, and then inserted through the inferior vena cava 15. The steerable sheath 40 can then be advanced from the right atrium 5 through the coronary sinus ostium 17 and into the coronary sinus 18. [0065] In Figure 3B, the steerable sheath 40 is shown as being inserted through the superior vena cava 16 and into the right atrium 5. The steerable sheath 40 can be introduced through the subclavian vein or jugular vein, and then inserted through the superior vena cava 16. The steerable sheath 40 can be positioned from the right atrium 5 through the coronary sinus ostium 17 and into the coronary sinus 18.
[0066] As shown in both Figures 3 A and 3B, the steerable sheath 40 can be bent when positioned from the inferior vena cava 15 or the superior vena cava 16 into the right atrium 5 and from the right atrium 5 through the coronary sinus ostium 17. This curvature in the steerable sheath 40 can render stable positioning of the steerable sheath 40 difficult when moving instrumentation through an inner lumen of the steerable sheath 40 to position instrumentation within the coronary sinus 18. Advancing and/or retracting instrumentation through the steerable sheath 40, and/or rigidity of the steerable sheath 40, may inadvertently move the steerable sheath 40 and dislodge the steerable sheath 40 from its desired position. Movement of instrumentation within the steerable sheath 40 can push a distal end of the steerable sheath 40 positioned within the coronary sinus 18 back toward the coronary sinus ostium 17.
[0067] In some embodiments, the present disclosure relates to devices, systems and/or methods for providing stable transcatheter access into the coronary sinus from the right atrium via the coronary sinus ostium. Described herein are delivery sheaths, including steerable sheaths, for positioning into the coronary sinus, the steerable sheaths comprising an anchor configured to engage with the coronary sinus ostium, or both the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium. The anchor can be on a distal portion of an elongate tubular member of the steerable sheath, a distal end of the steerable sheath being configured to be positioned within the coronary sinus for accessing the left atrial wall. The anchor can allow stable positioning of the distal end within the coronary sinus to facilitate reliable delivery of one or more medical implant devices and/or therapies to a target tissue site on the left atrial wall.
[0068] As described in further detail herein, an elongate tubular member of a steerable sheath can be bent when positioned through the coronary sinus ostium from the right atrium. The steerable sheath can be inserted into the right atrium through the inferior vena cava or superior vena cava. The bend or curvature in the elongate tubular member can present difficulties in maintaining a stable and secure position within the coronary sinus. Insertion and/or retraction of instrumentation through the elongate tubular member, such as to deliver implant devices and/or therapies to the left atrial wall, can cause undesired movement of the distal portion of the elongate tubular member. The distal portion may be pushed back towards the right atrium, dislodging the elongate tubular member from its desired location within the coronary sinus.
[0069] Engaging an anchor with the coronary sinus ostium, or with both the coronary sinus ostium and an adjacent portion of the coronary sinus, can facilitate docking of the elongate tubular member against the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion. Force can be exerted upon the elongate tubular member to maintain the distal portion of the elongate tubular member at its desired position within the coronary sinus. Engaging the anchor with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion, can prevent over insertion of the elongate tubular member into the coronary sinus, while reducing or avoiding movement of the elongate tubular member back towards the right atrium. The anchor can provide secure positioning of the elongate tubular member within the coronary sinus such that desired therapy device implants and/or therapeutic procedures can be delivered thereto. Engaging the anchor with the coronary sinus ostium can provide improved stability and/or reduce or prevent damage to the coronary sinus, such as compared to steerable sheaths comprising anchors for engaging only with portions within the coronary sinus.
[0070] An anchor can be positioned on a distal portion of an elongate tubular member, spaced from or at a distal end of the elongate tubular member. The anchor can comprise a shape configured to engage with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion. A cross-sectional size of the coronary sinus decreases along a direction extending into the coronary sinus and away from the ostium. In some embodiments, at least a portion of the anchor can comprise a taper configured to engage with the coronary sinus ostium and an adjacent portion of the coronary sinus. For example, a distal portion of the anchor can have a longitudinal profile comprising a taper toward a distal end of the anchor, the longitudinal profile extending along a direction parallel or substantially parallel to a longitudinal axis of the elongate tubular member. In some embodiments, the tapered distal portion can comprise a curvature, including a convex curvature. In some embodiments, an anchor can comprise a textured exterior surface configured to provide desired engagement with the coronary sinus ostium and/or an adjacent portion of the coronary sinus.
[0071] The anchor can be configured to be in engagement with the coronary sinus ostium and an adjacent portion of the coronary sinus, while permitting blood flow through the ostium past the anchor. Permitting blood flow through the ostium can advantageously allow performance of delivery procedures while a heart is beating, providing a lower risk of complications, shorter hospital stay and/or quicker recovery for the patient. For example, the anchor can be configured so as not to occlude the ostium. In some embodiments, the anchor can comprise any one of a partially circumferential balloon anchor, a circumferential balloon anchor comprising longitudinal indentations formed thereon, a helical rib anchor, a coil anchor, a partially circumferential ring anchor, and a suction anchor. As used herein, a partially circumferential anchor can refer to any anchor configured to be positioned on, disposed around and/or extending from, any partial portion of the circumference of a distal portion of an elongate tubular member, and where the anchor does not circumscribe the distal portion.
[0072] Although the description herein is made primarily with reference to positioning sheaths from the right atrium into the coronary sinus, it will be understood that the description can refer or generally apply to positioning of sheaths from a first body chamber or lumen into a second body chamber or lumen, where the sheaths may be bent when positioned from the first body chamber or lumen into the second body chamber or lumen. A body chamber or lumen can refer to any one of a number of fluid channels, blood vessels, and/or organ chambers (e.g., heart chambers). Additionally, reference herein to “sheaths”,“delivery sheaths” and/or“steerable sheaths” can refer or apply generally to any type of elongate tubular delivery device comprising an inner lumen configured to slidably receive instrumentation, such as for positioning within an atrium or coronary sinus.
“Sheaths”,“delivery sheaths” and/or“steerable sheaths” can include, for example, delivery catheters and/or cannulas. It will be understood that other types of medical implant devices and/or procedures can be delivered to the coronary sinus using a steerable sheath as described herein, including for example ablation procedures, drug delivery and/or placement of coronary sinus leads.
[0073] Figure 4 is a schematic diagram of a delivery system 50 which comprises a steerable sheath 100 that includes an anchor 140. The steerable sheath 100 can comprise an elongate tubular member 110 having a proximal portion 112 and a distal portion 114. The anchor 140 can be on the distal portion 114 of the elongate tubular member 110. Various examples of the anchor 140 are described herein. For example, the anchor 140 can comprise any one of a partially circumferential balloon anchor, a circumferential balloon anchor having longitudinal indentations formed thereon, a helical rib anchor, a coil anchor, a partially circumferential ring anchor, and a suction anchor, as described herein.
[0074] The steerable sheath 100 can be configured to facilitate positioning of instrumentation at a target site within various body chambers or lumens. In some embodiments, the steerable sheath 100 can be configured to facilitate positioning of instrumentation at a target site within the coronary sinus, including a target tissue site on the left atrial wall accessible from within the coronary sinus. A delivery catheter 60 can be slidably received within an inner lumen of the elongate tubular member 110. A distal end 116 of the elongate tubular member 110 can be placed at or proximate to a target tissue site, including a target site in the coronary sinus. A distal end 62 of the delivery catheter 60 can be extended from the distal end 116 of the elongate tubular member 110 to position the distal end 62 of the delivery catheter 60 at or proximate to the target tissue site, such as to deploy one or more therapy devices to the target tissue site. In some embodiments, the delivery catheter 60 can be configured to carry one or more therapy devices for treatment of elevated left atrial pressure, such as an atrial shunt device. In some embodiments, the distal end 62 of the delivery catheter 60 can be positioned at or adjacent to a target site on the left atrial wall so as to facilitate deployment of an atrial shunt device onto the left atrial wall. It will be understood that other instrumentation can be received within the inner lumen, in addition to or instead of the delivery catheter 60.
[0075] In some embodiments, the steerable sheath 100 can be used to access the left atrial wall from within the coronary sinus by entering the coronary sinus from the right atrium through the coronary sinus ostium. As described herein, access into the right atrium can be made through the inferior vena cava or the superior vena cava. For example, the distal portion 114 of the elongate tubular member 110 can be configured to be advanced into the right atrium from the inferior vena cava or the superior vena cava. The distal portion 114 can then be inserted through the coronary sinus ostium from the right atrium, and into the coronary sinus. In some embodiments, the anchor 140 on the distal portion 114 can be configured to engage with the coronary sinus ostium. In some embodiments, the anchor 140 can be configured to engage with the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium. The anchor 140 can comprise a shape and/or size to provide desired engagement with the coronary sinus ostium, or the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, while permitting flow of blood through the ostium past the anchor 140.
[0076] The anchor 140 can be at or a distance away from the distal end 116 of the elongate tubular member 110. In some embodiments, the anchor 140, such as a distal end of the anchor 140, can be at a distance of less than about 5 centimeters (cm) from the distal end 116 of the elongate tubular member 110, or less than about 4 cm, about 3 cm, about 2 cm, or about 1 cm. In some embodiments, the anchor 140 can be about 1 cm, about 2 cm, about 3 cm, or about 4 cm, from the distal end 116. In some embodiments, the anchor 140 can be at the distal end 116.
[0077] In some embodiments, the anchor 140 can comprise one or more radiopaque markers 140a to facilitate visualization of the positioning of the anchor 140, the distal portion 114 and/or the distal end 116 of the elongate tubular member 110. For example, the radiopaque markers 140a can facilitate desired positioning of the anchor 140 at the coronary sinus ostium. In some embodiments, the one or more radiopaque markers 140a can provide visualization of a shape, orientation, and/or location of the anchor 140 to facilitate correct positioning of the anchor 140 at the coronary sinus ostium, including visualization of a desired deformation of the anchor 140. For example, visualization of the deformation of a partially circumferential balloon anchor, a circumferential balloon anchor, and/or a helical rib anchor can be used to determine whether desired contact is made with the coronary sinus ostium and/or an adjacent portion of the coronary sinus.
[0078] As described herein, the anchor 140 can be configured to engage with the coronary sinus ostium, or the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, to reduce or prevent undesired movement of the elongate tubular member 110. The anchor 140 can be configured to prevent dislodging of the elongate tubular member 110 from its desired position within the coronary sinus, such as when
instrumentation is inserted and/or retracted through the inner lumen of the elongate tubular member 110. Reliable positioning of the elongate tubular member 110 within the coronary sinus can facilitate delivery of therapy device implants and/or application of therapeutic treatments to target sites accessible from within the coronary sinus, including target sites on the left atrial wall.
[0079] The anchor 140 can be configured to be in engagement with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion of the coronary sinus, while permitting blood flow through the ostium past the anchor 140. The anchor 140 can be configured so as not to occlude the ostium. Permitting blood flow through the ostium can have various advantages, including performance of procedures while a heart is beating.
Beating heart surgeries can provide a lower risk of complications, shorter hospital stay and/or quicker recovery for the patient.
[0080] In some embodiments, the anchor 140 can be an integral part of the elongate tubular member 110. In some embodiments, the anchor 140 can be separable from the elongate tubular member 110. For example, the anchor 140 can be a separate component associated with the elongate tubular member 110 where the anchor 140 is configured to be coupled to the distal portion 114 of the elongate tubular member 110. The anchor 140 can be selected for coupling to the elongate tubular member 110. For example, a desired anchor can be selected for positioning onto the elongate tubular member 110 based on a number of factors, including a size and/or shape of the coronary sinus ostium and/or a distance from the ostium of the target site within the coronary sinus.
[0081] Figure 5 is a schematic diagram showing the steerable sheath 100 positioned from a first body chamber or lumen 20 into a second body chamber or lumen 30. The first body chamber or lumen 20 and the second body chamber or lumen 30 can be any one of a number of fluid channels, blood vessels, and/or organ chambers. In some embodiments, the first body chamber or lumen 20 can be the right atrium and the second body chamber or lumen 30 can be the coronary sinus.
[0082] The distal portion 114 of the elongate tubular member 110 can have a bend while positioned from the first body chamber or lumen 20 into the second body chamber or lumen 30. The anchor 140 can be positioned at the opening of the second body chamber or lumen 30. The distal end 116 of the elongate tubular member 110 can extend into the second body chamber or lumen 30 while the anchor 140 is positioned at the opening of the second body chamber or lumen 30. As described herein, the anchor 140 can comprise one or more radiopaque markers 140a to facilitate visualization of the positioning of the anchor 140, the distal portion 114 and/or the distal end 116 of the elongate tubular member 110.
[0083] In some embodiments, one or more portions of the anchor 140 can be configured to engage with the opening of the second body chamber or lumen 30. In some embodiments, one or more portions of the anchor 140 can be configured to engage with both the opening of the second body chamber or lumen 30 and a portion of the second body chamber or lumen 30 adjacent to the opening. For example, the anchor 140 can have a proximal portion 142 and a distal portion 144, where the distal portion 144 of the anchor 140 can be configured to engage with the opening of the second body chamber or lumen 30. In some embodiments, the distal portion 144 of the anchor 140 can be configured to engage with both the opening of the second body chamber or lumen 30 and an adjacent portion of the second body chamber or lumen 30. It will be understood that although Figure 5 shows the anchor 140 as being positioned outside of the second body chamber or lumen 30, the anchor 140 can be positioned at least partially within the second body chamber or lumen 30.
[0084] Engaging the anchor 140 with the opening of the second body chamber or lumen 30, or with both the opening of the second body chamber or lumen 30 and an adjacent portion of the second body chamber or lumen 30, can facilitate docking of the elongate tubular member 110 against the opening of the second body chamber or lumen 30, or both the opening of the second body chamber or lumen 30 and an adjacent portion of the second body chamber or lumen 30. As such, over insertion of the elongate tubular member 110 into the second body chamber or lumen 30, and/or undesired movement of the elongate tubular member 110, can be prevented or reduced.
[0085] Figure 6 is a side view of an example of a steerable sheath 200 comprising a partially circumferential balloon anchor 240. The steerable sheath 200 can comprise an elongate tubular member 210 and the partially circumferential balloon anchor 240 can be positioned around only a portion of a circumference of a distal portion 214 of the tubular member 210. As used herein, a partially circumferential balloon anchor can refer to any balloon anchor configured to be positioned on, disposed around and/or extending from, any partial portion of the circumference of the distal portion 214, and where the balloon anchor does not circumscribe the distal portion 214.
[0086] In some embodiments, the partially circumferential balloon anchor 240 can be inflatable. For example, the steerable sheath 200 can comprise an inflation and deflation lumen 260 extending along at least a portion of the elongate tubular member 210, the inflation and deflation lumen 260 being configured to allow inflation or deflation of the partially circumferential balloon anchor 240. The partially circumferential balloon anchor 240, when in an inflated state, can be configured to contact and engage with the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, so as to facilitate reliable positioning of the elongate tubular member 210 within the coronary sinus.
[0087] The partially circumferential balloon anchor 240 can comprise a proximal end 246 and a distal end 248. The partially circumferential balloon anchor 240 can be positioned on the distal portion 214 of the elongate tubular member 210 such that both the proximal end 246 and the distal end 248 are on the distal portion 214. In some embodiments, the partially circumferential balloon anchor 240 can be positioned a distance away from a distal end 216 of the elongate tubular member 210. For example, the distal end 248 of the circumferential balloon anchor 240 can be spaced from the distal end 216 of the elongate tubular member 210 such that the circumferential balloon anchor 240 can be positioned at the coronary sinus ostium, while the distal end 216 of the elongate tubular member 210 can be positioned further within the coronary sinus, such as at or proximate to a target tissue location. In some embodiments, the distal end 248 of the partially circumferential balloon anchor 240 can be at the distal end 216 of the elongate tubular member 210. [0088] In some embodiments, the partially circumferential balloon anchor 240 can be inflatable. In the inflated state, the partially circumferential balloon anchor 240 can comprise a shape configured to engage the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium. As described herein, a cross-sectional size of the coronary sinus decreases along a direction extending into the coronary sinus and away from the ostium. A distal portion 244 of the partially circumferential balloon anchor 240 can be configured to engage with the coronary sinus ostium and an adjacent portion of the coronary sinus. For example, the distal portion 244 can have a longitudinal profile comprising a taper toward the distal end 248 of the partially circumferential balloon anchor 240, the longitudinal profile extending along a direction parallel or substantially parallel to a longitudinal axis of the elongate tubular member 210. The taper of the longitudinal profile can be configured to facilitate desired engagement of the distal portion 244 with the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium. In some embodiments, the tapered distal portion 244 can comprise a curvature, such as a convex curvature. For example, the longitudinal profile of the distal portion 244 can comprise a curved taper, such as a curved convex taper, which tapers towards the distal end 248 of the partially circumferential balloon anchor 240. The longitudinal profile of the distal portion 244 can be selected to provide secure engagement of the partially circumferential balloon anchor 240 with the coronary sinus ostium and an adjacent portion of the coronary sinus.
[0089] In some embodiments, a proximal portion 242 of the partially
circumferential balloon anchor 240 can comprise a shape configured to facilitate movement of the partially circumferential balloon anchor 240 through anatomical pathways, including during retraction of the partially circumferential balloon anchor 240. For example, the proximal portion 242 of the partially circumferential balloon anchor 240 can have a longitudinal profile comprising a taper toward the proximal end 246 of the partially circumferential balloon anchor 240, the longitudinal profile extending along a direction parallel or substantially parallel to a longitudinal axis of the elongate tubular member 210.
The longitudinal profile of the proximal portion 242 can comprise a curved taper, such as a curved convex taper, which tapers towards the proximal end 246 of the partially
circumferential balloon anchor 240. In some embodiments, the partially circumferential balloon anchor 240 can have a maximum cross-sectional size at or around a mid-portion of the anchor 240, and a longitudinal profile of both the proximal portion 242 and distal portion 244 comprising a taper, including a curved convex taper, from or around the mid-portion of the anchor 240 toward the proximal end 246 and the distal tend 248, respectively. [0090] In some embodiments, the partially circumferential balloon anchor 240 can have a length of up to about 10 millimeters (mm), including about 1 mm to about 9 mm, about 2 mm to about 8 mm, or about 3 mm to about 7 mm. In some embodiments, the partially circumferential balloon anchor 240 has a length of about 10 mm. In some embodiments, a width of the partially circumferential balloon anchor 240 can be about 1 mm to about 10 mm. In some embodiments, the partially circumferential balloon anchor 240 can have a width which varies from about 1 mm to about 10 mm. For example, the distal portion 244 can taper from a width of about 10 mm to a width of about 1 mm at the distal end 248, including from about 9 mm down to about 1 mm, about 8 mm down to about 1 mm, about 9 mm down to about 2 mm, about 8 mm down to about 2 mm, about 7 mm down to about 3 mm, or about 6 mm down to about 4 mm. In some embodiments, the proximal portion 242 can have the same or similar taper in width.
[0091] In some embodiments, the partially circumferential balloon anchor 240 can be kept in a deflated state during at least a part of its insertion to and/or retraction from the coronary sinus ostium. In some embodiments, the partially circumferential balloon anchor 240 can assume an inflated state after the distal portion 214 of the elongate tubular member 210 is positioned at a desired location. For example, after the distal end 216 of the elongate tubular member 210 is positioned at or adjacent to the target tissue site and the partially circumferential balloon anchor 240 is at the coronary sinus ostium, the partially
circumferential balloon anchor 240 can be inflated. The partially circumferential balloon anchor 240 can be inflated until desired engagement with the coronary sinus ostium and an adjacent portion of the coronary sinus is achieved. In some embodiments, the partially circumferential balloon anchor 240 can be inflated before the distal portion 214 of the elongate tubular member 210 is positioned at the desired location. For example, the partially circumferential balloon anchor 240 can assume an inflated state after being positioned within the right atrium but before being positioned to engage the coronary sinus ostium and an adjacent portion of the coronary sinus. In some embodiments, the partially circumferential balloon anchor 240 can be expanded both before and after being positioned at a target location. For example, the partially circumferential balloon anchor 240 can assume a partially inflated state while in the right atrium, and further inflation can be performed after being positioned to engage the coronary sinus ostium. In some embodiments, a degree of inflation of the partially circumferential balloon anchor 240 can be adjusted during a procedure in response to a size of a coronary sinus ostium and an adjacent portion of the coronary sinus. In some embodiments, the partially circumferential balloon anchor 240 can be deflated for retraction.
[0092] Figure 7 is a view of the distal portion 214 of the elongate tubular member 210. The distal end 248 and the distal portion 244 of the partially circumferential balloon anchor 240 is shown. As shown in Figure 7, the partially circumferential balloon anchor 240 can be positioned around only a portion of the circumference of the distal portion 214.
Having the partially circumferential balloon anchor 240 only around a portion of the circumference of the distal portion 214 can facilitate blood flow through the coronary sinus ostium and past the partially circumferential balloon anchor 240 while the partially circumferential balloon anchor 240 is positioned at and in engagement with the coronary sinus ostium and an adjacent portion of the coronary sinus. The partially circumferential balloon anchor 240 can provide sufficient contact with the coronary sinus ostium and an adjacent portion of the coronary sinus while allowing desired area around the steerable sheath 200 at the coronary sinus ostium such that sufficient blood flow can pass therethrough. In some embodiments, the partially circumferential balloon anchor 240 can be positioned around less than about 50% of the circumference of the distal portion 214 of the elongate tubular member 210, or less than about 40%, less than about 30%, less than about 25%, or less than about 20%.
[0093] As shown in Figure 7, an inner lumen 270 of the elongate tubular member 210 extends to the distal end 216 of the elongate tubular member 210. The inner lumen 270 can be configured to receive various instrumentation for delivering one or more therapy devices to a target tissue location.
[0094] Figure 8 shows the steerable sheath 200 in a position for accessing a target location within the coronary sinus 18. The elongate tubular member 210 can be advanced through the inferior vena cava 15, positioned into the right atrium 5, and inserted through the coronary sinus ostium 17 into the coronary sinus 18. The distal end (not shown) of the elongate tubular member 210 can be positioned within the coronary sinus 18. The partially circumferential balloon anchor 240 can be positioned against the coronary sinus ostium 17 such that the distal portion 244 engages the coronary sinus ostium 17 and a portion of the coronary sinus 18 adjacent to the ostium 17. The distal end of the partially circumferential balloon anchor 240 can be positioned within the coronary sinus 18. The tapering of the longitudinal profile of the distal portion 244 can facilitate stable and/or reliable engagement of the partially circumferential balloon anchor 240 with the coronary sinus ostium 17 and an adjacent portion of the coronary sinus 18. [0095] Figure 9 is a schematic diagram of an example of a steerable sheath 300 comprising a partially circumferential balloon anchor 340 and a deformable panel 380 coupled thereto. The steerable sheath 300 can comprise an elongate tubular member 310. A distal portion 314 of the elongate tubular member 310 can comprise the partially
circumferential balloon anchor 340 thereon.
[0096] In some embodiments, the partially circumferential balloon anchor 340 can comprise one or more features of the partially circumferential balloon anchor 240 described with reference to Figures 6 through 8. For example, the partially circumferential balloon anchor 340 can be inflatable. The partially circumferential balloon anchor 340, when in an inflated state, can be configured to contact and engage with the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, so as to facilitate reliable positioning of the elongate tubular member 310 within the coronary sinus. For example, the distal portion 344 of the partially circumferential balloon anchor 340 can comprise a tapered longitudinal profile, the tapered longitudinal profile tapering toward the distal end 348 of the partially circumferential balloon anchor 340. The longitudinal profile can extend along a direction parallel or substantially parallel to a longitudinal axis of the elongate tubular member 310. In some embodiments, the tapered longitudinal profile can comprise a curve, including a convex curve. The distal end 348 of the circumferential balloon anchor 340 can be spaced from or at the distal end 316 of the elongate tubular member 310.
[0097] In some embodiments, the partially circumferential balloon anchor 340 can be positioned around less than about 50% of the circumference of the distal portion 314 of the elongate tubular member 310, or less than about 40%, or less than about 30%, or less than about 25%, or less than about 20%.
[0098] The proximal portion 342 of the partially circumferential balloon anchor 340 can extend laterally from the distal portion 314 of the elongate tubular member 310. The deformable panel 380 can be coupled to the proximal portion 342. The deformable panel 380 can extend laterally from the distal portion 314, including an example which extends perpendicularly or substantially perpendicularly from the distal portion 314. For example, the deformable panel 380 can comprise a proximal surface 382 and a distal surface 384. The distal surface 384 can be coupled to the proximal portion 342 of the balloon anchor 340. The deformable panel 380 can provide mechanical support, for example providing mechanical reinforcement, for the proximal portion 342. The deformable panel 380 can be configured to reduce deformation of an inflated partially circumferential balloon anchor 340, such as when the partially circumferential balloon anchor 340 engages the coronary sinus ostium and an adjacent portion of the coronary sinus. Reduced deformation of the inflated balloon anchor 340 can provide increased reliability in positioning of the elongate tubular member 310 within the coronary sinus.
[0099] Figures 10A and 10B are schematic diagrams of examples of two steerable sheaths each of which includes a partially circumferential balloon anchor comprising a textured surface thereon. Figure 10A shows an example of a steerable sheath 400 including a partially circumferential balloon anchor 440 which comprises a plurality of bumps 490 on an exterior surface. Figure 10B shows an example of a steerable sheath 500 including partially circumferential balloon anchor 540 which comprises a plurality of ridges 590 on an exterior surface.
[0100] The plurality of bumps 490 and the plurality of ridges 590 can be on a portion or all of the exterior surface of the partially circumferential balloon anchors 440, 540. In some embodiments, the plurality of bumps 490 and the plurality of ridges 590 can be only on the distal portion 444 or the distal portion 544, respectively. The plurality of bumps 490 and the plurality of ridges 590 can facilitate desired engagement of the balloon anchor 440 or the balloon anchor 540, respectively, with the coronary sinus ostium and an adjacent portion of the coronary sinus.
[0101] In some embodiments, a partially circumferential balloon anchor can comprise a textured exterior surface configured to engage with the coronary sinus ostium and an adjacent portion of the coronary sinus, the textured exterior surface comprising both a plurality of bumps and a plurality of ridges. It will also be understood that textured surfaces comprising one or more other patterns, in addition or in the alternative, can be applicable.
[0102] In some embodiments, the partially circumferential balloon anchors 440, 540 can comprise one or more features of the partially circumferential balloon anchor 340 described with reference to Figure 9. For example, the partially circumferential balloon anchors 440, 540 can be inflatable. The partially circumferential balloon anchors 440, 540, when in an inflated state, can be configured to contact and engage with the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, so as to facilitate reliable positioning of the elongate tubular members 410, 510 within the coronary sinus. The partially circumferential balloon anchors 440, 540 can be positioned on distal portions 414, 514 of the elongate tubular members 410, 510. The distal ends 448, 548 of the circumferential balloon anchors 440, 540 can be spaced from or at the distal ends 416, 516 of the elongate tubular members 410, 510. While inflated, the partially circumferential balloon anchors 440, 540 can comprise a shape to engage the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium. For example, the distal portions 444, 544 of the partially circumferential balloon anchors 440, 540 can comprise a tapered longitudinal profile, the tapered longitudinal profile tapering toward the distal ends 448, 548 of the partially circumferential balloon anchors 440, 540. The longitudinal profile can extend along a direction parallel or substantially parallel to a longitudinal axis of the elongate tubular members 410, 510. In some embodiments, the tapered longitudinal profile can comprise a curve, including a convex curve. The proximal portions 442, 542 of the partially
circumferential balloon anchors 440, 540 can be coupled to deformable panels 480, 580. The deformable panels 480, 580 can comprise respective proximal surfaces 482, 582 and distal surfaces 484, 584. The distal surfaces 484, 584 can be coupled to the proximal portions 442, 542 of the partially circumferential balloon anchors 440, 540.
[0103] In some embodiments, the partially circumferential balloon anchors 440, 540 can be positioned around less than about 50% of the circumference of the distal portions 414, 514 of the elongate tubular members 410, 510, or less than about 40%, or less than about 30%, or less than about 25%, or less than about 20%.
[0104] Figures 11A and 11B are schematic diagrams showing an example of a steerable sheath 600 comprising a circumferential balloon anchor 640 circumferentially disposed around an elongate tubular member 610 of the steerable sheath 600 and a plurality of cords 650 circumferentially distributed around the circumferential balloon anchor 640. Figures 11A and 11B show an inflated circumferential balloon anchor 640. Figure 11A is a side view of the steerable sheath 600 and Figure 1 IB is a view of the steerable sheath 600 from a distal end 616 of the elongate tubular member 610. Figures 12A and 12B are schematic diagrams showing the plurality of cords 650 engaged with the inflated
circumferential balloon anchor 640 to form the corresponding indentations on the inflated circumferential balloon anchor 640. Figure 12A is a view of the steerable sheath 600 from the distal end 616 of the elongate tubular member 610. Figure 12B is a side view of the steerable sheath 600. The elongate tubular member 610 can comprise an inner lumen 670 configured to receive instrumentation for delivering one or more therapy devices to a target location, such as a delivery catheter for carrying an atrial shunt device to a target location on the left atrial wall. The inflated circumferential balloon anchor 640 can be configured to engage with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion of the coronary sinus, while blood flow is permitted through the ostium. Blood flow through the ostium may be along one or more paths defined at least in part by one or more of the plurality of indentations. As shown in the figures, the circumferential balloon anchor 640 can be a distance from the distal end 616 of the elongate tubular member 610. For example, a distal end 648 of the circumferential balloon anchor 640 can be a distance proximal of the distal end 616 of the elongate tubular member 610. In some embodiments, the circumferential balloon anchor 640 can be at the distal end 616 of the elongate tubular member 610.
[0105] Referring to Figure 11 A, the circumferential balloon anchor 640 can be circumferentially positioned around a distal portion 614 of the elongate tubular member 610. Distal ends 652 of each of the plurality of cords 650 can be coupled to respective locations on the distal portion 644 of the circumferential balloon anchor 640. In some embodiments, distal ends 652 of each of the plurality of cords 650 can be coupled to respective locations on the distal portion 614 of the elongate tubular member 610. Each of the plurality of cords 650 can comprise a portion which extends over at least a portion of the circumferential balloon anchor 640, extending along a longitudinal axis of the elongate tubular member 610.
[0106] Referring to Figure 1 IB, respective distal ends 652 of the plurality of cords 650 can be coupled to corresponding locations on the distal portion 644 of the circumferential balloon anchor 640 and be distributed around the circumferential balloon anchor 640. The circumferential balloon anchor 640 can have a longitudinal axis symmetry, for example being symmetrical around an axis parallel or substantially parallel to the longitudinal axis of the elongate tubular member 610. In some embodiments, the plurality of cords 650 can be evenly or substantially evenly distributed around the circumferential balloon anchor 640, for example dividing the circumferential balloon anchor 640 into even or substantially even portions. Figure 11B shows five cords 650 positioned around the balloon circumferential anchor 640. For example, the five cords 650 can be evenly or substantially evenly distributed around the circumferential balloon anchor 640 to divide the
circumferential balloon anchor into five equal or substantially equal portions. In some embodiments, the plurality of cords 650 may not be evenly distributed around the
circumferential balloon anchor 640.
[0107] The plurality of cords 650 can engage an inflated circumferential balloon anchor 640 to form corresponding indentations on the inflated circumferential balloon anchor 640. Referring to Figure 12A, the plurality of indentations can divide the circumferential balloon anchor 640 into a plurality of portions. For example, the five cords 650 can divide the inflated circumferential balloon anchor 640 into five portions 640a, 640b, 640c, 640d, 640e. In some embodiments, the five cords 650 can be evenly or substantially evenly distributed around the balloon anchor 640 such that the five portions 640a, 640b, 640c, 640d, 640e are uniform or substantially uniform in size and/or shape. [0108] The circumferential balloon anchor 640 can be inflated, and the plurality of cords 650 can be tensioned such that the plurality of cords 650 can compress the inflated circumferential balloon anchor 640 to form the corresponding plurality of indentations. The circumferential balloon anchor 640 can be inflated before and/or after being positioned at the coronary sinus ostium. After the circumferential balloon anchor 640 is in the inflated state, the plurality of cords 650 can be moved proximally relative to the elongate tubular member 610, for example proximally along a longitudinal axis of the elongate tubular member 610, to tension the plurality of cords 650. In some embodiments, the plurality of cords 650 can be in a tensioned state prior to inflation of the circumferential balloon anchor 640 such that inflating the circumferential balloon anchor 640 results in formation of the corresponding plurality of indentations. Pre-tensioning the plurality of cords 650 can reduce needed manipulation of the steerable sheath 600 during a procedure, providing a simplified procedure.
[0109] In some embodiments, the circumferential balloon anchor 640 can be configured to engage the ostium of the coronary sinus. In some embodiments, the
circumferential balloon anchor 640 can be configured to engage the ostium and an adjacent portion of the coronary sinus. Referring to Figure 12B, in some embodiments, the distal portion 644 of the circumferential balloon anchor 640 can have a longitudinal profile comprising a taper toward the distal end 648 of the circumferential balloon anchor 640, the longitudinal profile extending along a direction parallel or substantially parallel to the longitudinal axis of the elongate tubular member 610. The taper of the longitudinal profile can be configured to facilitate desired engagement of the distal portion 644 with the coronary sinus ostium and/or the portion of the coronary sinus adjacent to the ostium. In some embodiments, the tapered distal portion 644 can comprise a curvature, such as a convex curvature. In some embodiments, a proximal portion 642 of the circumferential balloon anchor 640 can comprise a taper to facilitate movement of the circumferential balloon anchor 640, including retraction of the circumferential balloon anchor 640. The longitudinal profile of the proximal portion 642 can comprise a curved taper, such as a curved convex taper, which tapers towards the proximal end 646 of the circumferential balloon anchor 640. In some embodiments, the circumferential balloon anchor 640 can have a maximum cross- sectional size at or around a mid-portion of the anchor 640, and a longitudinal profile of both the proximal portion 642 and distal portion 644 comprising a taper, including a curved convex taper, from or around the mid-portion of the anchor 640 toward the proximal end 646 and the distal tend 648, respectively. [0110] In some embodiments, a circumferential balloon anchor can comprise a textured exterior surface configured to engage with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion of the coronary sinus. The textured exterior surface can comprise one or both of a plurality of bumps and a plurality of ridges. It will be understood that textured surfaces comprising one or more other patterns, in addition or in the alternative, can be applicable.
[0111] Figures 13A and 13B show examples of steerable sheaths comprising helical rib anchors. Figure 13 A is a perspective view of an example of a steerable sheath 700 comprising a helical rib anchor 740 disposed around a distal portion 714 of an elongate tubular member 710. Figure 13B is a perspective view of another example of a steerable sheath 800 comprising a helical rib anchor 840 disposed around a distal portion 814 of an elongate tubular member 810. The helical rib anchors 740, 840 can be configured to engage with the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium. In some embodiments, the helical rib anchors 740, 840 can be deformable to facilitate insertion and/or retraction, and/or secure engagement with the coronary sinus ostium and an adjacent portion of the coronary sinus. The helical rib anchors 740, 840 can be a distance from or at respective distal ends 716, 816 of the elongate tubular members 710, 810 (e.g., distal ends 744, 844 of the helical rib anchors 740, 840 can be a distance from or at respective distal ends 716, 816 of the elongate tubular members 710, 810). The elongate tubular members 710, 810 can comprise respective inner lumens 770, 870 configured to receive instrumentation for delivering one or more therapy devices to a target location, such as a delivery catheter for carrying an atrial shunt device to a target location on the left atrial wall.
[0112] At least a portion of the helical anchors 740, 840 can be configured to be positioned within the coronary sinus. In some embodiments, one or both of the helical rib anchors 740, 840 can be configured to be entirely or substantially entirely positioned within the coronary sinus, both the distal ends 744, 844 and proximal ends 742, 842 being configured to be positioned within the coronary sinus. For example, the proximal ends 742, 842 can be configured to engage with the ostium. In some embodiments, one or both of the helical rib anchors 740, 840 can be configured to be only partially positioned within the coronary sinus. For example, the distal ends 744, 844 and not the proximal ends 742, 842 can be configured to be positioned within the coronary sinus. In some embodiments, an extent to which the helical rib anchors 740, 840 can be positioned into a coronary sinus can be based on individual anatomy. [0113] The helical rib anchors 740, 840 can be configured to allow blood flow through the coronary sinus ostium while the helical rib anchors 740, 840 are in their respective target positions. Blood can flow along a path defined at least in part by the helical rib anchors 740, 840. For example, blood can flow along the helical ribs, such as shown by the arrows in Figures 13A and 13B. While the helical rib anchors 740, 840 are positioned at their respective target locations, blood can flow along a path defined at least in part by the helical ribs of the helical anchors 740, 840 through the coronary sinus ostium.
[0114] Referring to Figure 13A, a height at which the helical rib anchor 740 extends from the elongate tubular member 710 can be uniform or substantially uniform along a dimension parallel or substantially parallel to a longitudinal axis of the elongate tubular member 710. For example, a first height, hi, a second height, h2, and a third height, h3, of the helical rib anchor 740 shown in Figure 13 A can be the same or substantially the same.
[0115] Referring to Figure 13B, a height at which the helical rib anchor 840 extends from the elongate tubular member 810 can increase along a dimension parallel or substantially parallel to a longitudinal axis of the elongate tubular member 810, for example increasing with increased distance from the distal end 816 of the elongate tubular member 810. In Figure 13B, a first height, hi, of the helical rib anchor 840 can be smaller than a second height, h2, which can be smaller than a third height, h3. In some embodiments, a decreasing height of the helical rib anchor 840 toward the distal end 816 of the elongate tubular member 810 can be configured to provide improved engagement with the coronary sinus ostium and an adjacent portion of the coronary sinus, such as by conforming to the anatomy of the coronary sinus.
[0116] Figures 14A and 14B show examples of steerable sheaths comprising one or more coil anchors. Figure 14A is a perspective view of an example of a steerable sheath 900 comprising a coil anchor 940 disposed around a distal portion 914 of an elongate tubular member 910. Figure 14B is a perspective view of an example of a steerable sheath 1000 comprising a first coil anchor 1040 and a second coil anchor 1050 disposed around a distal portion 1014 of an elongate tubular member 1010. Each of the elongate tubular members 910, 1010 can comprise an inner lumen 970, 1070 configured to receive instrumentation for delivering one or more therapy devices to a target location. For example, the inner lumens 970, 1070 can be configured to receive a delivery catheter for carrying an atrial shunt device to a target location on the left atrial wall.
[0117] The coil anchor 940 of the steerable sheath 900 can be configured to engage with the coronary sinus ostium. The coil anchor 940 can be positioned at the ostium while a distal end 916 of the elongate tubular member 910 can be at or proximate to a target tissue site on the left atrial wall accessible from within the coronary sinus. For example, the coil anchor 940 can be at a distance from the distal end 916 of the elongate tubular member 910 such that the distal end 916 can be positioned into the coronary sinus while at least a portion of the coil anchor 940 is in the ostium. In some embodiments, the coil anchor 940 can be positioned to engage the ostium such that a portion of the coil anchor 940 is in the right atrium and a portion of the coil anchor 940 is in the coronary sinus. The coil anchor 940 can be configured to permit blood to flow through the ostium while the coil anchor 940 is in desired engagement with the ostium. For example, blood can flow between the coils of the coil anchor 940.
[0118] Referring to Figure 14B, the first coil anchor 1040 of the steerable sheath 1000 can be positioned adjacent to and proximal of second coil anchor 1050 on the distal portion 1014 of the elongate tubular member 1010. The second coil anchor 1050 can include coils comprising a diameter smaller than that of the first coil anchor 1040. The first coil anchor 1040 can be configured to engage the coronary sinus ostium and the second coil anchor 1050 can be configured to engage a portion of the coronary sinus adjacent to the ostium. For example, the first coil anchor 1040 and the second coil anchor 1050 can be at a distance from the distal end 1016 of the elongate tubular member 1010 such that the distal end 1016 can be positioned within the coronary sinus while the first coil anchor 1040 and the second coil anchor 1050 engage the coronary sinus ostium and an adjacent portion of the coronary sinus, respectively. In some embodiments, the second coil anchor 1050 can be at the distal end 1016 of the elongate tubular member 1010.
[0119] The coil anchors 1040, 1050 can be configured to permit blood to flow through the ostium while the coil anchors 1040, 1050 are in desired engagement with the coronary sinus ostium and an adjacent portion of the coronary sinus. For example, blood can flow through the ostium between coils of the coil anchors 1040, 1050.
[0120] In some embodiments, one or more of the coil anchors 940, 1040, 1050 can be expandable. One or more of the coil anchors 940, 1040, 1050 can be kept in a compact state during at least a part of the insertion of the elongate tubular members 910, 1010 to the target tissue site. In some embodiments, one or more of the coil anchors 940, 1040, 1050 can comprise shape memory material. The one or more coil anchors 940, 1040, 1050 can be maintained in the compact state until a predetermined location is reached. The one or more coil anchors 940, 1040, 1050 can then be allowed to assume an expanded state, such as when the one or more coil anchors 940, 1040, 1050 comprising the shape memory material can assume their respective desired coil configurations. In some embodiments, a diameter of the coils of one or more of the coil anchors 940, 1040, 1050 can be adjusted based on patient anatomy. For example, a degree of expansion of the one or more coil anchors 940, 1040,
1050 can be adjusted during an implantation procedure in response to a size of a coronary sinus ostium, and/or an adjacent portion of the coronary sinus.
[0121] In some embodiments, the one or more of the coil anchors 940, 1040, 1050 can assume an expanded state after the coil anchors 940, 1040, 1050 are positioned at respective target locations. For example, after the distal ends 916, 1016 of the elongate tubular members 910, 1010 are positioned at or adjacent to the target tissue site, one or more of the coil anchors 940, 1040, 1050 can assume the expanded state. In some embodiments, the one or more of the coil anchors 940, 1040, 1050 can be expanded until desired
engagement with the coronary sinus ostium and/or an adjacent portion of the coronary sinus is achieved. In some embodiments, one or more of the coil anchors 940, 1040, 1050 can assume an expanded state before the coil anchors 940, 1040, 1050 are positioned at respective target locations. For example, the one or more of the coil anchors 940, 1040, 1050 can be expanded after the one or more of the coil anchors 940, 1040, 1050 are extended from the inferior vena cava or the superior vena cava into the right atrium but before the one or more of the coil anchors 940, 1040, 1050 are positioned at their respective desired locations. In some embodiments, the one or more of the coil anchors 940, 1040, 1050 can be expanded both before and after the coil anchors 940, 1040, 1050 are positioned at respective target locations. For example, the one or more of the coil anchors 940, 1040, 1050 can assume a partially expanded state before being positioned at the respective desired locations, such as while the one or more of the coil anchors 940, 1040, 1050 are in the right atrium. The coil anchors 940, 1040, 1050 can then assume a fully expanded state after the one or more of the coil anchors 940, 1040, 1050 are positioned at their respective desired locations.
[0122] Figure 15 is a perspective view of an example of a steerable sheath 1100 comprising a partially circumferential ring anchor 1140 positioned on an elongate tubular member 1110 of the steerable sheath 1100. The elongate tubular member 1110 can comprise an inner lumen 1170 configured to receive instrumentation for delivering one or more therapy devices to a target location, such as a delivery catheter for carrying an atrial shunt device to a target location on the left atrial wall. The partially circumferential ring anchor 1140 can be positioned on a distal portion 1114 of the elongate tubular member 1110. The partially circumferential ring anchor 1140 can be configured to be positioned to engage with the coronary sinus ostium. The partially circumferential ring anchor 1140 can be a distance from or at the distal end 1116 of the elongate tubular member 1110 (e.g., a distal portion 1144 of the partially circumferential ring anchor 1140 can be a distance from or at the distal end 1116 of the elongate tubular member 1110).
[0123] As shown in Figure 15, the partially circumferential ring anchor 1140 can be positioned around only a portion of the circumference of the distal portion 1114. As used herein, a“partially circumferential ring anchor” can refer to any ring anchor configured to be positioned on, disposed around and/or extending from, any partial portion of the
circumference of the distal portion 1114, and where the ring anchor does not circumscribe the distal portion 1114.
[0124] The partially circumferential ring anchor 1140 can facilitate blood flow through the coronary sinus ostium and past the partially circumferential ring anchor 1140 while the partially circumferential ring anchor 1140 is positioned at and in engagement with the coronary sinus ostium, or the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium. The partially circumferential ring anchor 1140 can provide desired contact with the coronary sinus ostium, or the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium, to provide stable positioning of the elongate tubular member 1110, while allowing sufficient area around the steerable sheath 1100 at the coronary sinus ostium such that sufficient blood flow can pass therethrough. In some embodiments, the partially circumferential ring anchor 1140 can be positioned around less than about 50% of the circumference of the distal portion 1114 of the elongate tubular member 1110, or less than about 40%, less than about 30%, less than about 25%, or less than about 20%.
[0125] The partially circumferential ring anchor 1140 can have a proximal portion 1142, a distal portion 1144 and a lateral portion 1146 extending between the proximal portion 1142 and the distal portion 1144. In some embodiments, the distal portion 1144 and/or the lateral portion 1146 can be configured to engage with the coronary sinus ostium, or both the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium. In some embodiments, at least a portion of the lateral portion 1146 can be configured to engage the ostium, or the ostium and a portion of the coronary sinus adjacent to the ostium. For example, the partially circumferential ring anchor 1140 can be sized such that when at least a portion of the anchor 1140 is positioned within the coronary sinus ostium, the lateral portion 1146 can be configured to engage the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion, to provide stable positioning of the elongate tubular member 1110.
[0126] In some embodiments, the distal portion 1144 can be configured to engage the ostium. In some embodiments, the partially circumferential ring anchor 1140 can be positioned against the ostium such that the distal portion 1144 is configured to engage the ostium. For example, the partially circumferential ring anchor 1140 can be positioned against the coronary sinus ostium such that the proximal portion 1142 and the lateral portion 1146 of the partially circumferential ring anchor 1140 are outside or substantially outside of the coronary sinus, and the distal portion 1144 can engage the coronary sinus ostium.
[0127] In some embodiments, a partially circumferential ring anchor can comprise a planar or substantially planar distal portion and/or proximal portion. In some embodiments, the distal portion and/or the proximal portion can be non-planar. In some embodiments, a distal portion of a partially circumferential ring anchor can comprise a shape and/or dimension to engage the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion of the coronary sinus ostium. For example, the distal portion can have a longitudinal profile comprising a taper toward a distal end of the partially circumferential ring anchor. The longitudinal profile can extend along a direction parallel or substantially parallel to a longitudinal axis of the elongate tubular member. The tapered longitudinal profile may comprise a curved taper, such as a convex taper, configured to engage the coronary sinus ostium and an adjacent portion of the coronary sinus. In some embodiments, the lateral portion can be configured to engage the coronary sinus ostium and the distal portion can be configured to engage a portion of the coronary sinus adjacent to the ostium.
[0128] In some embodiments, a steerable sheath can comprise a suction anchor. The steerable sheath can comprise an elongate tubular member, and the suction anchor can be positioned on a distal portion of the elongate tubular member. The suction anchor can be configured to engage with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion, and permit blood to flow through the ostium, while the suction anchor is positioned at the ostium.
[0129] Figure 16 is a flow diagram of an example of a procedure 1600 for deploying a steerable sheath into the coronary sinus. The steerable sheath can comprise an elongate tubular member and an anchor positioned on a distal portion of the elongate tubular member. The steerable sheath can have one or more configurations as described herein. For example, the anchor can comprise any one of the partially circumferential balloon anchor, circumferential balloon anchor, helical rib anchor, coil anchor, partially circumferential ring anchor, and suction anchor, as described herein.
[0130] In block 1602, the procedure 1600 involves providing the steerable sheath. In block 1604, the procedure 1600 involves introducing the distal portion of the elongate tubular member through the inferior vena cava or superior vena cava, and into the right atrium. In some embodiments, the elongate tubular member can be introduced through a femoral vein and into the inferior vena cava. In some embodiments, the elongate tubular member can be introduced through a jugular vein or a subclavian vein and into the superior vena cava. In block 1606, the procedure 1600 involves inserting the distal end of the elongate tubular member into the coronary sinus from the right atrium via the coronary sinus ostium, and the anchor can be positioned at the coronary sinus ostium. The anchor can be on the distal portion of the elongate tubular member and at a distance from a distal end of the elongate tubular member. The anchor can be spaced from the distal end of the elongate tubular member such that while the distal end is placed at or adjacent to a target tissue site, the anchor can be positioned to engage with the coronary sinus ostium. In some
embodiments, the anchor can be at the distal end of the elongate tubular member.
[0131] In block 1608, the procedure 1600 involves engaging the anchor with the coronary sinus ostium, while blood flow is permitted through the ostium past the anchor. In some embodiments, the anchor can be engaged with both the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium.
[0132] Figure 17 is a flow diagram of an example of a procedure 1700 for deploying a steerable sheath comprising a circumferential balloon anchor into the coronary sinus. The steerable sheath can comprise an elongate tubular member and a circumferential balloon anchor positioned on a distal portion of the elongate tubular member. A plurality of cords can be circumferentially distributed around the circumferential balloon anchor.
Respective distal ends of the plurality of cords can be coupled to corresponding locations on a distal portion of the circumferential balloon anchor. In some embodiments, respective distal ends of the plurality of cords can be coupled to corresponding locations on the distal portion of the elongate tubular member. In block 1702, the procedure 1700 involves providing the steerable sheath. In block 1704, the procedure 1700 involves introducing the distal portion of the elongate tubular member through the inferior vena cava or superior vena cava and into the right atrium. The circumferential balloon anchor can be on the distal portion of the elongate tubular member at a distance away from a distal end of the elongate tubular member. In some embodiments, the circumferential balloon anchor can be at the distal end of the elongate tubular member. In block 1706, the procedure 1700 involves inserting the distal end of the elongate tubular member into the coronary sinus from the right atrium via the coronary sinus ostium, and the circumferential balloon anchor can be positioned at the coronary sinus ostium. [0133] In block 1708, the procedure 1700 involves inflating the circumferential balloon anchor to engage the circumferential balloon anchor with the plurality of cords to create a plurality of corresponding circumferentially distributed indentations around the inflated circumferential balloon anchor. The plurality of cords can be tensioned such that the plurality of cords can engage the inflated circumferential balloon anchor to provide the corresponding circumferentially distributed indentations. For example, the plurality of cords can be moved proximally in a direction along a longitudinal axis of the elongate tubular member to tension the plurality of cords such that the plurality of cords compress the inflated circumferential balloon anchor. The plurality of indentations can be formed by compression of the inflated circumferential balloon anchor using the plurality of cords.
[0134] The circumferential balloon anchor can be inflated both before and/or after the distal portion of the elongate tubular member is positioned at a desired location. The circumferential balloon anchor can be kept in a deflated state during at least a part its insertion to the coronary sinus ostium. In some embodiments, the circumferential balloon anchor can be inflated after being positioned at the coronary sinus ostium. The
circumferential balloon anchor can be inflated until desired engagement with the coronary sinus ostium, or the coronary sinus ostium and an adjacent portion of the coronary sinus, is achieved. In some embodiments, the circumferential balloon anchor can be inflated after the circumferential balloon anchor is inserted into the right atrium but before the circumferential balloon anchor is positioned at the coronary sinus ostium. In some embodiments, a degree of inflation of the circumferential balloon anchor can be adjusted in response to individual anatomy.
[0135] In block 1710, the procedure 1700 involves engaging the inflated circumferential balloon anchor with the coronary sinus ostium, while blood flow is permitted through the ostium along the plurality of indentations. In some embodiments, the
circumferential balloon anchor can be engaged with both the coronary sinus ostium and a portion of the coronary sinus adjacent to the ostium. In some embodiments, the
circumferential balloon anchor can be deflated for retraction after the medical implant device and/or therapeutic procedure has been delivered.
Additional Embodiments
[0136] Depending on the embodiment, certain acts, events, or functions of any of the processes or algorithms described herein can be performed in a different sequence, may be added, merged, or left out altogether. Thus, in certain embodiments, not all described acts or events are necessary for the practice of the processes.
[0137] Conditional language used herein, such as, among others,“can,”“could,” “might,”“may,”“e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is intended in its ordinary sense and is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or steps. Thus, such conditional language is not generally intended to imply that features, elements and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and/or steps are included or are to be performed in any particular embodiment. The terms “comprising,”“including,”“having,” and the like are synonymous, are used in their ordinary sense, and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term“or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term“or” means one, some, or all of the elements in the list. Conjunctive language such as the phrase“at least one of X, Y and Z,” unless specifically stated otherwise, is understood with the context as used in general to convey that an item, term, element, etc. may be either X, Y or Z. Thus, such conjunctive language is not generally intended to imply that certain embodiments require at least one of X, at least one of Y and at least one of Z to each be present.
[0138] It should be appreciated that in the above description of embodiments, various features are sometimes grouped together in a single embodiment, Figure, or description thereof for the purpose of streamlining the disclosure and aiding in the understanding of one or more of the various inventive aspects. This method of disclosure, however, is not to be interpreted as reflecting an intention that any claim require more features than are expressly recited in that claim. Moreover, any components, features, or steps illustrated and/or described in a particular embodiment herein can be applied to or used with any other embodiment(s). Further, no component, feature, step, or group of components, features, or steps are necessary or indispensable for each embodiment. Thus, it is intended that the scope of the inventions herein disclosed and claimed below should not be limited by the particular embodiments described above, but should be determined only by a fair reading of the claims that follow. [0139] It should be understood that certain ordinal terms (e.g.,“first” or“second”) may be provided for ease of reference and do not necessarily imply physical characteristics or ordering. Therefore, as used herein, an ordinal term (e.g.,“first,”“second,”“third,” etc.) used to modify an element, such as a structure, a component, an operation, etc., does not necessarily indicate priority or order of the element with respect to any other element, but rather may generally distinguish the element from another element having a similar or identical name (but for use of the ordinal term). In addition, as used herein, indefinite articles (“a” and“an”) may indicate“one or more” rather than“one.” Further, an operation performed “based on” a condition or event may also be performed based on one or more other conditions or events not explicitly recited.
[0140] Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which example embodiments belong. It be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
[0141] The spatially relative terms“outer,”“inner,”“upper,”“lower,”“below,” “above,”“vertical,”“horizontal,” and similar terms, may be used herein for ease of description to describe the relations between one element or component and another element or component as illustrated in the drawings. It be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation, in addition to the orientation depicted in the drawings. For example, in the case where a device shown in the drawing is turned over, the device positioned“below” or“beneath” another device may be placed“above” another device. Accordingly, the illustrative term“below” may include both the lower and upper positions. The device may also be oriented in the other direction, and thus the spatially relative terms may be interpreted differently depending on the orientations.
[0142] Unless otherwise expressly stated, comparative and/or quantitative terms, such as“less,”“more,”“greater,” and the like, are intended to encompass the concepts of equality. For example,“less” can mean not only“less” in the strictest mathematical sense, but also,“less than or equal to.”

Claims

WHAT IS CLAIMED IS:
1. A steerable sheath comprising:
an elongate tubular member comprising an inner lumen configured to receive a plurality of instruments; and
a partially circumferential balloon anchor disposed partially circumferentially on a distal portion of the elongate tubular member and the partially circumferential balloon anchor including a proximal balloon portion and a distal balloon portion;
wherein, when the partially circumferential balloon anchor is in an inflated state the distal balloon portion has a tapered longitudinal profile tapering toward a distal end of the partially circumferential balloon anchor, and the partially circumferential balloon anchor is configured to, while positioned to engage with a coronary sinus, permit blood flow through an ostium of the coronary sinus.
2. The steerable sheath of claim 1, wherein the partially circumferential balloon anchor, in the inflated state, is configured to be positioned to engage with both the ostium and a portion of the coronary sinus adjacent to the ostium.
3. The steerable sheath of claim 1 or 2, wherein the tapered longitudinal profile comprises a convex curvature.
4. The steerable sheath of any one of claims 1 to 3, wherein the partially
circumferential balloon anchor is positioned around less than 50% of a circumference of the distal portion of the elongate tubular member.
5. The steerable sheath of any one of claims 1 to 4, wherein the partially
circumferential balloon anchor comprises a textured exterior surface configured to engage with the ostium and a portion of the coronary sinus adjacent to the ostium.
6. The steerable sheath of claim 5, wherein the textured exterior surface comprises a plurality of bumps.
7. The steerable sheath of claim 5 or 6, wherein the textured exterior surface comprises a plurality of ridges.
8. The steerable sheath of any one of claims 1 to 7, wherein the proximal balloon portion extends laterally from the distal portion of the elongate tubular member, a deformable panel being coupled to the proximal balloon portion.
9. The steerable sheath of any one of claims 1 to 8, wherein the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location.
10. The steerable sheath of claim 9, wherein the therapy device comprises a shunt device for deployment onto a left atrial wall.
11. A steerable sheath comprising:
an elongate tubular member comprising an inner lumen configured to receive a plurality of instruments; and
a circumferential balloon anchor disposed circumferentially around a distal portion of the elongate tubular member, and a plurality of cords circumferentially distributed around the circumferential balloon anchor;
wherein, when the circumferential balloon anchor is in an inflated state the plurality of cords are configured to engage the circumferential balloon anchor to create corresponding circumferentially distributed indentations on the circumferential balloon anchor, and the circumferential balloon anchor is configured to, while positioned to engage with a coronary sinus, permit blood flow through an ostium of the coronary sinus along a path defined at least in part by the circumferentially distributed indentations.
12. The steerable sheath of claim 11, wherein the circumferential balloon anchor, in the inflated state, is configured to be positioned to engage with the ostium.
13. The steerable sheath of claim 11 or 12, wherein the circumferential balloon anchor comprises a proximal balloon portion and a distal balloon portion, and respective distal ends of the plurality of cords are coupled to corresponding locations on the distal balloon portion, the plurality of cords being movable relative to the elongate tubular member along a longitudinal axis of the elongate tubular member, and wherein moving the plurality of cords proximally relative to the elongate tubular member is configured to engage the
circumferential balloon anchor in the inflated state with the plurality of cords to provide the corresponding circumferentially distributed indentations.
14. The steerable sheath of claim 13, wherein the distal balloon portion comprises a tapered longitudinal profile tapering toward a distal end of the circumferential balloon anchor, the distal balloon portion being configured to engage with the ostium and a portion of the coronary sinus adjacent to the ostium.
15. The steerable sheath of any one of claims 11 to 14, wherein the plurality of cords comprises five cords.
16. The steerable sheath of any one of claims 11 to 15, wherein the circumferential balloon anchor comprises a textured exterior surface configured to engage with the ostium and a portion of the coronary sinus adjacent to the ostium.
17. The steerable sheath of claim 16, wherein the textured exterior surface comprises a plurality of bumps.
18. The steerable sheath of claim 16 or 17, wherein the textured exterior surface comprises a plurality of ridges.
19. The steerable sheath of any one of claims 11 to 18, wherein the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location.
20. The steerable sheath of claim 19, wherein the therapy device comprises a shunt device for deployment onto a left atrial wall.
21. A method of accessing a heart location, the method comprising:
providing a steerable sheath comprising an elongate tubular member, a
circumferential balloon anchor circumferentially positioned around a distal portion of the elongate tubular member and a plurality of cords circumferentially distributed around the circumferential balloon anchor;
introducing the distal portion of the elongate tubular member through an inferior vena cava or a superior vena cava, and into a right atrium;
inserting a distal end of the elongate tubular member through an ostium of a coronary sinus into the coronary sinus from the right atrium, and positioning the distal end at a target location within the coronary sinus; inflating the circumferential balloon anchor to engage an inflated circumferential balloon anchor with the plurality of cords to create corresponding circumferentially distributed indentations on the inflated circumferential balloon anchor; and
engaging the inflated circumferential balloon anchor with the coronary sinus while permitting blood flow through the ostium past the inflated circumferential balloon anchor along a path defined at least in part by the circumferentially distributed indentations.
22. The method of claim 21, wherein engaging the coronary sinus comprises engaging the inflated circumferential balloon anchor with the ostium of the coronary sinus.
23. The method of claim 21 or 22, further comprising moving the plurality of cords proximally along a longitudinal axis of the elongate tubular member, respective distal ends of the plurality of cords being coupled to corresponding locations on a distal balloon portion, wherein moving the plurality of cords compresses the inflated circumferential balloon anchor to provide the corresponding circumferentially distributed indentations on the inflated circumferential balloon anchor.
24. The method of any one of claims 21 to 23, further comprising inserting into an inner lumen of the elongate tubular member a delivery catheter carrying a therapy device, and advancing a distal end of the delivery catheter from the distal end of the elongate tubular member for positioning at the target location.
25. The method of claim 24, wherein inserting into the inner lumen of the elongate tubular member a delivery catheter carrying a therapy device comprises inserting a shunt delivery catheter carrying an atrial shunt device.
26. A steerable sheath comprising:
an elongate tubular member comprising an inner lumen configured to receive a plurality of instruments; and
a deformable helical rib anchor disposed around a distal portion of the elongate tubular member, the deformable helical rib anchor being configured to engage with a coronary sinus, and to permit blood flow through an ostium of the coronary sinus along a path defined at least in part by the deformable helical rib anchor while the deformable helical rib is positioned to engage with the coronary sinus.
27. The steerable sheath of claim 26, wherein the deformable helical rib anchor is configured to be positioned to engage with both the ostium of the coronary sinus and a portion of the coronary sinus adjacent to the ostium.
28. The steerable sheath of claim 26 or 27, wherein a height at which the deformable helical rib anchor extends from the distal portion of the elongate tubular member increases with increased distance from a distal end of the elongate tubular member.
29. The steerable sheath of claim 26 or 27, wherein a height at which the deformable helical rib anchor extends from the distal portion of the elongate tubular member is uniform along a dimension of the deformable helical rib anchor parallel with a longitudinal axis of the elongate tubular member.
30. The steerable sheath of any one of claims 26 to 29, wherein the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location.
31. The steerable sheath of claim 30, wherein the therapy device comprises a shunt device for deployment onto a left atrial wall.
32. A steerable sheath comprising:
an elongate tubular member comprising an inner lumen configured to receive a plurality of instruments; and
a first expandable coil anchor disposed around a distal portion of the elongate tubular member, the first expandable coil being configured to engage with a coronary sinus and to permit blood flow through an ostium of the coronary sinus while the first expandable coil anchor is in an expanded state and positioned to engage with the coronary sinus.
33. The steerable sheath of claim 32, wherein the first expandable coil is configured to be positioned to engage with the ostium of the coronary sinus.
34. The steerable sheath of claim 32 or 33, further comprising a second expandable coil anchor positioned distally adjacent to the first expandable coil anchor, the second expandable coil anchor comprising a diameter smaller than that of the first expandable coil anchor, the second expandable coil anchor being configured to engage with a portion of the coronary ostium adjacent to the ostium when in an expanded state, and the first expandable coil anchor and the second expandable coil anchor being configured to permit blood flow through the ostium while the first expandable coil anchor and the second expandable coil anchor are positioned to engage with the ostium and the portion of the coronary sinus adjacent to the ostium.
35. The steerable sheath of any one of claims 32 to 34, wherein the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location.
36. The steerable sheath of claim 35, wherein the therapy device comprises a shunt device for deployment onto a left atrial wall.
37. A steerable sheath comprising:
an elongate tubular member comprising an inner lumen configured to receive a plurality of instruments; and
a partially circumferential ring anchor disposed partially circumferentially on a distal portion of the elongate tubular member, the partially circumferential ring anchor being configured to permit blood flow through an ostium of a coronary sinus while the partially circumferential ring anchor is positioned to engage with the coronary sinus.
38. The steerable sheath of claim 37, wherein the partially circumferential ring anchor is configured to be positioned to engage with the ostium.
39. The steerable sheath of claim 37 or 38, wherein the partially circumferential ring anchor comprises a proximal ring portion and a distal ring portion, the distal ring portion comprising a tapered longitudinal profile tapering toward a distal end of the ring, the partially circumferential ring anchor being configured to engage with the ostium and a portion of the coronary sinus adjacent to the ostium.
40. The steerable sheath of any one of claim 37 to 39, wherein the partially circumferential ring is disposed around less than 50% of a circumference of the distal portion of the elongate tubular member.
41. The steerable sheath of any one of claims 37 to 40, wherein the inner lumen is configured to receive a therapy device delivery catheter carrying a therapy device for deployment to a heart location.
42. The steerable sheath of claim 41, wherein the therapy device comprises a shunt device for deployment onto a left atrial wall.
43. A method of accessing a heart location, the method comprising:
providing a steerable sheath comprising an elongate tubular member and an anchor positioned on a distal portion of the elongate tubular member;
introducing the distal portion of the elongate tubular member through an inferior vena cava or a superior vena cava, and into a right atrium;
inserting a distal end of the elongate tubular member through an ostium of a coronary sinus into the coronary sinus from the right atrium, and positioning the distal end at a target location within the coronary sinus; and
engaging the anchor with the coronary sinus while permitting blood flow through the ostium past the anchor.
44. The method of claim 43, wherein engaging the coronary sinus comprises engaging the ostium of the coronary sinus with the anchor.
45. The method claim 43 or 44, further comprising inserting into an inner lumen of the elongate tubular member a delivery catheter carrying a therapy device, and advancing a distal end of the delivery catheter from the distal end of the elongate tubular member for positioning at the target location.
46. The method of claim 45, wherein inserting into the inner lumen of the elongate tubular member a delivery catheter carrying a therapy device comprises inserting a shunt delivery catheter carrying an atrial shunt device.
PCT/US2020/027147 2019-04-22 2020-04-08 Anchor for transcatheter access into the coronary sinus Ceased WO2020219265A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/507,734 US12678191B2 (en) 2019-04-22 2021-10-21 Anchor for transcatheter access into the coronary sinus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962836851P 2019-04-22 2019-04-22
US62/836,851 2019-04-22

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/507,734 Continuation US12678191B2 (en) 2019-04-22 2021-10-21 Anchor for transcatheter access into the coronary sinus

Publications (1)

Publication Number Publication Date
WO2020219265A1 true WO2020219265A1 (en) 2020-10-29

Family

ID=70554169

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2020/027147 Ceased WO2020219265A1 (en) 2019-04-22 2020-04-08 Anchor for transcatheter access into the coronary sinus

Country Status (2)

Country Link
US (1) US12678191B2 (en)
WO (1) WO2020219265A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11622695B1 (en) 2020-04-23 2023-04-11 Shifamed Holdings, Llc Intracardiac sensors with switchable configurations and associated systems and methods
US11633194B2 (en) 2020-11-12 2023-04-25 Shifamed Holdings, Llc Adjustable implantable devices and associated methods
US11801369B2 (en) 2020-08-25 2023-10-31 Shifamed Holdings, Llc Adjustable interatrial shunts and associated systems and methods
CN117202961A (en) * 2021-04-27 2023-12-08 爱德华兹生命科学公司 Guidewire delivery catheter with expandable anchoring mechanism for coronary sinus
US12090290B2 (en) 2021-03-09 2024-09-17 Shifamed Holdings, Llc Shape memory actuators for adjustable shunting systems, and associated systems and methods
US12151071B2 (en) 2019-09-09 2024-11-26 Shifamed Holdings, Llc Adjustable shunts and associated systems and methods
US12213817B2 (en) 2020-04-23 2025-02-04 Shifamed Holdings, Llc Systems and methods for radiographic monitoring of shunts
US12440656B2 (en) 2020-04-23 2025-10-14 Shifamed Holdings, Llc Power management for interatrial shunts and associated systems and methods
US12533500B2 (en) 2019-06-18 2026-01-27 Shifamed Holdings, Llc Adjustable interatrial shunts and associated systems and methods
US12544010B2 (en) 2020-10-28 2026-02-10 Shifamed Holdings, Llc Systems and methods for electrical monitoring of implantable devices
US12569296B2 (en) 2021-09-29 2026-03-10 Medtronic Vascular, Inc. Left-atrium-to-coronary-sinus shunt
US12661119B2 (en) 2020-10-16 2026-06-23 Shifamed Holdings, Llc Dual purpose inductors for implantable medical devices and associated systems and methods
US12661487B2 (en) 2021-06-25 2026-06-23 Shifamed Holdings, Llc Antenna assemblies for medical systems and associated systems and methods

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113395931A (en) 2018-12-12 2021-09-14 爱德华兹生命科学公司 Cardiac implant device with integrated pressure sensing
CN114206265A (en) * 2019-04-16 2022-03-18 尼奥绰德有限公司 Transverse spiral cardiac anchor for minimally invasive cardiac valve repair
WO2020219265A1 (en) 2019-04-22 2020-10-29 Edwards Lifesciences Corporation Anchor for transcatheter access into the coronary sinus
JP2022536362A (en) 2019-06-12 2022-08-15 エドワーズ ライフサイエンシーズ コーポレイション Fluid bypass conduit for left atrial pressure management
CN122297046A (en) 2019-08-22 2026-06-30 爱德华兹生命科学公司 Puncture needle
JP7528198B2 (en) 2019-09-19 2024-08-05 エドワーズ ライフサイエンシーズ コーポレイション Transcatheter Needle System
CN114727836B (en) 2019-11-14 2026-01-09 爱德华兹生命科学公司 Transcatheter delivery of medical implants
WO2022133070A1 (en) 2020-12-18 2022-06-23 Edwards Lifesciences Corporation Flexible shunt implants
US12527942B2 (en) 2021-02-01 2026-01-20 Edwards Lifesciences Corporation Pulmonary vein shunting
US20220257283A1 (en) * 2021-02-15 2022-08-18 Medtronic, Inc. Echogenic delivery system for leadless pacemaker
IL308303A (en) 2021-05-21 2024-01-01 Edwards Lifesciences Corp Securing a guidewire delivery catheter in the coronary sinus using a mechanically releasing arm
WO2024025981A1 (en) * 2022-07-27 2024-02-01 Medtronic, Inc. System for placement of a medical device including an inflatable balloon

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5669880A (en) * 1993-08-24 1997-09-23 Cordis Corporation Stent delivery system
US6758854B1 (en) * 1997-05-09 2004-07-06 St. Jude Medical Splittable occlusion balloon sheath and process of use
US20040230156A1 (en) * 2003-02-13 2004-11-18 Schreck Stefan Georg Methods and devices for in-situ crosslinking of vascular tissue
US6913600B2 (en) * 1991-07-16 2005-07-05 Heartport, Inc. Endovascular system for arresting the heart
US20100298930A1 (en) * 2007-12-02 2010-11-25 Boris Orlov Access to the left atrium and reduction of mitral valve leaflet mobility

Family Cites Families (566)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538917A (en) 1968-04-12 1970-11-10 Robert G Selker Balloon occlusion clip
US3675656A (en) 1969-05-26 1972-07-11 Salomon Hakim Fluid operatable hemostat
US3730186A (en) 1971-03-05 1973-05-01 Univ California Adjustable implantable artery-constricting device
DE2242165C3 (en) 1972-08-26 1975-02-20 Standard-Messgeraete-Fabrik Gmbh, 4760 Werl Dosing system
US3853126A (en) 1973-11-15 1974-12-10 Heyer Schulte Corp Artery-to-vein shunt
US3882862A (en) 1974-01-11 1975-05-13 Olga Berend Arteriovenous shunt
US3903894A (en) 1974-07-26 1975-09-09 Isaac Michael Rosen Implantable clamp
US4256094A (en) 1979-06-18 1981-03-17 Kapp John P Arterial pressure control system
US4578061A (en) 1980-10-28 1986-03-25 Lemelson Jerome H Injection catheter and method
US4428365A (en) 1982-03-01 1984-01-31 Hakky Said I Anti-incontinent prostheses
US5370675A (en) 1992-08-12 1994-12-06 Vidamed, Inc. Medical probe device and method
FR2534801A1 (en) 1982-10-21 1984-04-27 Claracq Michel DEVICE FOR PARTIALLY OCCLUDING A VESSEL, PARTICULARLY OF THE CAUDAL CAVE VEIN, AND CONSTITUENT PART THEREOF
US4546499A (en) 1982-12-13 1985-10-15 Possis Medical, Inc. Method of supplying blood to blood receiving vessels
US4774949A (en) 1983-06-14 1988-10-04 Fogarty Thomas J Deflector guiding catheter
US5190546A (en) 1983-10-14 1993-03-02 Raychem Corporation Medical devices incorporating SIM alloy elements
US4655777A (en) 1983-12-19 1987-04-07 Southern Research Institute Method of producing biodegradable prosthesis and products therefrom
US5423878A (en) 1984-03-06 1995-06-13 Ep Technologies, Inc. Catheter and associated system for pacing the heart
US4556050A (en) 1984-05-02 1985-12-03 Hodgson Darel E Artificial sphincter including a shape memory member
EP0192712A1 (en) 1984-09-05 1986-09-03 Intra Optics Laboratories Pty. Limited Control of blood flow
US4881939A (en) 1985-02-19 1989-11-21 The Johns Hopkins University Implantable helical cuff
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US5756696A (en) 1986-01-16 1998-05-26 Regents Of The University Of California Compositions for chromosome-specific staining
US4708140A (en) 1986-05-08 1987-11-24 Baron Howard C Atraumatic vascular balloon clamp
US4712551A (en) 1986-10-14 1987-12-15 Rayhanabad Simon B Vascular shunt
US4762128A (en) 1986-12-09 1988-08-09 Advanced Surgical Intervention, Inc. Method and apparatus for treating hypertrophy of the prostate gland
DE3710913A1 (en) 1987-04-01 1988-10-13 Manfred Wolfgang Dr Helzel PUNCTURE CATHETER
US4946457A (en) 1987-12-03 1990-08-07 Dimed, Incorporated Defibrillator system with cardiac leads and method for transvenous implantation
US5328471A (en) 1990-02-26 1994-07-12 Endoluminal Therapeutics, Inc. Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens
US4950227A (en) 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
US4961729A (en) 1988-12-13 1990-10-09 Vaillancourt Vincent L Catheter insertion assembly
US5222362A (en) 1989-01-10 1993-06-29 Maus Daryl D Heat-activated drug delivery system and thermal actuators therefor
US5242397A (en) 1989-06-20 1993-09-07 Cedars-Sinai Medical Center Catheter device and method of use for intramural delivery of protein kinase C and tyrosine protein kinase inhibitors to prevent restenosis after balloon angioplasty
EP0408245B1 (en) 1989-07-13 1994-03-02 American Medical Systems, Inc. Stent placement instrument
JPH07101548B2 (en) 1989-08-04 1995-11-01 パイオニア株式会社 Car audio system
US4997431A (en) 1989-08-30 1991-03-05 Angeion Corporation Catheter
DE69029141T2 (en) 1989-09-08 1997-04-10 Boston Scientific Corp., Natick, Mass. ANGIOPLASTY WITH LOW PHYSIOLOGICAL STRESS
US5267940A (en) 1989-11-29 1993-12-07 The Administrators Of The Tulane Educational Fund Cardiovascular flow enhancer and method of operation
US5477864A (en) 1989-12-21 1995-12-26 Smith & Nephew Richards, Inc. Cardiovascular guidewire of enhanced biocompatibility
US5491224A (en) 1990-09-20 1996-02-13 Bittner; Michael L. Direct label transaminated DNA probe compositions for chromosome identification and methods for their manufacture
US5190528A (en) 1990-10-19 1993-03-02 Boston University Percutaneous transseptal left atrial cannulation system
US5054492A (en) 1990-12-17 1991-10-08 Cardiovascular Imaging Systems, Inc. Ultrasonic imaging catheter having rotational image correlation
US5108420A (en) 1991-02-01 1992-04-28 Temple University Aperture occlusion device
US5242410A (en) 1991-04-15 1993-09-07 University Of Florida Wireless high flow intravascular sheath introducer and method
US5330496A (en) 1991-05-06 1994-07-19 Alferness Clifton A Vascular catheter assembly for tissue penetration and for cardiac stimulation and methods thereof
US5193546A (en) 1991-05-15 1993-03-16 Alexander Shaknovich Coronary intravascular ultrasound imaging method and apparatus
US5167239A (en) 1991-05-30 1992-12-01 Endomedix Corporation Anchorable guidewire
US5304220A (en) 1991-07-03 1994-04-19 Maginot Thomas J Method and apparatus for implanting a graft prosthesis in the body of a patient
WO1993006792A1 (en) 1991-10-04 1993-04-15 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5325860A (en) 1991-11-08 1994-07-05 Mayo Foundation For Medical Education And Research Ultrasonic and interventional catheter and method
US5704361A (en) 1991-11-08 1998-01-06 Mayo Foundation For Medical Education And Research Volumetric image ultrasound transducer underfluid catheter system
US5713363A (en) 1991-11-08 1998-02-03 Mayo Foundation For Medical Education And Research Ultrasound catheter and method for imaging and hemodynamic monitoring
US5661133B1 (en) 1991-11-12 1999-06-01 Univ Michigan Collateral blood vessel formation in cardiac muscle by injecting a dna sequence encoding an angiogenic protein
US5258042A (en) 1991-12-16 1993-11-02 Henry Ford Health System Intravascular hydrogel implant
FR2685208B1 (en) 1991-12-23 1998-02-27 Ela Medical Sa VENTRICULAR CANNULA DEVICE.
DE69334196T2 (en) 1992-01-21 2009-01-02 Regents Of The University Of Minnesota, Minneapolis Closure device of a septal defect
US5295959A (en) * 1992-03-13 1994-03-22 Medtronic, Inc. Autoperfusion dilatation catheter having a bonded channel
US5571166A (en) 1992-03-19 1996-11-05 Medtronic, Inc. Method of making an intraluminal stent
US5201757A (en) 1992-04-03 1993-04-13 Schneider (Usa) Inc. Medial region deployment of radially self-expanding stents
US5395331A (en) 1992-04-27 1995-03-07 Minnesota Mining And Manufacturing Company Retrograde coronary sinus catheter having a ribbed balloon
US5599300A (en) 1992-05-11 1997-02-04 Arrow Precision Products, Inc. Method for electrosurgically obtaining access to the biliary tree with an adjustably positionable needle-knife
US5507724A (en) 1992-07-01 1996-04-16 Genetronics, Inc. Electroporation and iontophoresis apparatus and method for insertion of drugs and genes into cells
US5538504A (en) 1992-07-14 1996-07-23 Scimed Life Systems, Inc. Intra-extravascular drug delivery catheter and method
US5383460A (en) 1992-10-05 1995-01-24 Cardiovascular Imaging Systems, Inc. Method and apparatus for ultrasound imaging and atherectomy
DE4235506A1 (en) 1992-10-21 1994-04-28 Bavaria Med Tech Drug injection catheter
US5287861A (en) 1992-10-30 1994-02-22 Wilk Peter J Coronary artery by-pass method and associated catheter
US5336178A (en) 1992-11-02 1994-08-09 Localmed, Inc. Intravascular catheter with infusion array
US5807306A (en) 1992-11-09 1998-09-15 Cortrak Medical, Inc. Polymer matrix drug delivery apparatus
US5718725A (en) 1992-12-03 1998-02-17 Heartport, Inc. Devices and methods for intracardiac procedures
US5368564A (en) 1992-12-23 1994-11-29 Angeion Corporation Steerable catheter
US5429634A (en) 1993-09-09 1995-07-04 Pdt Systems Biogenic implant for drug delivery and method
US5373849A (en) 1993-01-19 1994-12-20 Cardiovascular Imaging Systems, Inc. Forward viewing imaging catheter
US5728151A (en) 1993-02-22 1998-03-17 Heartport, Inc. Intercostal access devices for less-invasive cardiovascular surgery
US5456284A (en) 1993-05-10 1995-10-10 Applied Medical Resources Corporation Elastomeric valve assembly
US5462523A (en) 1993-05-18 1995-10-31 Target Therapeutics, Inc. Drug delivery system
US5989280A (en) 1993-10-22 1999-11-23 Scimed Lifesystems, Inc Stent delivery apparatus and method
US5445646A (en) 1993-10-22 1995-08-29 Scimed Lifesystems, Inc. Single layer hydraulic sheath stent delivery apparatus and method
JP2833456B2 (en) 1993-11-22 1998-12-09 株式会社東芝 Insertable ultrasound system
US5443497A (en) 1993-11-22 1995-08-22 The Johns Hopkins University Percutaneous prosthetic by-pass graft and method of use
RU2089131C1 (en) 1993-12-28 1997-09-10 Сергей Апполонович Пульнев Stent-expander
DE4401227C2 (en) 1994-01-18 1999-03-18 Ernst Peter Prof Dr M Strecker Endoprosthesis implantable percutaneously in a patient's body
DE4408108A1 (en) 1994-03-10 1995-09-14 Bavaria Med Tech Catheter for injecting a fluid or a drug
US5431700A (en) 1994-03-30 1995-07-11 Fsi International, Inc. Vertical multi-process bake/chill apparatus
US5464395A (en) 1994-04-05 1995-11-07 Faxon; David P. Catheter for delivering therapeutic and/or diagnostic agents to the tissue surrounding a bodily passageway
US5415636A (en) 1994-04-13 1995-05-16 Schneider (Usa) Inc Dilation-drug delivery catheter
US5445600A (en) 1994-04-29 1995-08-29 Abdulla; Ra-Id Flow control systemic to pulmonary arterial shunt
US5743874A (en) 1994-08-29 1998-04-28 Fischell; Robert E. Integrated catheter for balloon angioplasty and stent delivery
US5843170A (en) 1994-09-02 1998-12-01 Ahn; Sam Seunghae Apparatus and method for performing aneurysm repair
US5571151A (en) 1994-10-25 1996-11-05 Gregory; Kenton W. Method for contemporaneous application of laser energy and localized pharmacologic therapy
WO1996015819A1 (en) 1994-11-23 1996-05-30 Navarre Biomedical, Ltd. Flexible catheter
US5588960A (en) 1994-12-01 1996-12-31 Vidamed, Inc. Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence
US5614204A (en) 1995-01-23 1997-03-25 The Regents Of The University Of California Angiographic vascular occlusion agents and a method for hemostatic occlusion
US5665077A (en) 1995-04-24 1997-09-09 Nitrosci Pharmaceuticals Llc Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis
US5728123A (en) 1995-04-26 1998-03-17 Lemelson; Jerome H. Balloon actuated catheter
US5596990A (en) 1995-06-06 1997-01-28 Yock; Paul Rotational correlation of intravascular ultrasound image with guide catheter position
US5662711A (en) 1995-06-07 1997-09-02 Douglas; William Flow adjustable artery shunt
US5713853A (en) 1995-06-07 1998-02-03 Interventional Innovations Corporation Methods for treating thrombosis
US5827216A (en) 1995-06-07 1998-10-27 Cormedics Corp. Method and apparatus for accessing the pericardial space
US20060024359A1 (en) 1995-06-07 2006-02-02 Walker Jeffrey P Drug delivery system and method
US5693029A (en) 1995-07-10 1997-12-02 World Medical Manufacturing Corporation Pro-cell intra-cavity therapeutic agent delivery device
US5735847A (en) 1995-08-15 1998-04-07 Zomed International, Inc. Multiple antenna ablation apparatus and method with cooling element
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6375615B1 (en) 1995-10-13 2002-04-23 Transvascular, Inc. Tissue penetrating catheters having integral imaging transducers and their methods of use
US5830222A (en) 1995-10-13 1998-11-03 Transvascular, Inc. Device, system and method for intersititial transvascular intervention
US6726677B1 (en) 1995-10-13 2004-04-27 Transvascular, Inc. Stabilized tissue penetrating catheters
ATE275880T1 (en) 1995-10-13 2004-10-15 Transvascular Inc DEVICE FOR BYPASSING ARTERIAL Narrowings AND/OR FOR PERFORMING OTHER TRANSVASCULAR PROCEDURES
US5772629A (en) 1995-10-23 1998-06-30 Localmed, Inc. Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
US5866189A (en) 1996-01-12 1999-02-02 Nestec S.A. Process of modifying texture of food products
AU723785B2 (en) 1996-02-02 2000-09-07 Transvascular, Inc. Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures
IL125417A (en) 1996-02-02 2004-03-28 Transvascular Inc Apparatus for blocking flow through blood vessels
US6709444B1 (en) 1996-02-02 2004-03-23 Transvascular, Inc. Methods for bypassing total or near-total obstructions in arteries or other anatomical conduits
US6579311B1 (en) 1996-02-02 2003-06-17 Transvascular, Inc. Method for interstitial transvascular intervention
US5771895A (en) 1996-02-12 1998-06-30 Slager; Cornelis J. Catheter for obtaining three-dimensional reconstruction of a vascular lumen and wall
US5830224A (en) 1996-03-15 1998-11-03 Beth Israel Deaconess Medical Center Catheter apparatus and methodology for generating a fistula on-demand between closely associated blood vessels at a pre-chosen anatomic site in-vivo
US5810780A (en) 1996-05-10 1998-09-22 Becton Dickinson And Company Multiple cross section needle and elastic plug assembly for a medical device
US5755682A (en) 1996-08-13 1998-05-26 Heartstent Corporation Method and apparatus for performing coronary artery bypass surgery
US6123712A (en) 1996-08-23 2000-09-26 Scimed Life Systems, Inc. Balloon catheter with stent securement means
US5797879A (en) 1996-08-26 1998-08-25 Decampli; William M. Apparatus and methods for providing selectively adjustable blood flow through a vascular graft
US20020029079A1 (en) 1996-10-11 2002-03-07 Transvascular, Inc. Devices for forming and/or maintaining connections between adjacent anatomical conduits
US5843090A (en) 1996-11-05 1998-12-01 Schneider (Usa) Inc. Stent delivery device
US6036702A (en) 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
US5976178A (en) 1996-11-07 1999-11-02 Vascular Science Inc. Medical grafting methods
JP2001503657A (en) 1996-11-08 2001-03-21 ハウザー,ラッセル,エイ. Transcutaneous bypass graft and fixation system
US6019788A (en) 1996-11-08 2000-02-01 Gore Enterprise Holdings, Inc. Vascular shunt graft and junction for same
US20030157187A1 (en) 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
US5724975A (en) 1996-12-12 1998-03-10 Plc Medical Systems, Inc. Ultrasonic detection system for transmyocardial revascularization
US6026814A (en) 1997-03-06 2000-02-22 Scimed Life Systems, Inc. System and method for percutaneous coronary artery bypass
CA2284720C (en) 1997-04-11 2006-09-12 Transvascular, Inc. Methods and apparatus for transmyocardial direct coronary revascularization
US6776792B1 (en) 1997-04-24 2004-08-17 Advanced Cardiovascular Systems Inc. Coated endovascular stent
US5810871A (en) 1997-04-29 1998-09-22 Medtronic, Inc. Stent delivery system
US20040215168A1 (en) 1997-04-30 2004-10-28 Beth Israel Deaconess Medical Center Kit for transvenously accessing the pericardial space via the right atrium
US5836913A (en) 1997-05-02 1998-11-17 Innerdyne, Inc. Device and method for accessing a body cavity
US6056762A (en) 1997-05-22 2000-05-02 Kensey Nash Corporation Anastomosis system and method of use
US6092526A (en) 1997-06-19 2000-07-25 Scimed Life Systems, Inc. Percutaneous chamber-to-artery bypass
US6443158B1 (en) 1997-06-19 2002-09-03 Scimed Life Systems, Inc. Percutaneous coronary artery bypass through a venous vessel
US5938660A (en) 1997-06-27 1999-08-17 Daig Corporation Process and device for the treatment of atrial arrhythmia
US6071292A (en) 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
DE19731021A1 (en) 1997-07-18 1999-01-21 Meyer Joerg In vivo degradable metallic implant
US6095878A (en) 1997-08-21 2000-08-01 7V2 Corporation Adjustable oarlock pin and rigging assembly
US6361545B1 (en) 1997-09-26 2002-03-26 Cardeon Corporation Perfusion filter catheter
US6074416A (en) 1997-10-09 2000-06-13 St. Jude Medical Cardiovascular Group, Inc. Wire connector structures for tubular grafts
US5807258A (en) 1997-10-14 1998-09-15 Cimochowski; George E. Ultrasonic sensors for monitoring the condition of a vascular graft
US6120534A (en) 1997-10-29 2000-09-19 Ruiz; Carlos E. Endoluminal prosthesis having adjustable constriction
AU754067B2 (en) 1997-11-14 2002-11-07 Boston Scientific Limited Multi-sheath delivery catheter
US6217527B1 (en) 1998-09-30 2001-04-17 Lumend, Inc. Methods and apparatus for crossing vascular occlusions
US6081738A (en) 1998-01-15 2000-06-27 Lumend, Inc. Method and apparatus for the guided bypass of coronary occlusions
US6530902B1 (en) 1998-01-23 2003-03-11 Medtronic, Inc. Cannula placement system
US6193734B1 (en) 1998-01-23 2001-02-27 Heartport, Inc. System for performing vascular anastomoses
JP4187411B2 (en) 1998-01-30 2008-11-26 セント ジュード メディカル エーティージー, インコーポレイテッド Device for use in closing a septal defect
US5944738A (en) 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
US6808498B2 (en) 1998-02-13 2004-10-26 Ventrica, Inc. Placing a guide member into a heart chamber through a coronary vessel and delivering devices for placing the coronary vessel in communication with the heart chamber
EP1054641A1 (en) 1998-02-13 2000-11-29 Ventrica Inc. Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
US6102918A (en) 1998-02-18 2000-08-15 Montefiore Hospital And Medical Center Collapsible low-profile vascular graft implantation instrument and method for use thereof
US6325798B1 (en) 1998-02-19 2001-12-04 Curon Medical, Inc. Vacuum-assisted systems and methods for treating sphincters and adjoining tissue regions
US6645201B1 (en) 1998-02-19 2003-11-11 Curon Medical, Inc. Systems and methods for treating dysfunctions in the intestines and rectum
EP0943300A1 (en) 1998-03-17 1999-09-22 Medicorp S.A. Reversible action endoprosthesis delivery device.
US6561998B1 (en) 1998-04-07 2003-05-13 Transvascular, Inc. Transluminal devices, systems and methods for enlarging interstitial penetration tracts
US20050021085A1 (en) 1998-05-11 2005-01-27 Surgical Connections, Inc. Surgical stabilizer devices and methods
US20030060876A1 (en) 2000-09-28 2003-03-27 Amir Loshakove Graft delivery system
EP0966979B1 (en) 1998-06-25 2006-03-08 Biotronik AG Implantable bioresorbable support for the vascular walls, in particular coronary stent
US7335220B2 (en) 2004-11-05 2008-02-26 Access Closure, Inc. Apparatus and methods for sealing a vascular puncture
US6120522A (en) 1998-08-27 2000-09-19 Scimed Life Systems, Inc. Self-expanding stent delivery catheter
EP1112041A1 (en) 1998-09-10 2001-07-04 Percardia, Inc. Tmr shunt
JP2003524444A (en) 1998-09-10 2003-08-19 パーカーディア,インコーポレイティド TMR shunt
US6290728B1 (en) 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit
US6261304B1 (en) 1998-09-10 2001-07-17 Percardia, Inc. Delivery methods for left ventricular conduit
US6196230B1 (en) 1998-09-10 2001-03-06 Percardia, Inc. Stent delivery system and method of use
US6575927B1 (en) 1998-09-25 2003-06-10 The Regents Of The University Of Michigan System and method for determining blood flow rate in a vessel
US6458092B1 (en) 1998-09-30 2002-10-01 C. R. Bard, Inc. Vascular inducing implants
US6152937A (en) 1998-11-06 2000-11-28 St. Jude Medical Cardiovascular Group, Inc. Medical graft connector and methods of making and installing same
US6113612A (en) 1998-11-06 2000-09-05 St. Jude Medical Cardiovascular Group, Inc. Medical anastomosis apparatus
US6475226B1 (en) 1999-02-03 2002-11-05 Scimed Life Systems, Inc. Percutaneous bypass apparatus and method
US6174681B1 (en) 1999-03-05 2001-01-16 Mayo Foundation For Medical Education And Research Method and probe set for detecting cancer
US6613074B1 (en) 1999-03-10 2003-09-02 Cordis Corporation Endovascular aneurysm embolization device
US6315752B1 (en) 1999-03-26 2001-11-13 Scimed Life Systems, Inc. Implantable bypass device
US6248117B1 (en) 1999-04-16 2001-06-19 Vital Access Corp Anastomosis apparatus for use in intraluminally directed vascular anastomosis
US6743244B2 (en) 1999-04-16 2004-06-01 Integrated Vascular Interventional Technologies, L.C. Soft anvil apparatus for cutting anastomosis fenestra
DE19917197C1 (en) 1999-04-16 2000-07-27 Fresenius Medical Care De Gmbh Method to determine blood flow in vessel entrance of haemodialysis unit; involves measuring arterial and venous pressures when vessel entrance is open to allow blood flow and closed to prevent blood flow
US6623494B1 (en) 1999-04-16 2003-09-23 Integrated Vascular Interventional Technologies, L.C. (Ivit, Lc) Methods and systems for intraluminally directed vascular anastomosis
US6712836B1 (en) 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
US6241743B1 (en) 1999-05-13 2001-06-05 Intellicardia, Inc. Anastomosis device and method
US6699256B1 (en) 1999-06-04 2004-03-02 St. Jude Medical Atg, Inc. Medical grafting apparatus and methods
US6692482B2 (en) 1999-06-14 2004-02-17 Scimed Life Systems, Inc. Adjustable length conversion adapter for dilatation catheters
US6280412B1 (en) 1999-06-17 2001-08-28 Scimed Life Systems, Inc. Stent securement by balloon modification
US6387116B1 (en) 1999-06-30 2002-05-14 Pharmasonics, Inc. Methods and kits for the inhibition of hyperplasia in vascular fistulas and grafts
US6086553A (en) 1999-07-01 2000-07-11 Akbik; Mohamad J. Arteriovenous shunt
EP1072282A1 (en) 1999-07-19 2001-01-31 EndoArt S.A. Flow control device
US6458140B2 (en) 1999-07-28 2002-10-01 Vasconnect, Inc. Devices and methods for interconnecting vessels
US7892246B2 (en) 1999-07-28 2011-02-22 Bioconnect Systems, Inc. Devices and methods for interconnecting conduits and closing openings in tissue
US6165185A (en) 1999-07-28 2000-12-26 Vasconnect, Inc. Method for interconnecting vessels in a patient
US6251116B1 (en) 1999-07-28 2001-06-26 Vasconnect, Inc. Device for interconnecting vessels in a patient
US6302892B1 (en) 1999-08-04 2001-10-16 Percardia, Inc. Blood flow conduit delivery system and method of use
US7175644B2 (en) 2001-02-14 2007-02-13 Broncus Technologies, Inc. Devices and methods for maintaining collateral channels in tissue
US7815590B2 (en) 1999-08-05 2010-10-19 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
US7462162B2 (en) 2001-09-04 2008-12-09 Broncus Technologies, Inc. Antiproliferative devices for maintaining patency of surgically created channels in a body organ
US6748484B1 (en) 1999-08-11 2004-06-08 Intel Corporation Match resolution circuit for an associative memory
US6494889B1 (en) 1999-09-01 2002-12-17 Converge Medical, Inc. Additional sutureless anastomosis embodiments
US6702828B2 (en) 1999-09-01 2004-03-09 Converge Medical, Inc. Anastomosis system
US6254631B1 (en) 1999-09-23 2001-07-03 Intratherapeutics, Inc. Stent with enhanced friction
US6915154B1 (en) 1999-09-24 2005-07-05 National Research Council Of Canada Method and apparatus for performing intra-operative angiography
US6638263B1 (en) 1999-10-12 2003-10-28 Durect Corporation Regulation of drug delivery through flow diversion
US6726659B1 (en) 1999-12-09 2004-04-27 John E. Stocking Catheter assembly having a fenestrated dilator
US6736825B2 (en) 1999-12-14 2004-05-18 Integrated Vascular Interventional Technologies, L C (Ivit Lc) Paired expandable anastomosis devices and related methods
US6595941B1 (en) 2000-01-11 2003-07-22 Integrated Vascular Interventional Technologies, L.C. Methods for external treatment of blood
US7118546B2 (en) 2000-01-11 2006-10-10 Integrated Vascular Interventional Technologies, L.C. Apparatus and methods for facilitating repeated vascular access
US6508824B1 (en) 2000-02-18 2003-01-21 Transvascular, Inc. Catheter-based methods for enlarging blood vessels to facilitate the formation of penetration tracts, fistulas and/or blood flow channels
USD581054S1 (en) 2000-03-09 2008-11-18 Invatec S.R.L. Material for an expandable stent
US6468303B1 (en) 2000-03-27 2002-10-22 Aga Medical Corporation Retrievable self expanding shunt
US20010045698A1 (en) 2000-03-30 2001-11-29 Lo Henry Tien Card game
US7056294B2 (en) 2000-04-13 2006-06-06 Ev3 Sunnyvale, Inc Method and apparatus for accessing the left atrial appendage
US8518062B2 (en) 2000-04-29 2013-08-27 Medtronic, Inc. Devices and methods for forming magnetic anastomoses between vessels
AU2001259488A1 (en) 2000-05-05 2001-11-20 The Board Of Trustees Of The Leland Standford Junior University Multilayer stents having enhanced flexibility and hoop strength
US6695878B2 (en) 2000-06-26 2004-02-24 Rex Medical, L.P. Vascular device for valve leaflet apposition
US6464665B1 (en) 2000-07-05 2002-10-15 Richard R. Heuser Catheter apparatus and method for arterializing a vein
US6746426B1 (en) 2000-07-11 2004-06-08 Medtronic Vascular, Inc. Transluminally deliverable vascular blockers and methods for facilitating retrograde flow of arterial blood through veins
US6585762B1 (en) 2000-08-10 2003-07-01 Paul Stanish Arteriovenous grafts and methods of implanting the same
US20080091264A1 (en) 2002-11-26 2008-04-17 Ample Medical, Inc. Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools
US7623926B2 (en) 2000-09-27 2009-11-24 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US6985774B2 (en) 2000-09-27 2006-01-10 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US20070276476A1 (en) 2000-09-29 2007-11-29 Llanos Gerard H Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon
US6616684B1 (en) 2000-10-06 2003-09-09 Myocor, Inc. Endovascular splinting devices and methods
US6776785B1 (en) 2000-10-12 2004-08-17 Cardica, Inc. Implantable superelastic anastomosis device
US6616624B1 (en) 2000-10-30 2003-09-09 Cvrx, Inc. Systems and method for controlling renovascular perfusion
US20040092879A1 (en) 2000-11-06 2004-05-13 Medamicus, Inc. Safety introducer apparatus and method therefor
US6869437B1 (en) 2000-11-13 2005-03-22 Cardica, Inc. Method and system for performing closed-chest bypass
CA2434972C (en) 2001-01-16 2010-06-08 Vascular Therapies, Llc Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US6602241B2 (en) 2001-01-17 2003-08-05 Transvascular, Inc. Methods and apparatus for acute or chronic delivery of substances or apparatus to extravascular treatment sites
US8214015B2 (en) 2001-02-06 2012-07-03 Medtronic Vascular, Inc. In vivo localization and tracking of tissue penetrating catheters using magnetic resonance imaging
US6562066B1 (en) 2001-03-02 2003-05-13 Eric C. Martin Stent for arterialization of the coronary sinus and retrograde perfusion of the myocardium
US7011094B2 (en) 2001-03-02 2006-03-14 Emphasys Medical, Inc. Bronchial flow control devices and methods of use
US20030017150A1 (en) 2001-03-14 2003-01-23 Torphy Theodore J. Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses
EP1246048A1 (en) 2001-03-26 2002-10-02 SAP Aktiengesellschaft Method and computer system for executing functions for objects based on the movement of an input device
US6719804B2 (en) 2001-04-02 2004-04-13 Scimed Life Systems, Inc. Medical stent and related methods
US8091556B2 (en) 2001-04-20 2012-01-10 V-Wave Ltd. Methods and apparatus for reducing localized circulatory system pressure
US6620122B2 (en) 2001-04-26 2003-09-16 Scimed Life Systems, Inc. Gastric pseudocyst drainage and stent delivery system for use therein
US6660034B1 (en) 2001-04-30 2003-12-09 Advanced Cardiovascular Systems, Inc. Stent for increasing blood flow to ischemic tissues and a method of using the same
US20020173803A1 (en) 2001-05-01 2002-11-21 Stephen Ainsworth Self-closing surgical clip for tissue
US7422579B2 (en) 2001-05-01 2008-09-09 St. Jude Medical Cardiology Divison, Inc. Emboli protection devices and related methods of use
US20060293701A1 (en) 2001-05-02 2006-12-28 Medtronic, Inc. Self-closing surgical clip for tissue
US8182527B2 (en) 2001-05-07 2012-05-22 Cordis Corporation Heparin barrier coating for controlled drug release
AU2002259215A1 (en) 2001-05-14 2002-11-25 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US6797083B2 (en) 2001-06-11 2004-09-28 Ev3 Inc. Method of training nitinol wire
US7115136B2 (en) 2001-06-20 2006-10-03 Park Medical Llc Anastomotic device
US6565542B2 (en) 2001-06-22 2003-05-20 Minnesota High-Tech Resources Epidural needle having a distal flare
US6626920B2 (en) 2001-07-05 2003-09-30 Converge Medical, Inc. Distal anastomosis system
US6858035B2 (en) 2001-07-05 2005-02-22 Converge Medical, Inc. Distal anastomosis system
US6972023B2 (en) 2001-07-05 2005-12-06 Converge Medical, Inc. Distal anastomosis system
US6743259B2 (en) 2001-08-03 2004-06-01 Core Medical, Inc. Lung assist apparatus and methods for use
US6629988B2 (en) 2001-08-28 2003-10-07 Ethicon, Inc. Composite staple for completing an anastomosis
US20050060041A1 (en) 2001-09-04 2005-03-17 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
US20030065345A1 (en) 2001-09-28 2003-04-03 Kevin Weadock Anastomosis devices and methods for treating anastomotic sites
US7108701B2 (en) 2001-09-28 2006-09-19 Ethicon, Inc. Drug releasing anastomosis devices and methods for treating anastomotic sites
US7892247B2 (en) 2001-10-03 2011-02-22 Bioconnect Systems, Inc. Devices and methods for interconnecting vessels
US6620202B2 (en) 2001-10-16 2003-09-16 Scimed Life Systems, Inc. Medical stent with variable coil and related methods
JP3754353B2 (en) 2001-11-15 2006-03-08 大同メタル工業株式会社 Sliding member with composite plating film
US7182771B1 (en) 2001-12-20 2007-02-27 Russell A. Houser Vascular couplers, techniques, methods, and accessories
US7025746B2 (en) 2001-12-26 2006-04-11 Yale University Vascular access device
US6893413B2 (en) 2002-01-07 2005-05-17 Eric C. Martin Two-piece stent combination for percutaneous arterialization of the coronary sinus and retrograde perfusion of the myocardium
US7037329B2 (en) 2002-01-07 2006-05-02 Eric C. Martin Bifurcated stent for percutaneous arterialization of the coronary sinus and retrograde perfusion of the myocardium
WO2003061457A2 (en) 2002-01-24 2003-07-31 The Johns Hopkins University Methods and devices for percutaneous and surgical interventions
AU2003212875A1 (en) 2002-01-31 2003-09-02 Battelle Memorial Institute Anastomosis device and method
EP1482864B2 (en) 2002-01-31 2010-08-18 Radi Medical Systems Ab Dissolvable stent
SE0200370D0 (en) 2002-02-08 2002-02-08 Gambro Lundia Ab Method and apparatus for determining access flow
US7008397B2 (en) 2002-02-13 2006-03-07 Percardia, Inc. Cardiac implant and methods
DE10207161B4 (en) 2002-02-20 2004-12-30 Universität Hannover Process for the production of implants
US7004964B2 (en) 2002-02-22 2006-02-28 Scimed Life Systems, Inc. Apparatus and method for deployment of an endoluminal device
US7235095B2 (en) 2002-02-22 2007-06-26 Scimed Life Systems, Inc. Method and system for deploying multi-part endoluminal devices
US7002491B2 (en) 2002-05-02 2006-02-21 Microsoft Corporation System and method for filtering far east languages
US20030225425A1 (en) 2002-06-03 2003-12-04 David Kupiecki Devices and methods for interconnecting vessels
US20070083258A1 (en) 2005-10-06 2007-04-12 Robert Falotico Intraluminal device and therapeutic agent combination for treating aneurysmal disease
US6979351B2 (en) 2002-08-02 2005-12-27 Potencia Medical Ag Implantable ceramic valve pump assembly
US20040087997A1 (en) 2002-08-09 2004-05-06 Theracardia, Inc. Medical devices incorporating elastically deformable SIM elements
MXPA05001845A (en) 2002-08-15 2005-11-17 Gmp Cardiac Care Inc Stent-graft with rails.
CA2497042A1 (en) 2002-08-29 2004-03-11 Md3 Technologies Llc Implantable devices for controlling the internal circumference of an anatomic orifice or lumen
US7972346B2 (en) 2002-09-04 2011-07-05 Allergan Medical S.A. Telemetrically controlled band for regulating functioning of a body organ or duct, and methods of making, implantation and use
US7351247B2 (en) 2002-09-04 2008-04-01 Bioconnect Systems, Inc. Devices and methods for interconnecting body conduits
US7361181B2 (en) 2002-10-04 2008-04-22 St. Jude Medical Atg, Inc. Apparatus and methods for creating anastomoses
US8221495B2 (en) 2002-11-07 2012-07-17 Abbott Laboratories Integration of therapeutic agent into a bioerodible medical device
US6928313B2 (en) 2003-01-27 2005-08-09 Cardiac Pacemakers, Inc. System and method for accessing the coronary sinus to facilitate insertion of pacing leads
US20050107723A1 (en) 2003-02-15 2005-05-19 Wehman Thomas C. Methods and apparatus for determining work performed by an individual from measured physiological parameters
IL154531A (en) 2003-02-19 2006-04-10 Yair Tal Device and method for regulating blood flow
JP2006520244A (en) 2003-03-13 2006-09-07 メドトロニック バスキュラー インコーポレイテッド Light-guided penetrating catheter and method of use thereof
WO2004087236A2 (en) 2003-03-28 2004-10-14 Board Of Regents, The University Of Texas System Stents and methods for creating an anastomosis
WO2004091696A1 (en) 2003-04-08 2004-10-28 The Board Of Trustees Of The Leland Stanford Junior University Implantable arteriovenous shunt device
US7967769B2 (en) 2003-04-08 2011-06-28 Rox Medical Inc. Implantable arterio-venous shunt devices and methods for their use
US20040215220A1 (en) 2003-04-24 2004-10-28 Dolan Mark J. Anastomotic stent, apparatus and methods of use thereof
US7530963B2 (en) 2003-04-24 2009-05-12 Wisconsin Alumni Research Foundation Method of maintaining patency of opening in third ventricle floor
US20040215323A1 (en) 2003-04-24 2004-10-28 Medtronic Ave, Inc. Membrane eyelet
US7655022B2 (en) * 2003-04-28 2010-02-02 Cardiac Pacemakers, Inc. Compliant guiding catheter sheath system
JP2006525855A (en) 2003-05-23 2006-11-16 アンジオテック インターナショナル アクツィエン ゲゼルシャフト Anastomosis joining device
US7025741B2 (en) 2003-06-06 2006-04-11 Creativasc Medical Llc Arteriovenous access valve system and process
US7316706B2 (en) 2003-06-20 2008-01-08 Medtronic Vascular, Inc. Tensioning device, system, and method for treating mitral valve regurgitation
US8052751B2 (en) 2003-07-02 2011-11-08 Flexcor, Inc. Annuloplasty rings for repairing cardiac valves
US8308682B2 (en) 2003-07-18 2012-11-13 Broncus Medical Inc. Devices for maintaining patency of surgically created channels in tissue
US7317951B2 (en) 2003-07-25 2008-01-08 Integrated Sensing Systems, Inc. Anchor for medical implant placement and method of manufacture
US20050038501A1 (en) 2003-08-12 2005-02-17 Moore James E. Dynamic stent
US20060258980A1 (en) * 2003-09-19 2006-11-16 The Trustees Of The University Of Pennsylvania Global myocardial perfusion catheter
US20050075656A1 (en) 2003-09-30 2005-04-07 Jean Beaupre Applier for a surgical device
US20050119676A1 (en) 2003-09-30 2005-06-02 Bumbalough Timothy R. Applier having automated release of surgical device
US20050137614A1 (en) 2003-10-08 2005-06-23 Porter Christopher H. System and method for connecting implanted conduits
US20050113631A1 (en) 2003-11-12 2005-05-26 Bolling Steven F. Cannulae having a redirecting tip
WO2005049113A1 (en) 2003-11-20 2005-06-02 Gambro Lundia Ab Method, apparatus and software program for measurement of a parameter relating to a heart-lung system of a mammal.
US20050165344A1 (en) 2003-11-26 2005-07-28 Dobak John D.Iii Method and apparatus for treating heart failure
US7318804B2 (en) 2003-12-09 2008-01-15 The Regents Of The University Of Michigan Methods and systems for measuring mechanical property of a vascular wall and method and system for determining health of a vascular structure
US20050249776A1 (en) 2003-12-19 2005-11-10 Chen Chao C Coated aneurysmal repair device
US20050149096A1 (en) 2003-12-23 2005-07-07 Hilal Said S. Catheter with conduit traversing tip
EP1771132B1 (en) 2004-02-03 2019-03-27 V-Wave Ltd. Device and method for controlling in-vivo pressure
US8282591B2 (en) 2004-03-29 2012-10-09 Iftikhar Khan Hybrid arteriovenous shunt
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US20090187116A1 (en) 2004-04-05 2009-07-23 Yasuharu Noishiki Method for harvesting bone marrow and its medical apparatus
JP4643328B2 (en) 2004-04-07 2011-03-02 オリンパス株式会社 Medical ligature suturing device
US20160022293A1 (en) 2004-04-15 2016-01-28 Genesis Technologies Llc Medical device and method
AU2005253930B2 (en) 2004-05-11 2011-04-28 Oregon Health And Science University Interfacial stent and method of maintaining patency of surgical fenestrations
EP1766476B1 (en) 2004-05-25 2013-11-06 United States Endoscopy Group, Inc. Snare injection device
US20050278013A1 (en) 2004-05-26 2005-12-15 Matthew Rust Method for endovascular bypass stent graft delivery
EP1604697A1 (en) 2004-06-09 2005-12-14 J.A.C.C. GmbH Implantable device
JP5178194B2 (en) 2004-06-14 2013-04-10 ロックス メディカル, インコーポレイテッド Devices, systems, and methods for arterio-venous fistula generation
US8409167B2 (en) 2004-07-19 2013-04-02 Broncus Medical Inc Devices for delivering substances through an extra-anatomic opening created in an airway
ATE368592T1 (en) 2004-08-10 2007-08-15 Volkswagen Ag VOICE ASSISTANCE SYSTEM FOR A MOTOR VEHICLE
WO2006016351A2 (en) 2004-08-12 2006-02-16 Neovasc Medical Ltd. Drug delivery in the coronary sinus
US9706997B2 (en) 2004-08-27 2017-07-18 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US20060047337A1 (en) 2004-08-27 2006-03-02 Brenneman Rodney A Device and method for establishing an artificial arterio-venous fistula
US7828814B2 (en) 2004-08-27 2010-11-09 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US8926545B2 (en) 2004-08-27 2015-01-06 Rox Medical, Inc. Device and method for establishing an artificial arterio-venous fistula
US8029470B2 (en) 2004-09-30 2011-10-04 Pacesetter, Inc. Transmembrane access systems and methods
US20060111704A1 (en) 2004-11-22 2006-05-25 Rox Medical, Inc. Devices, systems, and methods for energy assisted arterio-venous fistula creation
JP4950900B2 (en) 2004-11-29 2012-06-13 グラニット メディカル イノヴェーションズ, リミティッド ライアビリティ カンパニー Rotating fine needle for core tissue sampling
EP1827527B1 (en) 2004-12-06 2016-08-24 Cook Incorporated Inflatable occlusion devices, methods, and systems
US8226592B2 (en) 2004-12-15 2012-07-24 Rox Medical, Inc. Method of treating COPD with artificial arterio-venous fistula and flow mediating systems
US20060130591A1 (en) 2004-12-21 2006-06-22 Perkins, Corban Enterprises Venous needle dislodgement sensor
US7255747B2 (en) 2004-12-22 2007-08-14 Sokudo Co., Ltd. Coat/develop module with independent stations
US7651306B2 (en) 2004-12-22 2010-01-26 Applied Materials, Inc. Cartesian robot cluster tool architecture
US7699863B2 (en) 2005-03-01 2010-04-20 Tulip Medical Ltd. Bioerodible self-deployable intragastric implants
US20060198869A1 (en) 2005-03-03 2006-09-07 Icon Medical Corp. Bioabsorable medical devices
EP2366422A1 (en) 2005-03-30 2011-09-21 Access Scientific, Inc. Vascular access device
US20100106171A1 (en) 2005-05-06 2010-04-29 Johns Hopkins University Transcaval mesenteric venous anastomosis and access system
US7896891B2 (en) 2005-05-20 2011-03-01 Neotract, Inc. Apparatus and method for manipulating or retracting tissue and anatomical structure
US20060271196A1 (en) 2005-05-26 2006-11-30 Saal Jeffrey A Spinal disc annulus augmentation
WO2006130755A2 (en) 2005-06-01 2006-12-07 William A. Cook Australia Pty. Ltd. Side branch stent graft
EP1898811B1 (en) 2005-06-30 2019-03-06 Rox Medical, Inc. Devices and systems for creation of a peripherally located fistula
EP1912592A4 (en) 2005-07-26 2016-01-06 Rox Medical Inc DEVICES, SYSTEMS AND METHODS FOR ARTERIOVINOUS FISTULA CREATION
US7846179B2 (en) 2005-09-01 2010-12-07 Ovalis, Inc. Suture-based systems and methods for treating septal defects
US7563277B2 (en) 2005-10-24 2009-07-21 Cook Incorporated Removable covering for implantable frame projections
US8784860B2 (en) 2005-10-27 2014-07-22 Cordis Corporation Local administration of a combination of rapamycin and cilostazol for the treatment of vascular disease
US20070173787A1 (en) 2005-11-01 2007-07-26 Huang Mark C T Thin-film nitinol based drug eluting stent
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
WO2007083288A2 (en) 2006-01-23 2007-07-26 Atria Medical Inc. Heart anchor device
US7374567B2 (en) 2006-01-25 2008-05-20 Heuser Richard R Catheter system for connecting adjacent blood vessels
US20080161904A1 (en) 2006-01-25 2008-07-03 Heuser Richard R Connection of adjacent blood vessels
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US7964210B2 (en) 2006-03-31 2011-06-21 Abbott Cardiovascular Systems Inc. Degradable polymeric implantable medical devices with a continuous phase and discrete phase
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
SE530213C2 (en) 2006-04-21 2008-04-01 Carponovum Ab Device and method of anastomosis
US7951194B2 (en) 2006-05-26 2011-05-31 Abbott Cardiovascular Sysetms Inc. Bioabsorbable stent with radiopaque coating
US7722665B2 (en) 2006-07-07 2010-05-25 Graft Technologies, Inc. System and method for providing a graft in a vascular environment
US7794495B2 (en) 2006-07-17 2010-09-14 Advanced Cardiovascular Systems, Inc. Controlled degradation of stents
US8506984B2 (en) 2006-07-26 2013-08-13 Cordis Corporation Therapeutic agent elution control process
US7923022B2 (en) 2006-09-13 2011-04-12 Advanced Cardiovascular Systems, Inc. Degradable polymeric implantable medical devices with continuous phase and discrete phase
JP2010503491A (en) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド Bioerodible endoprosthesis with biologically stable inorganic layers
ATE517590T1 (en) 2006-09-15 2011-08-15 Boston Scient Ltd BIOLOGICALLY ERODABLE ENDOPROTHESES
WO2008036548A2 (en) 2006-09-18 2008-03-27 Boston Scientific Limited Endoprostheses
CA2664557C (en) 2006-11-07 2015-05-26 Corvia Medical, Inc. Devices and methods for the treatment of heart failure
US10413284B2 (en) 2006-11-07 2019-09-17 Corvia Medical, Inc. Atrial pressure regulation with control, sensing, monitoring and therapy delivery
US9232997B2 (en) 2006-11-07 2016-01-12 Corvia Medical, Inc. Devices and methods for retrievable intra-atrial implants
US8460372B2 (en) 2006-11-07 2013-06-11 Dc Devices, Inc. Prosthesis for reducing intra-cardiac pressure having an embolic filter
US20080109069A1 (en) 2006-11-07 2008-05-08 Coleman James E Blood perfusion graft
US20110257723A1 (en) 2006-11-07 2011-10-20 Dc Devices, Inc. Devices and methods for coronary sinus pressure relief
WO2008079828A2 (en) 2006-12-20 2008-07-03 Onset Medical Corporation Expandable trans-septal sheath
US20080234842A1 (en) 2007-03-21 2008-09-25 Microsoft Corporation Microphones as contact sensors for device control
WO2008134651A2 (en) 2007-04-27 2008-11-06 St. Jude Medical, Atrial Fibrillation Division, Inc. Apparatus and method for positioning and retention of catheter
JP2010535073A (en) 2007-08-02 2010-11-18 バイオコネクト システムズ Embedded flow connector
KR100876516B1 (en) 2007-08-29 2008-12-31 대구 손 Absorbent Vascular Anastomosis Device
US8376979B2 (en) 2007-09-25 2013-02-19 The Cleveland Clinic Foundation Method and apparatus of a cardiac fluid flow path
US20090082803A1 (en) 2007-09-26 2009-03-26 Aga Medical Corporation Braided vascular devices having no end clamps
US9414842B2 (en) 2007-10-12 2016-08-16 St. Jude Medical, Cardiology Division, Inc. Multi-component vascular device
US8500697B2 (en) 2007-10-19 2013-08-06 Pressure Products Medical Supplies, Inc. Transseptal guidewire
US20090125097A1 (en) 2007-11-13 2009-05-14 Medtronic Vascular, Inc. Device and Method for Stent Graft Fenestration in Situ
US20090143760A1 (en) 2007-11-30 2009-06-04 Jacques Van Dam Methods, Devices, Kits and Systems for Defunctionalizing the Gallbladder
US9439746B2 (en) 2007-12-13 2016-09-13 Insightra Medical, Inc. Methods and apparatus for treating ventral wall hernia
EP2249716B1 (en) 2008-03-14 2012-09-26 Applied Medical Resources Corporation Instrument seal
US10456259B2 (en) 2008-04-16 2019-10-29 Heart Repair Technologies, Inc. Transvalvular intraannular band for mitral valve repair
US20090281379A1 (en) 2008-05-12 2009-11-12 Xlumena, Inc. System and method for transluminal access
USD612499S1 (en) 2008-06-13 2010-03-23 Ella-Cs, S.R.O. Braided stent
US8591460B2 (en) 2008-06-13 2013-11-26 Cardiosolutions, Inc. Steerable catheter and dilator and system and method for implanting a heart implant
US20100030321A1 (en) 2008-07-29 2010-02-04 Aga Medical Corporation Medical device including corrugated braid and associated method
US8247191B2 (en) 2008-11-13 2012-08-21 Ritzen Kalle Disposable cassette and method of use for blood analysis on blood analyzer
US20100217382A1 (en) 2009-02-25 2010-08-26 Edwards Lifesciences Mitral valve replacement with atrial anchoring
EP2416734A1 (en) 2009-04-02 2012-02-15 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Stent graft fenestration
US9044588B2 (en) 2009-04-16 2015-06-02 Cochlear Limited Reference electrode apparatus and method for neurostimulation implants
WO2010128501A1 (en) 2009-05-04 2010-11-11 V-Wave Ltd. Device and method for regulating pressure in a heart chamber
US10076403B1 (en) 2009-05-04 2018-09-18 V-Wave Ltd. Shunt for redistributing atrial blood volume
US12186176B2 (en) 2009-05-04 2025-01-07 V-Wave Ltd. Shunt for redistributing atrial blood volume
US12453626B2 (en) 2009-05-04 2025-10-28 V-Wave Ltd. Shunt for redistributing atrial blood volume
US9034034B2 (en) 2010-12-22 2015-05-19 V-Wave Ltd. Devices for reducing left atrial pressure, and methods of making and using same
EP2434961B1 (en) 2009-05-29 2015-01-14 Xlumena, Inc. Apparatus and method for deploying stent across adjacent tissue layers
EP2473123B1 (en) 2009-09-03 2019-01-30 Boston Scientific Limited Lancet micro-catheter
US20220313234A1 (en) 2009-09-04 2022-10-06 Corvia Medical, Inc. Intra-atrial implants made of non-braided material
US9757107B2 (en) 2009-09-04 2017-09-12 Corvia Medical, Inc. Methods and devices for intra-atrial shunts having adjustable sizes
US12426789B2 (en) 2009-09-23 2025-09-30 Lightlab Imaging, Inc. Blood vessel lumen morphology and minimum lumen area measurements data collection by intravascular imaging systems for stenosis or stent planning
US20110096036A1 (en) 2009-10-23 2011-04-28 Mcintosh Jason Method and device for an acoustic sensor switch
US20110251482A1 (en) 2009-10-29 2011-10-13 Rox Medical, Inc. Devices, systems and methods for enhanced visualization of the anatomy of a patient
US20110184504A1 (en) 2010-01-22 2011-07-28 Medtronic Vascular, Inc. Methods and Apparatus for Providing an Arteriovenous Fistula
JP5730909B2 (en) 2010-01-29 2015-06-10 ディーシー ディヴァイシーズ インコーポレイテッド Device and system for treating heart failure
US9277995B2 (en) 2010-01-29 2016-03-08 Corvia Medical, Inc. Devices and methods for reducing venous pressure
WO2011100568A1 (en) 2010-02-11 2011-08-18 Circulite, Inc. Cannula lined with tissue in-growth material and method of using the same
US8951229B2 (en) 2010-02-22 2015-02-10 Boston Scientific Limited Pressure actuated catheter seal and method for the same
WO2011106547A2 (en) 2010-02-26 2011-09-01 Silk Road Medical, Inc. Systems and methods for transcatheter aortic valve treatment
WO2012018917A1 (en) 2010-08-03 2012-02-09 World Heart Corporation Conformal cannula device and related methods
US9463269B2 (en) 2010-09-10 2016-10-11 W. L. Gore & Associates, Inc. Anastomotic devices and methods
US9872981B2 (en) 2010-09-28 2018-01-23 Biotrace Medical, Inc. Device and method for positioning an electrode in a body cavity
US9655666B2 (en) 2010-10-29 2017-05-23 Medtronic Ablatio Frontiers LLC Catheter with coronary sinus ostium anchor
US9198756B2 (en) 2010-11-18 2015-12-01 Pavilion Medical Innovations, Llc Tissue restraining devices and methods of use
AU2012214279A1 (en) 2011-02-10 2013-08-22 Corvia Medical, Inc. Apparatus and methods to create and maintain an intra-atrial pressure relief opening
USD665500S1 (en) 2011-04-15 2012-08-14 Novostent Corporation Stent
CN102793577A (en) 2011-05-27 2012-11-28 心诺普医疗技术(北京)有限公司 Pericardium puncture needle assembly
US8920449B2 (en) 2011-06-29 2014-12-30 Cordis Corporation System and method for re-entering a vessel lumen
US9042571B2 (en) 2011-07-19 2015-05-26 Dolby Laboratories Licensing Corporation Method and system for touch gesture detection in response to microphone output
US9629715B2 (en) 2011-07-28 2017-04-25 V-Wave Ltd. Devices for reducing left atrial pressure having biodegradable constriction, and methods of making and using same
US11135054B2 (en) 2011-07-28 2021-10-05 V-Wave Ltd. Interatrial shunts having biodegradable material, and methods of making and using same
IN2014CN04089A (en) 2011-11-04 2015-07-10 Caymus Medical Inc
US20130178784A1 (en) 2011-12-22 2013-07-11 Dc Devices, Inc. Methods and devices for intra-atrial shunts having adjustable sizes
US9474884B2 (en) 2012-01-13 2016-10-25 Teleflex Medical Incorporated Bumped dilator tip
US9005155B2 (en) 2012-02-03 2015-04-14 Dc Devices, Inc. Devices and methods for treating heart failure
KR101968885B1 (en) 2012-03-16 2019-04-15 테루모 코퍼레이션 Stent and stent delivery device
US20130253342A1 (en) 2012-03-26 2013-09-26 Medtronic, Inc. Pass-through implantable medical device delivery catheter
US9067050B2 (en) * 2012-03-30 2015-06-30 Medtronic Vascular, Inc. Arteriovenous shunt having a flow control mechanism
US10588611B2 (en) 2012-04-19 2020-03-17 Corvia Medical Inc. Implant retention attachment and method of use
USD679015S1 (en) 2012-05-09 2013-03-26 Peter Nakaji Cranial bur hole cover
USD685476S1 (en) 2012-05-25 2013-07-02 Ams Research Corporation Implant
US9649480B2 (en) 2012-07-06 2017-05-16 Corvia Medical, Inc. Devices and methods of treating or ameliorating diastolic heart failure through pulmonary valve intervention
EP2900175A4 (en) 2012-09-28 2015-08-19 Rox Medical Inc Methods, systems and devices for treating hypertension
US9339927B2 (en) 2012-12-29 2016-05-17 Chervon (Hk) Limited Accessory clamping mechanism and power tool having the same
US20140203939A1 (en) 2013-01-21 2014-07-24 Rtc Inc. Control and monitoring of light-emitting-diode (led) bulbs
US10565835B2 (en) 2013-01-21 2020-02-18 Rtc Inc. Control and monitoring of light-emitting-diode (LED) bulbs
US10448953B2 (en) 2013-01-23 2019-10-22 Rox Medical, Inc. Methods, systems and devices for treating cardiac arrhythmias
US20140222040A1 (en) 2013-02-01 2014-08-07 Jin S. Park Method and Device for Connecting a Conduit to a Hollow Organ
US9775636B2 (en) 2013-03-12 2017-10-03 Corvia Medical, Inc. Devices, systems, and methods for treating heart failure
KR20140113832A (en) 2013-03-15 2014-09-25 현대자동차주식회사 Voice transmission starting system and starting method for vehicle
US20140277054A1 (en) 2013-03-15 2014-09-18 Dc Devices, Inc. Devices, systems, and methods for percutaneous trans-septal puncture
CA2902353C (en) 2013-05-13 2019-07-09 Edwards Lifesciences Corporation Aortic occlusion device
CN105555204B (en) 2013-05-21 2018-07-10 V-波有限责任公司 Apparatus for delivering a device for reducing left atrial pressure
JP6742239B2 (en) 2013-07-22 2020-08-19 アトリウム メディカル コーポレーションAtrium Medical Corporation Graft with expandable area
AU353978S (en) 2013-08-16 2014-02-26 Kyoto Medical Planning Co Stent
US20150119796A1 (en) 2013-10-26 2015-04-30 Dc Devices, Inc. Anti-Lockup Thread Attachment Mechanism and Method of Use Thereof
US20150238729A1 (en) 2014-02-24 2015-08-27 Mark Lynn Jenson Cardiac Access Catheter, System, and Method
US10675450B2 (en) 2014-03-12 2020-06-09 Corvia Medical, Inc. Devices and methods for treating heart failure
US11369405B2 (en) 2014-06-13 2022-06-28 InterShunt Technologies, Inc. Method and septostomy device for creating an interatrial aperture
US9814483B2 (en) 2014-06-13 2017-11-14 InterShunt Technologies, Inc. Method and catheter for creating an interatrial aperture
US20160270810A1 (en) 2014-06-13 2016-09-22 InterShunt Technologies, Inc. Method and catheter for creating an interatrial aperture
US12471948B2 (en) 2014-06-13 2025-11-18 InterShunt Technologies, Inc. Method and septostomy device for creating an interatrial aperture
US10993735B2 (en) 2014-06-13 2021-05-04 InterShunt Technologies, Inc. Method and catheter for creating an interatrial aperture
WO2016014821A1 (en) 2014-07-23 2016-01-28 Corvia Medical, Inc. Devices and methods for treating heart failure
US10595999B2 (en) 2014-09-09 2020-03-24 Occlutech Holding Ag Flow regulating device in the heart
ES2676060T3 (en) 2014-09-26 2018-07-16 Nvt Ag Implantable device for the treatment of mitral valve regurgitation
US10932786B2 (en) 2014-11-04 2021-03-02 Corvia Medical, Inc. Devices and methods for treating patent ductus arteriosus
CN104378886A (en) 2014-11-14 2015-02-25 生迪光电科技股份有限公司 Intelligent illumination control system and method
US20160220357A1 (en) 2015-02-04 2016-08-04 Boston Scientific Scimed, Inc. Novel concept to reduce left atrial pressure in systolic and diastolic hf patients to treat pulmonary edema and reduce hospitalization rates
US10426497B2 (en) 2015-07-24 2019-10-01 Route 92 Medical, Inc. Anchoring delivery system and methods
US20160296317A1 (en) 2015-04-09 2016-10-13 Oregon Health & Science University Reducing stent for a transjugular intrahepatic portosystemic shunt
US10940296B2 (en) 2015-05-07 2021-03-09 The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center Temporary interatrial shunts
EP3349687B1 (en) 2015-09-15 2020-09-09 THE UNITED STATES OF AMERICA, represented by the S Devices for effectuating percutaneous glenn and fontan procedures
US9858948B2 (en) 2015-09-29 2018-01-02 Apple Inc. Electronic equipment with ambient noise sensing input circuitry
US9789294B2 (en) * 2015-10-07 2017-10-17 Edwards Lifesciences Corporation Expandable cardiac shunt
WO2017075544A1 (en) 2015-10-30 2017-05-04 Cerevasc, Llc Systems and methods for treating hydrocephalus
US10463477B2 (en) 2015-11-09 2019-11-05 Corvia Medical, Inc. Retrievable devices for treating heart failure
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US10835394B2 (en) 2016-05-31 2020-11-17 V-Wave, Ltd. Systems and methods for making encapsulated hourglass shaped stents
US20170340460A1 (en) 2016-05-31 2017-11-30 V-Wave Ltd. Systems and methods for making encapsulated hourglass shaped stents
US11304698B2 (en) 2016-07-25 2022-04-19 Virender K. Sharma Cardiac shunt device and delivery system
US10154844B2 (en) 2016-07-25 2018-12-18 Virender K. Sharma Magnetic anastomosis device and delivery system
US10925731B2 (en) 2016-12-30 2021-02-23 Pipeline Medical Technologies, Inc. Method and apparatus for transvascular implantation of neo chordae tendinae
CN110402113B (en) 2017-01-11 2023-02-17 维兰德.K.沙马 Cardiac shunt device and delivery system
WO2018132758A1 (en) 2017-01-12 2018-07-19 I-V Access Technology, Inc. Catheter valves
US11395644B2 (en) 2017-02-13 2022-07-26 Gulf Medical Technologies Sinus venosus atrial septal defect treatment device
US11135410B2 (en) 2017-02-26 2021-10-05 Corvia Medical, Inc. Devices and methods for treating heart failure
US11291807B2 (en) 2017-03-03 2022-04-05 V-Wave Ltd. Asymmetric shunt for redistributing atrial blood volume
EP3589238A1 (en) 2017-03-03 2020-01-08 V-Wave Ltd. Shunt for redistributing atrial blood volume
US10850108B2 (en) 2017-03-08 2020-12-01 Pacesetter, Inc. Coronary sinus-anchored sheath for delivery of his bundle pacing lead
US10925756B2 (en) 2017-05-03 2021-02-23 St. Jude Medical, Cardiology Division, Inc. Collapsible medical device having an open lumen
US20220296865A1 (en) 2017-09-01 2022-09-22 Transmural Systems Llc Percutaneous potts shunt devices and related methods
WO2019085841A1 (en) 2017-10-31 2019-05-09 杭州诺生医疗科技有限公司 Atrial septostomy device, atrial septostomy system, operating method for same, and opening-creation method
WO2019109013A1 (en) 2017-11-30 2019-06-06 Alleviant Medical, Inc. Transcatheter device for interatrial anastomosis
US11458287B2 (en) 2018-01-20 2022-10-04 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
US10898698B1 (en) 2020-05-04 2021-01-26 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
EP3740163A1 (en) 2018-01-20 2020-11-25 V-Wave Ltd. Devices and methods for providing passage between heart chambers
GB201805309D0 (en) 2018-03-29 2018-05-16 Imperial Innovations Ltd Method and apparatus
WO2019189079A1 (en) 2018-03-29 2019-10-03 テルモ株式会社 Medical device
JP7357604B2 (en) 2018-03-29 2023-10-06 テルモ株式会社 Medical devices and treatment methods
EP3777740B1 (en) 2018-03-29 2024-10-16 TERUMO Kabushiki Kaisha Medical device
WO2020018699A1 (en) 2018-07-18 2020-01-23 W. L. Gore & Associates, Inc. Medical devices for shunts, occluders, fenestrations and related systems and methods
US20200054867A1 (en) 2018-08-14 2020-02-20 NXT Biomedical System And Method For Treatment Via Bodily Drainage Or Injection
JP7570320B2 (en) 2018-09-19 2024-10-21 エヌエックスティー バイオメディカル,エルエルシー Methods and techniques for forming connections and shunts between cavities and vessels in biological structures - Patents.com
US20200101270A1 (en) 2018-09-24 2020-04-02 Michael Warren Sutherland Pulmonary arterial compliance enhancement and control device
US11426563B2 (en) 2018-12-03 2022-08-30 Nxt Biomedical, Llc Blood pump or balloon cycling and venous occlusion
CN113395931A (en) 2018-12-12 2021-09-14 爱德华兹生命科学公司 Cardiac implant device with integrated pressure sensing
AU2019396622B2 (en) 2018-12-13 2024-11-07 Edwards Lifesciences Corporation Blood oxygenation treatment methods and devices
US20220039671A1 (en) 2019-01-02 2022-02-10 Shifamed Holdings, Llc Multi-transmitter sensor system
EP3920855B1 (en) 2019-02-07 2025-07-23 NXT Biomedical, LLC Rivet shunt
WO2020163659A1 (en) 2019-02-08 2020-08-13 NXT Biomedical Left atrial appendage stasis reduction
US11612385B2 (en) 2019-04-03 2023-03-28 V-Wave Ltd. Systems and methods for delivering implantable devices across an atrial septum
US12226602B2 (en) 2019-04-03 2025-02-18 V-Wave Ltd. Systems for delivering implantable devices across an atrial septum
WO2020215090A1 (en) 2019-04-18 2020-10-22 NXT Biomedical Temporary shunt for post-operative atrial fibrillation
EP3955832B1 (en) 2019-04-18 2026-07-01 Edwards Lifesciences Corporation Transcaval venturi
WO2020219265A1 (en) 2019-04-22 2020-10-29 Edwards Lifesciences Corporation Anchor for transcatheter access into the coronary sinus
WO2020229636A1 (en) 2019-05-14 2020-11-19 Ohalloran Tony A shunting device
WO2020234751A1 (en) 2019-05-20 2020-11-26 V-Wave Ltd. Systems and methods for creating an interatrial shunt
JP2022536362A (en) 2019-06-12 2022-08-15 エドワーズ ライフサイエンシーズ コーポレイション Fluid bypass conduit for left atrial pressure management
US20200391016A1 (en) 2019-06-17 2020-12-17 NXT Biomedical Method For Bypassing Defective Portions Of A Heart
EP3986331A4 (en) 2019-06-18 2023-06-21 Shifamed Holdings, LLC ADJUSTABLE INTERAURICULAR SHUNTS AND RELATED SYSTEMS AND METHODS
EP3991700A4 (en) 2019-06-25 2023-07-12 Hangzhou Noya Medtech Co., Ltd. Atrial septostomy device
JP2022542952A (en) 2019-07-31 2022-10-07 エヌエックスティー バイオメディカル,エルエルシー Methods and devices for establishing connections between adjacent anatomical spaces using magnets
CN122297046A (en) 2019-08-22 2026-06-30 爱德华兹生命科学公司 Puncture needle
US11832805B2 (en) 2019-08-26 2023-12-05 St. Jude Medical, Cardiology Division, Inc. Occluder with access passage and closure thereof
WO2021050589A1 (en) 2019-09-09 2021-03-18 Shifamed Holdings, Llc Adjustable shunts and associated systems and methods
CA3306523A1 (en) 2019-09-13 2026-05-13 Alleviant Medical, Inc. Systems, devices, and methods for forming an anastomosis
WO2021055266A1 (en) 2019-09-19 2021-03-25 Edwards Lifesciences Corporation Low-stress compressible implants
JP7528198B2 (en) 2019-09-19 2024-08-05 エドワーズ ライフサイエンシーズ コーポレイション Transcatheter Needle System
US11039250B2 (en) 2019-09-20 2021-06-15 Peiker Acustic Gmbh System, method, and computer readable storage medium for controlling an in car communication system
CR20220179A (en) 2019-10-28 2022-10-25 Edwards Lifesciences Corp Sensor integration in cardiac implant devices
WO2021091566A1 (en) 2019-11-07 2021-05-14 InterShunt Technologies, Inc. Method and septostomy device for creating an interatrial aperture
CN114727836B (en) 2019-11-14 2026-01-09 爱德华兹生命科学公司 Transcatheter delivery of medical implants
AU2020387211B2 (en) 2019-11-22 2026-07-02 Edwards Lifesciences Corporation Mechanically expandable shunt implant
US20210153776A1 (en) 2019-11-25 2021-05-27 InterShunt Technologies, Inc. Method and device for sizing an interatrial aperture
EP4069345B1 (en) 2019-12-05 2025-11-12 Shifamed Holdings, LLC Implantable shunt systems
US20210177508A1 (en) 2019-12-12 2021-06-17 Avenu Medical, Inc. Devices and methods for the creation of an inter-atrial shunt for the treatment of congestive heart failure
EP4099913A1 (en) 2020-02-03 2022-12-14 St. Jude Medical, Cardiology Division, Inc. Frame and patch design for occluder with access passage
EP4084701A1 (en) 2020-02-11 2022-11-09 Edwards Lifesciences Corporation Shunt systems and methods with tissue growth prevention
US20210369321A1 (en) 2020-04-14 2021-12-02 Medtronic, Inc. Apparatus and system for creating chronically stable atrial shunt
US20230165672A1 (en) 2020-04-16 2023-06-01 Shifamed Holdings, Llc Adjustable interatrial devices, and associated systems and methods
US12599756B2 (en) 2020-05-04 2026-04-14 V-Wave Ltd. Devices with dimensions that can be reduced and increased In Vivo
CA3181885A1 (en) 2020-06-24 2021-12-30 Joseph Passman Pulmonary arterial hypertension catheters
CN115884801A (en) 2020-06-30 2023-03-31 Nxt生物医疗有限责任公司 Rivet docking platform, occluder
KR20230048069A (en) 2020-08-03 2023-04-10 에드워즈 라이프사이언시스 코포레이션 sensor stabilization structure
JP2023542116A (en) 2020-09-15 2023-10-05 エドワーズ ライフサイエンシーズ コーポレイション compression shunt implant
EP4243915A4 (en) 2020-11-12 2024-08-07 Shifamed Holdings, LLC ADJUSTABLE IMPLANTABLE DEVICES AND RELATED METHODS
US20220151784A1 (en) 2020-11-13 2022-05-19 V-Wave Ltd. Interatrial shunt having physiologic sensor
US11234702B1 (en) 2020-11-13 2022-02-01 V-Wave Ltd. Interatrial shunt having physiologic sensor
WO2022133070A1 (en) 2020-12-18 2022-06-23 Edwards Lifesciences Corporation Flexible shunt implants
US20220211380A1 (en) 2021-01-07 2022-07-07 Alleviant Medical, Inc. Systems, devices, and methods for diagnosing amyloidosis
US12527942B2 (en) 2021-02-01 2026-01-20 Edwards Lifesciences Corporation Pulmonary vein shunting
JP2024506875A (en) 2021-02-05 2024-02-15 エドワーズ ライフサイエンシーズ コーポレイション Shunt sensor implant device
CA3208987A1 (en) 2021-02-16 2022-08-25 Edwards Lifesciences Corporation Implant devices with shunt channel sensors
WO2022187560A1 (en) 2021-03-03 2022-09-09 BALCOM, Alexis Percutaneous shunt devices and related methods
EP4529834A3 (en) 2021-03-15 2025-04-16 Edwards Lifesciences Corporation Shunt implant devices with over-channel sensor arms
EP4280939A1 (en) 2021-03-15 2023-11-29 Edwards Lifesciences Corporation Shunt implant devices with offset sensor arms
WO2022232133A1 (en) 2021-04-27 2022-11-03 Edwards Lifesciences Corporation A guidewire delivery catheter with an expandable anchoring mechanism for use in the coronary sinus
IL308303A (en) 2021-05-21 2024-01-01 Edwards Lifesciences Corp Securing a guidewire delivery catheter in the coronary sinus using a mechanically releasing arm
AU2022276422A1 (en) 2021-05-21 2023-11-30 Edwards Lifesciences Corporation Implant-coupled sensors
WO2022251249A1 (en) 2021-05-24 2022-12-01 Medtronic, Inc. Interatrial multi-cuspid valvular shunt
US20220387009A1 (en) 2021-06-04 2022-12-08 V-Wave Ltd. Systems and methods for temporary shunting between heart chambers
EP4358870B1 (en) 2021-06-25 2026-04-01 Edwards Lifesciences Corporation Cardiac shunt delivery system with a stagnation device
WO2023022883A1 (en) 2021-08-18 2023-02-23 Edwards Lifesciences Corporation Hemostasis seal with low pass-through friction force
EP4392110A1 (en) 2021-08-27 2024-07-03 Edwards Lifesciences Corporation Locking mechanism for medical device delivery
US12569296B2 (en) 2021-09-29 2026-03-10 Medtronic Vascular, Inc. Left-atrium-to-coronary-sinus shunt
AU2022381919A1 (en) 2021-11-04 2024-05-16 V-Wave Ltd. Systems for delivering devices for regulating blood pressure across an atrial septum
EP4412535A1 (en) 2021-11-08 2024-08-14 Edwards Lifesciences Corporation Blood vessel connection shunt
CN118401184A (en) 2021-11-08 2024-07-26 爱德华兹生命科学公司 Shunt with offset anchor arm
WO2023154235A1 (en) 2022-02-09 2023-08-17 Edwards Lifesciences Corporation Hollow needle for delivering a guidewire
KR20240144963A (en) 2022-02-14 2024-10-04 에드워즈 라이프사이언시스 코포레이션 Shunt implant device with adjustable barrel
WO2023172435A1 (en) 2022-03-08 2023-09-14 Edwards Lifesciences Corporation Stabilizer systems for medical procedures that maintain sterility of an articulating arm above a sterile barrier
WO2023172436A1 (en) 2022-03-10 2023-09-14 Edwards Lifesciences Corporation Dual frame shunt
EP4482398A1 (en) 2022-04-04 2025-01-01 Edwards Lifesciences Corporation Systems and methods for shunting and device implantation
US11813386B2 (en) 2022-04-14 2023-11-14 V-Wave Ltd. Interatrial shunt with expanded neck region
WO2023239784A1 (en) 2022-06-07 2023-12-14 Edwards Lifesciences Corporation Cardiovascular implant devices with flow conditioners to minimize disruption to and enhance cardiovascular hemodynamics
WO2023239788A2 (en) 2022-06-07 2023-12-14 Edwards Lifesciences Corporation Cardiac shunt device to minimize disruption to and enhance natural flow patterns of blood through the heart
EP4510945A1 (en) 2022-06-07 2025-02-26 Edwards Lifesciences Corporation Cardiovascular shunt devices with flow conditioners to minimize disruption to and enhance cardiovascular hemodynamics

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913600B2 (en) * 1991-07-16 2005-07-05 Heartport, Inc. Endovascular system for arresting the heart
US5669880A (en) * 1993-08-24 1997-09-23 Cordis Corporation Stent delivery system
US6758854B1 (en) * 1997-05-09 2004-07-06 St. Jude Medical Splittable occlusion balloon sheath and process of use
US20040230156A1 (en) * 2003-02-13 2004-11-18 Schreck Stefan Georg Methods and devices for in-situ crosslinking of vascular tissue
US20100298930A1 (en) * 2007-12-02 2010-11-25 Boris Orlov Access to the left atrium and reduction of mitral valve leaflet mobility

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12533500B2 (en) 2019-06-18 2026-01-27 Shifamed Holdings, Llc Adjustable interatrial shunts and associated systems and methods
US12151071B2 (en) 2019-09-09 2024-11-26 Shifamed Holdings, Llc Adjustable shunts and associated systems and methods
US12343487B2 (en) 2019-09-09 2025-07-01 Shifamed Holdings, Llc Adjustable shunts and associated systems and methods
US12440656B2 (en) 2020-04-23 2025-10-14 Shifamed Holdings, Llc Power management for interatrial shunts and associated systems and methods
US11622695B1 (en) 2020-04-23 2023-04-11 Shifamed Holdings, Llc Intracardiac sensors with switchable configurations and associated systems and methods
US12213817B2 (en) 2020-04-23 2025-02-04 Shifamed Holdings, Llc Systems and methods for radiographic monitoring of shunts
US11801369B2 (en) 2020-08-25 2023-10-31 Shifamed Holdings, Llc Adjustable interatrial shunts and associated systems and methods
US12491347B2 (en) 2020-08-25 2025-12-09 Shifamed Holdings, Llc Adjustable interatrial shunts and associated systems and methods
US12661119B2 (en) 2020-10-16 2026-06-23 Shifamed Holdings, Llc Dual purpose inductors for implantable medical devices and associated systems and methods
US12544010B2 (en) 2020-10-28 2026-02-10 Shifamed Holdings, Llc Systems and methods for electrical monitoring of implantable devices
US11857197B2 (en) 2020-11-12 2024-01-02 Shifamed Holdings, Llc Adjustable implantable devices and associated methods
US11633194B2 (en) 2020-11-12 2023-04-25 Shifamed Holdings, Llc Adjustable implantable devices and associated methods
US12090290B2 (en) 2021-03-09 2024-09-17 Shifamed Holdings, Llc Shape memory actuators for adjustable shunting systems, and associated systems and methods
CN117202961A (en) * 2021-04-27 2023-12-08 爱德华兹生命科学公司 Guidewire delivery catheter with expandable anchoring mechanism for coronary sinus
US12661487B2 (en) 2021-06-25 2026-06-23 Shifamed Holdings, Llc Antenna assemblies for medical systems and associated systems and methods
US12569296B2 (en) 2021-09-29 2026-03-10 Medtronic Vascular, Inc. Left-atrium-to-coronary-sinus shunt

Also Published As

Publication number Publication date
US12678191B2 (en) 2026-07-14
US20220039833A1 (en) 2022-02-10

Similar Documents

Publication Publication Date Title
US20220039833A1 (en) Anchor for transcatheter access into the coronary sinus
US12408907B1 (en) Method of reducing left atrial pressure
JP7528198B2 (en) Transcatheter Needle System
US20250288782A1 (en) Method of reducing left atrial pressure
US20220203078A1 (en) Low-stress compressible implants
US20220280760A1 (en) Mechanically expandable shunt implant
US20230338028A1 (en) Flexible shunt implants
US20230218395A1 (en) Compressible shunt implant
US20240424286A1 (en) Minimally invasive medical device delivery

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20724251

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20724251

Country of ref document: EP

Kind code of ref document: A1